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Abstract 
Clonally expanded mitochondrial DNA (mtDNA) point mutations have been shown to cause 
mitochondrial dysfunction in the form of cytochrome c oxidase deficiency (COX deficiency) 
within ageing human colonic epithelium. Currently, there are a lack of robust stem cell 
markers within human colonic epithelium, however the detection of mitochondrial 
dysfunction has been shown to be a useful stem cell lineage marker, enabling the 
investigation of stem cell dynamics within colonic crypts.  
Using the most robust data set of COX deficiency frequency and mtDNA mutation number, a 
computational model that simulates stem cell dynamics within human colonic crypts was 
constructed. In silico stem cell modelling suggests: there are approximately 5 stem cells 
within human colonic crypts, stem cell divisions occur asymmetrically the majority of the 
time, and that infrequent symmetric stem cell division permits niche succession of individual 
stem cell clones. However, the in silico data was unable to match the biological data when a 
model simulating neutral drift stem cell dynamics was used, suggesting a change in stem cell 
biology when mitochondrial dysfunction was present.  
In order to assess the impact of mitochondrial dysfunction within colonic stem cells in vivo,  
a mouse model of mitochondrial dysfunction was crossed with a mouse model enabling the 
visualisation of cells expressing Lgr5 (a well-accepted stem cell marker). Double thymidine 
analogue labelling was used to identify cells traversing through the cell cycle, together with a 
marker of proliferation. This data suggests that stem cells with mitochondrial dysfunction 
have a small but significant increase in cell cycle progression rate compared to normal stem 
cells. When these data were included in the model, a better fit to the biological data was 
achieved. 
These findings suggest that mitochondrial dysfunction does significantly impact on stem cell 
homeostasis. As stem cells with mitochondrial dysfunction are more likely to out-compete 
normal stem cells over time, this may have potential implications for an increased risk of 
cancer propagation within the colon. 
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Chapter 1 Introduction 
1.1 MITOCHONDRIA 
Mitochondria are dynamic organelles within all nucleated mammalian cells. They have a 
number of functions including: adenosine triphosphate (ATP) synthesis, calcium handling 
(Pozzan et al., 2000), iron-sulphur (Fe-S) cluster formation (Rouault and Tong, 2005) and 
apoptosis (Newmeyer and Ferguson-Miller, 2003). Mitochondria are the only extra nuclear 
source of DNA, with mitochondrial DNA encoding integral proteins for ATP synthesis. 
Though mitochondria contain their own DNA, many more proteins are encoded by the 
nuclear DNA that are essential for the mitochondria to carry out their function (Anderson et 
al., 1981). Mitochondria are believed to have evolved from free-living Eubacteria, whereby 
Eubacteria were engulfed by the Archaebacterium, leading to the creation of primitive 
eukaryotic cells (Margulis, 1971). This process is termed endosymbiosis and was thought to 
have manifested due to the increasing atmospheric O2 concentrations present at the time. 
Another explanation for endosymbiosis suggests that the mitochondrion and nucleus were 
formed simultaneously upon the fusion of hydrogen dependent archaebacterium and 
hydrogen producing eubacterium (Martin and Muller, 1998). 
1.2 MITOCHONDRIAL STRUCTURE 
Mitochondria are typically thought of as elongated rod-shaped structures with a double 
plasma membrane. Electron microscopy (EM) studies show that mitochondria measure 
~2.5µm in length and ~0.5µm in diameter and have a highly folded inner membrane, termed 
cristae, all enveloped by an outer membrane (Palade, 1952). This is depicted within Figure 
1.1. 
The outer mitochondrial membrane (OMM) contains high levels of the mitochondrial voltage 
dependent anion channel (VDAC) which allows molecules of up to 10kDa in size through to 
the intermembrane space (Alberts, 2002). The inner mitochondrial membrane (IMM) 
separates the intermembrane space from the mitochondrial matrix. Due to the presence of 
cardiolipin, it is effectively an impermeable barrier, with entry to and exit from the matrix 




dependent on transport proteins, with the exception of O2, CO2, H2O and NH3 which can pass 
freely. The IMM is comprised of the inner boundary membrane (IBM) and the cristae 
membrane (CM) (Frey and Mannella, 2000). The IMM contains a high concentration of 
protein with the CM acting as a scaffold for the respiratory complexes to carry out oxidative 
phosphorylation (OXPHOS), along with providing an environment where a proton 
Figure 1-1 Mitochondrial structure 
Electron micrograph of the mitochondrion organelle (upper panel). Schematic of a 
mitochondrion organelle with labelled structure and compartments. Scale bar represents 
500nm. EM image courtesy of Dr Amy Reeve (Newcastle University) and Dr Eve Simcox 
(Newcastle University). 
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electrochemical gradient can be generated for the synthesis of ATP (Mitchell, 1961; Ardail et 
al., 1990). As the CM is highly folded, this effectively creates a large surface area for 
maximum respiratory complex protein integration for the production of ATP via OXPHOS. 
The mitochondrial matrix contains multiple copies of the mitochondrial genome, along with 
the mtDNA transcription and translation machinery necessary for the expression of 
respiratory chain protein subunits. Furthermore, it is the site of the TCA cycle and fatty acid 
β-oxidation, which are integral intermediary steps necessary for oxidative metabolism. Fe-S 
cluster biogenesis is also carried out within the mitochondrial matrix that is necessary for 
electron shuttling within the respiratory chain complexes. In order to maintain the 
electrochemical gradient for OXPHOS, access to the mitochondrial matrix is highly regulated 
(Alberts, 2002). As the majority of mitochondrial proteins are nuclear encoded, peptides are 
required to traverse the inner and outer mitochondrial membranes before they can perform 
their function. TOM (translocase of the outer membrane) allows peptide transport across the 
outer membrane and TIM (translocase of the inner membrane) allows peptide transport across 
the inner membrane. TOM and TIM recognise targeting sequences that are attached to the N-
terminal of mitochondrial peptides, which are then cleaved and processed further once they 
have entered the mitochondrial matrix (Hawlitschek et al., 1988; Pfanner et al., 1988). 
Adenine nucleotide translocator (ANT) is an extremely abundant transporter within the IMM 
and is responsible for ATP and ADP transport between the matrix and intermembrane space 
(Pfaff and Klingenberg, 1968). 
1.3 MITOCHONDRIAL DYNAMICS 
Live cell imaging has shown that mitochondria are not the simple rod-shaped organelles as 
was classically thought to be the case, but in fact exist as complex dynamic networks that are 
constantly undergoing remodelling via fission and fusion (Bereiter-Hahn, 1978; Nunnari et 
al., 1997). Fission and fusion are thought to be essential for mitochondrial interaction, 
mitochondrial turnover, and efficient ATP generation throughout the cell (Skulachev, 2001). 
1.3.1 Mitochondrial fusion 
The aptly named Mitofusin proteins, Mfn1 and Mfn2 are responsible for the process of 
mitochondrial fusion. They are mammalian outer membrane proteins and are part of the 
Dynamin protein family. They interact via their exposed cytosolic surface between 
hydrophobic heptad repeat regions (HR2), with subsequent GTPase activity inducing 
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conformational changes that result in mitochondrial fusion (Koshiba et al., 2004). Within 
humans, Opa1, in partnership with Mfn1, is responsible for the fusion of the inner 
mitochondrial membrane (Cipolat et al., 2004). 
1.3.2 Mitochondrial fission 
The proteins responsible for mitochondrial fission were identified within yeast cells via 
genetic screens (Bleazard et al., 1999). Unlike fusion of mitochondria, fission requires only 
one Dynamin protein, known as Dmn1 in yeast. The homolog of Dmn1 within mammalian 
cells was found to be Drp1 (Shin et al., 1997). Homologs of Dmn1 are also GTPases and are 
hypothesised to separate mitochondria by forming a ring-like structure, constricting the 
mitochondria to achieve separation (Hoppins et al., 2007). Within yeast, a small outer 
membrane bound protein known as Fis1 is responsible for recruiting Dmn1 (Mozdy et al., 
2000), however, within mammalian cells, mitochondrial fission may not require a Fis1 
homolog as depletion does not significantly alter mitochondrial fission (Otera et al., 2010). 
1.3.3 Mitochondrial biogenesis 
As the energy requirements of the cell fluctuate, mitochondria must rapidly respond to the 
cellular demand to maintain an adequate supply of ATP within the cell at all times. One way 
of increasing ATP concentrations is by increasing mitochondrial mass via mitochondrial 
biogenesis. Peroxisome proliferator activated receptor γ coactivator 1 α (PGC-1α) is the main 
regulator of mitochondrial biogenesis. It initiates the transcription of nuclear encoded 
mitochondrial proteins such as nuclear respiratory factors 1 and 2 (NRF1 and NRF2), 
oestrogen related receptor α (ERRα), forkhead box class-O (FoxO1), and peroxisome 
proliferator activated receptors (PPARs) (Puigserver and Spiegelman, 2003). Expression of 
these proteins leads to the eventual increase in mitochondrial mass. 
Increased PGC-1α expression has been shown to occur within skeletal muscle in response to 
exercise. Exercise within skeletal muscle increases Ca2+ signalling, resulting in 
Ca2+/calmodulin dependent kinase IV (CaMKIV) or calcineurin phosphorylat ing CREB 
(cAMP response element binding protein) binding to the CRE (CREB response element), 
thereby increasing PGC-1α expression (Herzig et al., 2001). Mitochondrial biogenesis is also 
triggered by cold temperatures in brown adipose tissues upon β3 adrenergic receptor 
activation via the sympathetic nervous system as measure of non-shivering thermogenesis, 
which involves proton uncoupling protein UCP-1 (Puigserver et al., 1998). On the other 
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hand, if ATP concentrations within the cell are higher than required, histone acetyltransferase 
(GCN5) has been shown to trigger the down-regulation of PGC-1α (Lerin et al., 2006). 
Furthermore, PGC-1α is insulin sensitive, with insulin triggering the phosphorylation of 
FoxO1 by Akt (protein kinase B), with the subsequent inhibition of PGC1-α. 
1.4 MITOCHONDRIAL FUNCTIONS 
1.4.1 ATP synthesis 
ATP is generated via oxidative phosphorylation (OXPHOS). Respiratory complexes within 
the inner mitochondrial membrane act as electron carriers, transporting electrons from 
intermediary molecules generated from the tricarboxylic acid (TCA) cycle and fatty acid 
oxidation (Hatefi, 1985). Glycolysis generates the initial substrates for aerobic respiration. 
This takes place within the cytoplasm, converting glucose into pyruvate, with the generation 
of 2 ATP molecules (Berg et al., 2011). Glycolysis is shown in its simplest form in Equation 
1-1. 
 
𝑔𝑙𝑢𝑐𝑜𝑠𝑒 + 2𝑁𝐴𝐷++ 2𝐴𝐷𝑃 + 2𝑃𝑖 → 2 𝑝𝑦𝑟𝑢𝑣𝑎𝑡𝑒 + 2𝑁𝐴𝐷𝐻 + 2𝐻
++ 2𝐴𝑇𝑃+ 2𝐻2𝑂 
Equation 1-1 Glycolysis 
 
The resulting pyruvate enters the mitochondrial matrix where pyruvate dehydrogenase 
converts it into acetyl CoA. This is shown in its simplest form in Equation 1-2 (Berg et al., 
2011). 
 
𝑝𝑦𝑟𝑢𝑣𝑎𝑡𝑒 + 𝐶𝑜𝐴+ 𝑁𝐴𝐷+ → 𝑎𝑐𝑒𝑡𝑦𝑙𝐶𝑜𝐴+ 𝑁𝐴𝐷𝐻+ 𝐻++ 𝐶𝑂2 
Equation 1-2 Pyruvate decarboxylation 
 
Acetyl CoA is the main substrate that feeds into the TCA cycle. The TCA cycle is a series of 
enzyme-catalysed reactions within the mitochondrial matrix that produces the electron 
carriers NADH and FADH2, which are essential for OXPHOS. ATP and CO2 are also 
generated from the TCA cycle. The TCA cycle is shown in its simplest form in Equation 1-3 
(Berg et al., 2011). 
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𝑎𝑐𝑒𝑡𝑦𝑙𝐶𝑜𝐴 + 3𝑁𝐴𝐷+ + 𝐹𝐴𝐷 +𝐴𝐷𝑃 + 𝑃𝑖+ 2𝐻2𝑂
→ 𝐶𝑜𝐴+ 3𝑁𝐴𝐷𝐻+ 2𝐻+ +𝐹𝐴𝐷𝐻2 +𝐴𝑇𝑃 + 2𝐶𝑂2  
Equation 1-3 TCA cycle overview 
 
NADH and FADH2 generated from the TCA cycle donate electrons to respiratory chain 
Complexes I and II which are shuttled to Complexes III and IV with the eventual formation 
of molecular oxygen. Shuttling electrons across the respiratory complexes allows the 
transport of protons from the mitochondrial matrix to the intermembrane space, setting up the 
H+ electrochemical potential gradient, allowing Complex V (ATP synthase) to convert ADP 
and Pi into ATP (Berg et al., 2011). This is depicted in Figure 1-2. 
1.4.1.1 Complex I 
Complex I, aka NADH: ubiquinone oxidoreductase, comprises ~39 subunits, 7 of which are 
encoded by the mitochondrial genome (Hirst et al., 2003). Three modules exist within 
Complex I (N, Q and P), each having a different function. Module N is where NADH is 
oxidised, resulting in the release of 2 electrons which are then donated to the flavin 
mononucleotide (FMN) (Walker, 1992). The Q module comprises a chain of Fe-S clusters, 
allowing the electrons to pass through leading to the eventual reduction of ubiquinone (Q) to 
ubiquinol (QH2), adding to the QH2 pool (Sazanov, 2007). It is thought that Module P 
undergoes a conformational change in response to electron shuttling, allowing 4H+ ions to 
flow from the matrix into the intermembrane space (Efremov et al., 2010; Baradaran et al., 
2013). The simple function of Complex I is shown in Equation 1-4. 
 
𝑁𝐴𝐷𝐻 +𝑄 + 5𝐻𝑚𝑎𝑡𝑟𝑖𝑥
+ →  𝑁𝐴𝐷+ 𝑄𝐻2  4𝐻𝑖𝑚𝑠
+  
Equation 1-4 Complex I reaction 
 
1.4.1.2 Complex II 
Complex II, aka Succinate ubiquinone oxidoreductase, comprises 4 subunits, all encoded by 
the nuclear genome. SDHA and SDHB are located within the matrix, containing the catalytic 
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domain, with SDHC and SDHD attaching the whole complex to the inner mitochondrial 
membrane (Hagerhall, 1997). Complex II is part of the TCA cycle as it converts succinate 
into fumarate, with FADH2 generated as a result. FADH2 is oxidised to FAD+ with the 
donated electrons being shuttled via Fe-S clusters leading to the reduction of Q to QH2 
(Hagerhall, 1997). The simple function of Complex II is shown in Equation 1-5. 
 
𝑠𝑢𝑐𝑐𝑖𝑛𝑎𝑡𝑒 + 𝑄 → 𝑓𝑢𝑚𝑎𝑟𝑎𝑡𝑒 +  𝑄𝐻2 
Equation 1-5 Complex II reaction 
1.4.1.3 Complex III 
Complex III, aka Ubiquinol: cytochrome c oxidoreductase, comprises 11 subunits, 1 of which 
is encoded by the mitochondrial genome. Complex III receives electrons from QH2 via haem 
containing cytochromes and the Rieske Fe-S cluster (Xia et al., 1997). The transfer of 
electrons from QH2 is coupled with the translocation of 2H+ from the matrix to the 
intermembrane space (Mitchell, 1976). When QH2 is bound to the Q0 site, two electrons and 
two protons are released. One electron binds the Rieske Fe-S cluster with subsequent 
shuttling to cytochrome c1 and then to cyctochrome c which is released upon reduction. The 
remaining electron is shuttled to cytochrome b and then the haem groups before Q is reduced 
to semiubiquinone (Q-) at the Q1 site. Subsequently, the Q0 site binds another QH2, releasing 
two electrons and two protons. Again, one electron is eventually transferred to cytochrome c, 
however the second electron is used to further reduce Q- to Q (Berg et al., 2011). The Q cycle 
is integral for the shuttling of electrons between respiratory chain complexes. The simple 
function of Complex III is shown in Equation 1-6. 
 
2𝑄𝐻2 +𝑄 +2𝐶𝑦𝑡𝑐𝑜𝑥 + 2𝐻𝑚𝑎𝑡𝑟𝑖𝑥
+ → 2𝑄 + 𝑄𝐻2 + 2𝐶𝑦𝑡𝑐𝑟𝑒𝑑 + 4𝐻𝑖𝑚𝑠
+  
Equation 1-6 Complex III Q cycle 
 
1.4.1.4 Complex IV 
Complex IV, aka Cytochrome c oxidase, comprises 13 subunits, 3 of which are encoded by 
the mitochondrial genome. Complex IV is responsible for the reduction of molecular oxygen 
(O2) into water (H2O). Cytochrome c donates electrons to CuA and then to haem that are then 
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shuttled to haema3 and CuB (Tsukihara et al., 1996; Faxen et al., 2005). There are two stages 
of electron transfer for the formation of H2O and, each stage requires 2 electrons from 2 
cytochrome c molecules. The first stage sees one electron reducing haema3 and the other 
reducing CuB. With O2, a peroxide bridge is established between haema3 and CuB (Faxen et 
al., 2005). The second stage is similar to the first, however the metal groups are bound by 
2H+ ions, therefore electron transfer releases the peroxide bridge and two H2O molecules are 
formed. 4 shuttled electrons results in the translocation of 4H+ and the production of H2O 
(Faxen et al., 2005). The simple function of Complex IV is shown in Equation 1-7. 
 
4𝐶𝑦𝑡𝑐𝑟𝑒𝑑 + 8𝐻
++ 𝑂2 → 4𝐶𝑦𝑡𝑐𝑜𝑥 + 2𝐻2𝑂+ 4𝐻𝑖𝑚𝑠
+  
Equation 1-7 Complex IV reaction 
1.4.1.5 Complex V 
Complex V, aka FoF1 ATP synthase is comprised of 16 subunits, 2 of which are encoded by 
the mitochondrial genome. Its main function is to synthesise ATP using the H+ 
electrochemical potential energy set up by the translocation of H+ ions across the IMM from 
the matrix to the intermembrane space by Complexes I, III and IV. Complex V is comprised 
of two domains, the Fo domain, which is fixed within the membrane, and the F1 domain, 
which is anchored within the matrix (Yoshida et al., 2001). The Fo domain is made up of 8 
hydrophobic c subunits, which form a c ring, allowing protons to pass from the 
intermembrane space back into the matrix. The F1 domain is made up of five subunits in total 
(α, β, γ, δ and ε), with 3α and 3β subunits making up the stationary ring, and the γ, δ and ε 
subunits constituting the rotary stalk (Wittig and Schagger, 2008; Wittig et al., 2008). 
The flow of H+ ions through the Fo domain provides the molecular torque necessary for the c 
ring to rotate about the central stalk. Protonation and deprotonation of glutamate residues 
within c ring subunits result in the conformational changes required to drive the rotation of α 
and β subunits of the F1 domain, allowing the formation of ATP from ADP and Pi (Noji et al., 
1997). One full rotation of the c ring allows 8H+ ions to pass through, with the formation of 3 
ATP molecules (Watt et al., 2010; Berg et al., 2011). 
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1.4.2 Iron-sulphur cluster biogenesis 
Fe-S cluster biogenesis and haem synthesis are carried out within the mitochondrial matrix as 
the majority of intracellular iron contributes towards the electron transport chain, in 
particular, within the assembly of Complexes I and III (Schultz and Chan, 2001; Wang and 
Pantopoulos, 2011). Mitoferrins transport reduced iron (Fe2+) into the mitochondrial matrix 
(Paradkar et al., 2009). Mitochondrial proteins such as Isu1/2, Grx5 and Abcb7 are essential 
for the formation of Fe-S clusters (Wang and Pantopoulos, 2011). Cysteine desulphurase is 
the enzyme that releases sulphide ions from cysteine residues for their integration into Fe-S 
clusters (Tong and Rouault, 2000). There are 12 unique Fe-S clusters which are able to carry 
electrons, contributing to the function of the electron transport chain with their ability to 
switch between Fe2+ and Fe3+ redox states (Schultz and Chan, 2001).  
1.4.3 Apoptosis 
Apoptosis, also known as programmed cell death, can be triggered by either cell surface 
receptors or cell damage mediated pathways. Once apoptosis is triggered, this leads to the 
eventual release of cytochrome c from mitochondria. Once cytochrome c has been released, it 
binds with APAF1 to form an apoptosome, activating caspase-9, resulting in the death of the 
cell (Wang and Youle, 2009). Pro-apoptotic Bcl2 and anti-apoptotic BH3 families of proteins 
are integral for the prevention and regulation of programmed cell death (Willis et al., 2007). 
Bax and Bak are members of the Bcl2 family, and when activated, they locate to the outer 
mitochondrial membrane causing cytochrome c release (Wei et al., 2001). Under normal 
conditions, proteins of the BH3 family inhibit Bcl2 proteins from triggering apoptosis via 
cytochrome c release (Willis et al., 2007). 
1.4.4 ROS production 
Mitochondria are known to be a major source of reactive oxygen species (ROS) within cells, 
primarily at the sites of Complex I and III within the electron transport chain (Turrens and 
Boveris, 1980; Sugioka et al., 1988). Superoxide radicals (O2-) are produced at these sites 
when stray electrons reduce O2 (Starkov, 2008). Loschen and colleagues showed that 
hydrogen peroxide (H2O2) accumulation, which is produced through the reduction of O2- by 
superoxide dismutase II within the mitochondrial matrix (Brand, 2010), was linked to the rate 
of OXPHOS respiration within isolated pigeon heart mitochondria (Loschen et al., 1972). 
ROS cause oxidative stress within cells by damaging macromolecular complexes such as 
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DNA, proteins and lipids. However, ROS have also been shown to be involved in cellular 
signalling pathways, impacting on highly regulated cell functions such as differentiation, 
proliferation, autophagy, senescence and apoptosis (Valko et al., 2007). 
1.4.5 Calcium homeostasis 
Mitochondria act as the intracellular Ca2+ buffers, being able to absorb 1000nmol Ca2+/mg 
mitochondrial mass (Kirichok et al., 2004). Ca2+ concentrations need to be highly regulated 
as Ca2+ can cause perturbations to a variety of cellular functions, including inter-cell 
communication, apoptosis and ATP generation (Duchen, 2000). Ca2+ plays an important role 
at presynaptic terminals; therefore mitochondrial Ca2+ buffering is crucial for the correct 
transmission of nerve impulses (Jacobson and Duchen, 2004; Abramov and Duchen, 2010). 
Exercise has been shown to increase Ca2+ signalling within skeletal muscle cells which 
impacts on the rate of mitochondrial biogenesis as previously described (section 1.3.3) 
(Herzig et al., 2001). It also increases the rate at which intermediary metabolic substrates are 
generated from the TCA cycle and the rate at which ATP is produced through OXPHOS 
(McCormack et al., 1990; Jouaville et al., 1999). 
1.5 MITOCHONDRIAL GENOME 
Mitochondria contain multiple copies of a ~16,569bp circular genome located within the 
mitochondrial matrix. The mitochondrial genome encodes a total of 37 genes, 13 of which 
contribute protein subunits towards the OXPHOS complexes. It also encodes 22 tRNAs and 2 
rRNAs to enable OXPHOS subunit expression (Anderson et al., 1981). The remaining ~77 
proteins required for OXPHOS are encoded by the nuclear genome and are translated within 
the cytosol and imported into the mitochondria; therefore mitochondria have to rely on both 
their own genome and the nuclear genome to carry out their function (Anderson et al., 1981). 
Unlike the nuclear genome, the mitochondrial genome does not contain introns (Anderson et 
al., 1981). Figure 1-3 is a schematic of the mitochondrial genome, indicating the location of 
each gene. 
The number of mtDNA copies that exist within a cell is dependent on the cell type. Female 
germline oocytes contain ~100,000 copies of mtDNA, with approximately 1-2 mtDNA 
molecules present within each mitochondrial organelle (Shoubridge and Wai, 2007). A 
typical somatic cell has been suggested to contain >1000 copies of mtDNA (Lightowlers et 
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al., 1997). However, adult stem cells are postulated to contain ~250 mtDNA molecules due to 
their small size and high nuclear: cytoplasmic ratio (Coller et al., 2001). 
MtDNA content within a cell is linked to energy consumption requirements, therefore cells 
with a high energy demand, such as muscle and nerve cells, will require the most mtDNA 
(Shoubridge and Wai, 2007). Super resolution EM has provided evidence to suggest mtDNA 
cluster as a nucleoprotein complex, which includes proteins necessary for mtDNA 
replication, transcription and translation, for instance, single stranded DNA binding protein, 
twinkle helicase and mitochondrial transcription factor A (Garrido et al., 2003; Wang and 
Bogenhagen, 2006; Brown et al., 2011). 
  





Figure 1-3 The human mitochondrial genome 
Human mtDNA is a ~16.6kb circular molecule with both heavy (outer) and light strands 
(inner) encoding genes. MtDNA encodes 37 genes, 13 protein encoding genes, 2 rRNAs 
and 22 tRNAs. Protein encoding genes include 5 subunits of Complex I (ND1-5), 1 
subunit of Complex III (CytB), 3 subunits of Complex IV (COX1-3), and 2 subunits of 
Complex V (ATPases 6 and 8). Orange circles with letters in represent the 22 encoded 
tRNAs. The only non-coding region is the D-loop, where the origin of heavy strand 
replication (OH) is located. The origin of light strand replication (OL) is also shown. Image 
has been adapted from (Taanman, 1999). 
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1.5.1 MtDNA transcription 
The mitochondrial genome contains three promoter regions that initiate transcription, two 
heavy strand promoter (HSP) regions (H1 and H2) initiate the transcription of the heavy 
strand and one light strand promoter (LSP) initiates the transcription of the light strand. The 
result is a bi-directional transcription of the heavy and light mtDNA strands. The H1 
promoter site transcribes the genes encoding both rRNAs and tRNAPhe and tRNAVal. The H2 
promoter site transcribes almost the remainder of the heavy strand, thereby producing 2 
polycistronic transcripts, one short and one long (Montoya et al., 1982; Chang and Clayton, 
1984; Zollo et al., 2012). The polycistronic transcripts are then processed via RNA 
processing enzymes which target tRNA cloverleaf folds, this is known as the tRNA 
punctuation model (Ojala et al., 1981). Once the RNase processing enzymes have cleaved the 
polycistronic transcript, secondary RNase enzymes cleave the 5’ and 3’ ends of the tRNAs 
(Dubrovsky et al., 2004; Holzmann et al., 2008). 
The mitochondrial transcription machinery is made up of mitochondrial RNA polymerase 
(POLMRT), mitochondrial transcription factor A (TFAM), and mitochondrial transcription 
factor B2 (TFB2M), all of which allow mtDNA transcription to be carried out (Falkenberg et 
al., 2002; Litonin et al., 2010). TFAM is thought to unwind mtDNA promoter regions, 
allowing POLMRT to initiate transcription (Fisher et al., 1992), however there is some 
debate as to how essential TFAM is, with the absence of the yeast homolog of TFAM not 
being required for transcription initiation (Xu and Clayton, 1992). ChIP-seq experiments in 
fact show that TFAM may be much more important in mtDNA packaging for the formation 
of the nucleoprotein complex as it appears to bind the whole of the mitochondrial genome 
(Wang et al., 2013). POLMRT forms a heterodimer with TFB2M in order for transcription to 
occur; with TFB2M stabilising single stranded DNA (ssDNA) formed during unwinding 
before transcription can progress (Falkenberg et al., 2007). Once the mitochondrial 
transcription machinery has transcribed the polycistronic mRNA, mitochondrial termination 
factors are required. There are four proteins that are believed to have roles in the termination 
of mitochondrial transcription (mTERF1-4) (Falkenberg et al., 2007). mTERF1 is believed to 
bend, unwind and melt the DNA duplex followed by base flipping for termination to be 
carried out (Yakubovskaya et al., 2010). mTERF2-4 are not as well understood, however 
mTERF2 is hypothesised to be a positive regulator of transcription, with the binding of 
mTERF3 at the D-loop acting as a transcriptional repressor (Rebelo et al., 2011). 
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1.5.2 MtDNA translation 
Mitochondria are responsible for the translation of their own mitochondrial DNA encoded 
proteins. They have a unique set of 22 tRNAs which have distinct codon:anti-codon pairings 
from those founds within the nucleus, and they also have their own rRNAs (12S and 16S) 
that contribute to the ribosomal translation machinery (Anderson et al., 1981; Bibb et al., 
1981). It is assumed that mtDNA translation is similar to bacterial translation with the three 
main stages being initiation, elongation and termination (Smits et al., 2010). Mammalian 
mitochondrial tRNAs are similar to cytosolic tRNAs as they form the characteristic cloverleaf 
structure with 4 stems and 3 loops (i.e. an acceptor stem, a dihydrouridine stem/loop, a TΨ 
stem/loop and an anticodon stem/loop). The mammalian mitochondrial translation machinery 
(the mitoribosome) consists of: a small 28S subunit, a large 39S subunit and two 
mitochondrial rRNAs (12S and 16S) and is located within the mitochondrial matrix (Smits et 
al., 2010). Mammalian mitoribosomes differ to cytosolic ribosomes in that they have a 
decreased rRNA: protein ratio (Smits et al., 2010). As with most functions of the 
mitochondria, translation still requires nuclear encoded initiation factors such as aminoacyl-
tRNA synthetases and methionyl tRNA transformylase, in addition to elongation and 
termination factors (Smits et al., 2010). 
Translation initiation within mitochondrial genes occurs at AUA and AUU codons within the 
mRNA, which is in contrast to nuclear encoded genes where translation initiation occurs at 
the AUG codon instead, highlighting the differences between cytosolic and mitochondrial 
translation systems (Anderson et al., 1981). Translation termination within mitochondrial 
genes occurs at UAA and UAG codons within the mRNA which is recognised by the 
mitochondrial termination factor 1a (mtRF1a), triggering the release of the peptide chain and 
the mRNA from the ribosome (Barrell et al., 1980; Anderson et al., 1981). It has previously 
been reported that mtRF1a is sufficient for the termination of all 13 ORFs within mammalian 
mitochondria (Temperley et al., 2010). Evidence suggests that ribosome stalling at AGA or 
AGG triplets, due to the absence of tRNAs that recognise these codons, leads to a -1 
frameshift that promotes non-canonical translation termination, allowing the synthesis of all 
13 polypeptides for integration into the OXPHOS complexes (Temperley et al., 2010). 
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1.5.3 MtDNA replication 
1.5.3.1 MtDNA replication machinery 
Mitochondrial DNA replication requires the expression of the replication machinery from the 
nuclear genome. The replication machinery is made up of mtDNA polymerase γ (Polγ), 
single stranded DNA binding protein (mtSSB), and the mitochondrial TWINKLE DNA 
helicase (Falkenberg et al., 2007). Replication is orchestrated from the D-loop located at the 
origin of heavy strand replication (OH). Polγ is the mitochondrial DNA polymerase and 
comprises the 140kDa catalytic PolγA domain and the 55kDa accessory subunit PolγB 
domain, forming a heterodimer (PolγAB2) that performs the replication of mtDNA as shown 
in Figure 1-4 (Gray and Wong, 1992; Yakubovskaya et al., 2006). The catalytic domain 
(PolγA) also has 3’-5’ exonuclease activity, thereby providing a replication proofreading 
function (Pinz and Bogenhagen, 1998; Kaguni, 2004). The accessory subunit domain (PolγB) 
binds double stranded mtDNA, enhancing the catalytic activity of PolγA (Kaguni, 2004). 
RNA primers are provided by POLRMT in order for replication to be initiated at the origin of 
replication sites for both the heavy (OH) and the light (OL) strands (Shadel and Clayton, 
1997). 
TWINKLE is responsible for the ATP dependent unwinding of mtDNA ahead of Polγ in the 
5’ to 3’ direction as can be seen in Figure 1-4 (Korhonen et al., 2003). Once unwound, a 
~14kDa single stranded DNA binding protein (mtSSB) stabilises the single stranded DNA for 
uninterrupted replication, increasing the processivity of Polγ (Kaguni, 2004). Even though 
Polγ, TWINKLE and mtSSB form the essential apparatus for mtDNA replication, other 
proteins are involved, for instance, Ribonuclease H1, which removes primers from the origin 
of replication sites (Cerritelli et al., 2003), and also mitochondrial topoisomerase (TOP1mt) 
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which reduces the torsional force that is created during replication (Zhang et al., 2001). 
 
 
1.5.3.2 MtDNA replication models 
There are two models of mtDNA replication that have been proposed, with experimental 
evidence supporting both. One is termed the asynchronous strand displacement model 
(Clayton, 1982) and the other is termed the synchronous model (Holt et al., 2000). 
The asynchronous strand displacement model suggests that leading heavy strand replication 
starts at the OH site, due to the presence of RNA primers from transcription, and proceeds 
two-thirds around the genome until it reaches the OL site, which becomes exposed as single 
stranded DNA. The presence of single stranded DNA at the OL site allows the replication 
machinery to bind to the light strand, allowing replication to commence for the lagging 
strand. MtDNA replication then proceeds to completion for both the leading (heavy strand) 
and the lagging (light strand) (Clayton, 1982). Once replication is complete, mtDNA is 
circularised via ligation and supercoils are introduced via mitochondrial topoisomerases 
(Clayton, 1982). Evidence suggests that mammalian mtDNA replicates itself in ~90 minutes 
(Clayton, 1982). 
Figure 1-4 MtDNA replication machinery 
TWINKLE unwinds double stranded mtDNA, creating a replication fork travelling in the 
3’ to 5’ direction. Single stranded DNA binding proteins (mtSSB) stabilise the single 
stranded DNA, allowing Polγ (PolγAB2) to carry out mtDNA replication. 
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The synchronous model suggests that replication of the leading (heavy strand) and the 
lagging (light strand) occur simultaneously, as evidence shows the existence of replication 
intermediates that are resistant to single stranded nuclease digestion (Holt et al., 2000). 
Therefore, the lagging strand would have to generate multiple Okazaki fragments which 
would have to be processed before a newly synthesised mtDNA molecules was completed 
(Holt et al., 2000). Within vertebrates, a method known as RITOLS (ribonucleotide 
incorporation throughout the lagging strand) has been suggested as the method that allows 
synchronous strand replication (Yasukawa et al., 2006). RNA fragments of various length 
bind to the lagging strand, which are eventually processed into DNA before mtDNA 
completion (Yasukawa et al., 2006). 
1.6 MITOCHONDRIAL GENETICS 
1.6.1 Heteroplasmy 
As there are multiple copies of mtDNA molecules within cells, different species of mtDNA 
can exist within the same cell. Different species can be classed as polymorphic or pathogenic 
variants. A cell with a mixture of mtDNA variants is termed heteroplasmic. Percentage 
heteroplasmy is determined by the fraction of mutated mtDNA within a cell. Changes in 
heteroplasmy can lead to a cell that comprises purely mutated mtDNA, this is termed 
homoplasmy (Taylor and Turnbull, 2005). 
A good example of how heteroplasmy can change significantly between generations is 
provided by experiments conducted on Holstein cows, which have been shown to harbour 
two mitochondrial genotypes (one with a polymorphic variant) (Hauswirth and Laipis, 1982). 
It was shown that a cow with 35% heteroplasmy gave rise to offspring that had lost the 
mutant mitochondrial genotype, or had heteroplasmy levels ranging between 20-80% (Ashley 
et al., 1989). 
1.6.2 Clonal expansion 
Clonal expansion is the term that describes the gradual increase in one mutant mtDNA 
species within an individual cell over time. Several hypotheses have been proposed to explain 
clonal expansion. MtDNA molecules with a deletion mutation were postulated to have an 
advantage over wild type mtDNA molecules as they are shorter and so take less time to 
replicate, enabling their clonal expansion (Wallace, 1992). However, this would not explain 
the clonal expansion of mtDNA point mutations, for instance the m.3243A>G mtDNA 
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mutation within cybrid cell lines that was also shown to clonally expand (Yoneda et al., 
1992). In an effort to explain the clonal expansion of mtDNA point mutations, the “sick 
mitochondria” theory was postulated. This theory states that mitochondria with a high 
mtDNA mutation load proliferate quicker to negate the effects of their deficiency, enabling 
the clonal expansion of both deletion and point mutations within cells (Yoneda et al., 1992). 
The assumption that an advantage was required to allow mutated mtDNA molecules to 
clonally expand with cells was tested (Elson et al., 2001). Random genetic drift was 
simulated, which describes a pool of mtDNA molecules, containing both normal and mutated 
mtDNA, having an equal chance of replicating over time. This was simulated for post-mitotic 
cells with parameters including: number of mtDNA molecules per cell (1000), number of 
cells simulated (600) and mtDNA half-life (10 days). For every degraded mtDNA, a 
randomly chosen mtDNA molecule was replicated with a copy error probability associated 
with it (5 x 10-5 mutated mtDNA per mtDNA replication). With these parameters, mutated 
mtDNA were able to clonally expand. It was also shown that those mutations occurring 
earlier were able to clonally expand to higher heteroplasmy levels (Elson et al., 2001). This 
indicates that clonal expansion of mutated mitochondrial genomes may be simply subject to 
random genetic drift and that mutations occurring during development and early adulthood 
may have greater significance in later life. 
1.6.2.1 Threshold effect 
As there are many mtDNA molecules within cells, there exists a high level of functional 
redundancy whereby wild-type mtDNA is able to compensate for the presence of mutated 
mtDNA (Sciacco et al., 1994). Before a cell displays a functional deficit, a threshold level of 
mutation must be surpassed. This is exemplified within Figure 1-5. The threshold level is 
dependent on the type of mutation present, for instance 60% for mtDNA deletions, ~85% for 
mtDNA point mutations and ~90% for tRNA mutations (Boulet et al., 1992; Chomyn et al., 
1992; Sciacco et al., 1994). However, the threshold level will always be dependent on the 
specific type of mutation present, for instance some tRNA mutations require only a 7% 
mutant fraction before a cell displays a deficient phenotype (Alston et al., 2010). 




1.6.3 Mitotic segregation 
Mitotic segregation is another mechanism that can permit the clonal expansion of mutated 
mtDNA within a population of dividing cells. With the example of stem cell divisions, in 
order for daughter cells to maintain the same number of mtDNA as the stem cell, the mtDNA 
population is required to double. If there are mutations within the stem cell pool before 
division, replication of the mtDNA pool is likely to increase the number of mutated mtDNA 
molecules. Upon stem cell division, one daughter cell may get more, less, or the same 
number of mutated mtDNA as the original stem cell, thereby allowing clonal expansion to 
occur. This mechanism is exemplified within Figure 1-6. Clonal expansion via mitotic 
segregation was modelled computationally and was successfully fitted to experimental data 
from normal buccal epithelial cells and tumour cells (Coller et al., 2001). It is likely that a 
Figure 1-5 MtDNA heteroplasmy and the threshold effect 
The fraction of mutated mtDNA molecules determines the heteroplasmy level within 
individual cells. Wild type mtDNA (green circles) compensate for the mutated mtDNA 
(white circles) to maintain normal OXPHOS activity. This is true up until a threshold level 
is reached, at which point OXPHOS activity is compromised and the cell will have a 
mutant phenotype. The threshold level will be determined by the type of mutation that is 
present within the cell. 
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combination of random genetic drift and mitotic segregation contribute towards the clonal 
expansion of mutated mtDNA (Coller et al., 2001; Elson et al., 2001). 
 
 
1.6.4 Maternal inheritance 
Mammalian mtDNA is inherited strictly through the maternal lineage within mammals and is 
therefore not subject to Mendelian inheritance unlike nuclear DNA. The number of oocyte 
mitochondria vastly outweighs the number of sperm mitochondria, with sperm mitochondria 
being degraded by proteolysis and autophagy after fertilisation (Cummins et al., 1997; 
Moreno et al., 2000; Al Rawi et al., 2011). Therefore, only pathogenic mtDNA mutations can 
be transmitted through the maternal germline (Giles et al., 1980). The transmission of 
pathogenic mutations through the germline can be rather complex as there exists a restriction 
amplification step during oocyte maturation, termed the genetic “bottleneck”. This involves 
mtDNA within primordial germ cells being selectively segregated into each primary oocyte, 
with subsequent amplification of mtDNA during oocyte development (Taylor and Turnbull, 
2005). If pathogenic mtDNA mutations are present within the germline, this leads to 
substantial heteroplasmy variability in the offspring. It is likely that the genetic bottleneck 
Figure 1-6 Mutated mtDNA clonal expansion via mitotic segregation 
Mitotic tissues permit clonal expansion of mutated mtDNA via random segregation upon 
division. As stem cells are the only cells that persist within the tissue for substantial 
periods of time, it is likely that mutated mtDNA clonally expand purely within the stem 
cell pool, with increasing and decreasing heteroplasmy levels subject to the retention and 
disappearance of mutated mtDNA from the stem cell pool upon division. 
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evolved in an effort to reduce the likelihood of pathogenic mtDNA mutations being 
transmitted through the germline (Fan et al., 2008; Stewart et al., 2008). 
1.7 AGEING 
Ageing has been described as the accumulation of molecular and cellular damage that leads 
to diminished fecundity with an increased likelihood of death (Kirkwood, 2008). As the 
human population is transitioning to a more elderly demographic, the social and economic 
challenges society faces have never been so demanding. Ageing research not only aims to 
understand the causes of ageing and why it makes us more susceptible to disease, it also aims 
to provide the means for people to live healthier lives for longer, benefiting both the 
individual and their impact on society. There are a number of theories proposed to explain 
why we age, these can be classed into two categories: evolutionary and molecular. However, 
it is unlikely that one theory can explain ageing as a whole as it may be that ageing is in fact 
an emergent multi- factorial process.   
1.7.1 Evolutionary theories of ageing 
As different species have different lifespans, with the subtle differences between species 
being determined by their genomes, this suggested that ageing was also under the control of 
the genome and that it was in fact programmed (Finch and Tanzi, 1997). The influence of the 
genome on ageing has laid the foundation for evolutionary theories postulated over the years. 
It was first suggested by August Weismann in 1889 that there was an ‘ageing gene’ that 
existed in order to maintain the population size of a species. It was later suggested by 
Medawar in 1952 that ageing was driven by the accumulation of deleterious mutations 
throughout life, leading to a progressive ageing phenotype (Medawar, 1952). Whether ageing 
is programmed or not, it is still likely that genes influence the ageing process. The 
Antagonistic Pleiotropy theory is a recurrent concept within the ageing field, stating that the 
selection of genes that favour increased reproductive advantage drives the evolution of a 
species, even if that gene is detrimental later on in life (Williams, 1957). The Disposable 
Soma theory states that ageing is brought about due to metabolic trade-offs made between 
reproduction, cell growth and repair within somatic cells (Kirkwood, 1977). Furthermore, it 
states that energy resources are allocated in favour of reproduction, leading to a lack of 
energy resources for cell maintenance and repair, hence driving the ageing process 
(Kirkwood, 1977). It makes sense that genes are more likely to be retained within a species if 
they increase the chance of reproduction. However, the selection of genes that are deleterious 
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to an organism’s survival is a major source of contention for evolutionary theories of ageing 
(Kirkwood, 1995). 
1.7.2 Molecular theories of ageing 
Molecular theories of ageing state that ageing is due to the accumulation of cellular damage 
that takes place during normal metabolic processes within cells. Damage to DNA, telomeres, 
proteins, lipids, and macromolecular complexes within cells, is thought to be the cause of 
ageing phenotypes observed within a variety of organisms observed. 
The accumulation of DNA mutations throughout life is thought to be a leading cause of 
cellular dysfunction which contributes to the ageing process (Szilard, 1959). This is 
compounded by the fact that with increasing age there is a reduced base-excision DNA repair 
capacity, which has been linked to the longevity of a species (Hart and Setlow, 1974). Age 
associated telomere damage is also thought to contribute towards the ageing process (Harley 
et al., 1992). Telomeres are the repeat regions that exist at the end of chromosomes. Due to 
the end replication problem, there is a natural shortening of telomeres with each cell division 
event. Within embryonic stem cells and some adult stem cells, telomerase is expressed which 
maintains the length of the telomere, however most somatic cells do not express it. Once a 
telomere limit has been reached, the cell undergoes replicative senescence (Harley et al., 
1992). Telomere DNA damage can therefore increase the rate at which cells enter replicative 
senescence, leading to a functional decline within tissues, contributing to the ageing process 
(Harley et al., 1992). Abnormal protein turnover and homeostasis can also contribute towards 
the ageing process (Cuervo and Dice, 2000). Abnormal peptide cross-linking during post-
translational modification can cause damage to the DNA replication machinery, contributing 
to DNA damage (Bjorksten and Tenhu, 1990). In 1956, Harman proposed the free radical 
theory of ageing that suggested oxidative damage was at the centre of age related decline in 
function of an organism (Harman, 1956). Since then, oxidative damage has been shown to 
accumulate within a variety of ageing tissues (Balaban et al., 2005). It is now known that 
ROS can cause oxidative damage to DNA, proteins, lipids and macromolecules, with 
OXPHOS being a major source of ROS. Therefore, what was once the free radical theory of 
ageing became the mitochondrial free radical theory of ageing (MFRTA) (Harman, 1972). 
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1.7.2.1 The mitochondrial free radical theory of ageing  
It is now known that mitochondria are the main source of ROS production, with ~90% of 
total cellular ROS generated via OXPHOS (Balaban et al., 2005). This leads to the 
accumulation of oxidative damage that has been hypothesised to contribute towards ageing 
(Harman, 1956; Harman, 1972). The main ROS that are generated from OXPHOS are 
superoxide radicals (O2-) and hydroxyl radicals (OH·). Mitochondria have adapted to the 
presence of O2- via superoxide dismutase expression within the mitochondrial matrix, 
attenuating the burden of ROS induced oxidative damage (McCord and Fridovich, 1969). 
However, OH· have such a short half-life that no enzyme exists for it to be metabolised and 
therefore can be very damaging to the cell (Cadenas and Davies, 2000). As the mtDNA 
molecules are in such close proximity to the site of ROS generation, mtDNA is vulnerable to 
high levels of oxidative damage (Harman, 1972). It is thought that mtDNA has a high 
mutation rate due to the increased oxidative damage burden which results in attenuated 
OXPHOS function in later life (Miquel et al., 1980). It is likely that attenuated OXPHOS 
function leads to increased electron “leakage” from the electron transport chain, increasing 
ROS concentrations in the cell. This is the foundation of the “vicious cycle” theory where 
increased ROS leads to increased mtDNA mutations leading to increased ROS (Harman, 
1972). This increasing level of ROS generation and oxidative damage as a result is thought to 
lead to the cells eventual death (Harman, 1972). 
There are a number of studies that have demonstrated a link between ROS induced oxidative 
damage and longevity. One study showed that there was reduced superoxide radical 
concentrations within the heart, liver and kidneys of species with increased lifespans (Sohal 
et al., 1989). Another study showed that there was decreased protein oxidation within longer 
lived species (Agarwal and Sohal, 1996). Furthermore, it was shown that Pigeon 
mitochondria release 30% less hydrogen peroxide compared with mitochondria from rats, 
which have a ~7 year shorter lifespan. These studies provide compelling evidence to suggest 
mitochondria, and the ROS they produce, play a major role within the ageing process.  
Due to mitochondria having such an integral role within the cell, it is likely that perturbations 
bestowed to the mitochondria’s function will have a significant effect on the cell as a whole 
and have the potential to contribute towards the ageing process. 
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1.7.3 Mitochondrial dysfunction and ageing 
A variety of aged human tissues have been shown to display mitochondrial dysfunction in the 
form of focal respiratory chain deficiency for cytochrome c oxidase enzymatic activity (COX 
deficiency). This has been shown in skeletal muscle (Muller-Hocker, 1990), brain (Cottrell et 
al., 2001), colon (Taylor et al., 2003), liver (Fellous et al., 2009), and stomach (McDonald et 
al., 2008). It would seem that there is a progressive accumulation of COX deficiency with 
age within these tissues, as is the case within human colon (Taylor et al., 2003). It has been 
shown that aged human cells presenting with COX deficiency harbour single clonally 
expanded mtDNA mutations (Brierley et al., 1998). This casts doubt over the “vicious cycle” 
hypothesis of ROS induced mtDNA mutation accumulation as this mechanism would lead to 
multiple mtDNA mutations being present within aged cells. Therefore, it is more likely that 
the mtDNA mutations that are acquired in early life through mtDNA replication errors and 
oxidative damage go onto clonally expand to become the dominant species within aged cells 
(Elson et al., 2001; Greaves et al., 2014). 
Interestingly, the types of mtDNA mutations that cause mitochondrial dysfunction in aged 
tissue are different between mitotic and post-mitotic tissues. Previous studies have shown that 
aged skeletal muscle fibres predominantly harbour clonally expanded mtDNA deletions 
(Kopsidas et al., 1998). Furthermore, aged post-mitotic tissues can harbour a mosaic pattern 
of mtDNA deletions, with different mtDNA deletions present in different cells of the same 
tissue (Brierley et al., 1998; Bender et al., 2006; Kraytsberg et al., 2006). This is in contrast 
to mitotic tissues, for instance aged colon, which predominantly harbour clonally expanded 
point mutations (Taylor et al., 2003; Greaves et al., 2006; Greaves et al., 2010). There are a 
number of reasons as to why this may be the case. For instance, it may reflect alternate 
mechanisms of clonal expansion between mitotic and post-mitotic tissues, even though 
computational modelling suggests random genetic drift is sufficient to explain clonal 
expansion within mitotic and post mitotic tissues (Coller et al., 2001; Elson et al., 2001). It 
could be that the post-mitotic cellular environment is more conducive for the acquisition of 
mtDNA deletions. On the other hand, it may be that mitotic cells (such as stem cells) have 
enhanced DNA repair mechanisms. 
It is clear that mtDNA mutations do accumulate within post-mitotic and mitotic tissues and 
that these mutations go onto cause mitochondrial dysfunction as seen via focal respiratory 
chain enzyme deficiency. Mitochondrial dysfunction has the potential to severely affect a 
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cells ability to function, which can lead to cellular senescence, apoptosis and eventual tissue 
failure (Taylor and Turnbull, 2005). Therefore, it is vital we understand the acquisition and 
subsequent clonal expansion of mtDNA mutations within all cell and tissue types, as this will 
make it easier to identify potential methods of halting the accumulation of mitochondrial 
dysfunction within ageing tissues. 
1.7.4 Mouse models of mitochondrial dysfunction 
Mouse models are an important tool which are used to try and understand the link between 
mitochondrial dysfunction and ageing. Mitochondrial abnormalities that are of relevance to 
ageing human tissues can be investigated in their entirety. Two such mouse models are the 
TFAM knockout mice (Silva and Larsson, 2002; Wredenberg et al., 2006; Ekstrand et al., 
2007; Vernochet et al., 2012) and the PolγA “mitochondrial mutator” mice (Trifunovic et al., 
2004; Kujoth et al., 2005), which allow the effects of mtDNA reduction and mutagenesis to 
be observed. 
1.7.4.1 TFAM knockout mice 
TFAM knockout mice are one such mouse model that can be used to investigate this link. 
TFAM is a transcriptional activator within mitochondria and is also important for 
mitochondrial DNA replication (Reyes et al., 2002). As such, heterozygous TFAM knockout 
mice (Tfam(+/-)) have reduced mtDNA copy number with associated respiratory chain 
complex deficiency, however, homozygous TFAM knockout mice (Tfam(-/-)) were embryonic 
lethal at embryonic day (E) 8.5 and (E) 10.5. Therefore, tissue specific TFAM knockouts 
were created using cre-loxP-mediated recombination. This was done within pancreatic β-cell 
specific TFAM knockout mice, where β-cells exhibited disrupted mitochondrial membrane 
potential along with altered calcium buffering upon Cre-recombinase induction (Silva and 
Larsson, 2002). Mitochondrial dysfunction within TFAM knockout mice was directly linked 
to reduced β-cell insulin secretion along with an increased loss of β-cells with age, 
resembling the acquisition of diabetes in human ageing (Silva and Larsson, 2002). A 
dopaminergic (DA) neuron specific knockout of TFAM was also engineered, which resulted 
in respiratory chain deficiency. Mice with this alteration displayed tremors, slow progressive 
movement, and age associated Parkinson’s disease (Ekstrand et al., 2007). These studies 
indicate that mitochondrial dysfunction can bring about the characteristics within cells that 
lead to age related diseases. However, it has been shown that mitochondrial dysfunction 
affects different tissue types in different ways. For instance, tissue specific TFAM knockouts 
Chapter One  Introduction 
29 
in skeletal muscle (Wredenberg et al., 2006) and adipose tissue (Vernochet et al., 2012) do 
not result in age related disease. This indicates that the potential for mitochondrial 
dysfunction to cause age-related phenotypes is dependent on the tissue type in which it 
resides, adding to the complexity of how mitochondrial dysfunction contributes towards 
ageing within humans. 
1.7.4.2 MtDNA mutator mouse 
MtDNA mutator mice are another mouse model that can be used to investigate the link 
between mitochondrial dysfunction and ageing. They are associated with a progressive 
accumulation of mtDNA mutations along with the development of age related phenotypes. 
Homozygote mitochondrial mutator mice (PolγA(-/-)) were generated with a knock-in 
missense mutation (D257A) that changes the amino acid from aspartic acid to alanine within 
the second proofreading domain of the PolγA catalytic subunit of the mtDNA polymerase 
gamma (Trifunovic et al., 2004; Kujoth et al., 2005). The mitochondrial mutator mouse 
created by Trifunovic et al has a C57Bl/6N background which includes the Flp-recombinase 
system, meaning the POLG gene is flanked by two loxP sites (Trifunovic et al., 2004). 
However, the mitochondrial mutator mouse created by Kujoth et al has a C57Bl/6J 
background which includes a Cre-recombinase system with only one loxP site present 
(Kujoth et al., 2005). Both mitochondrial mutator mice have an increased rate of mutation 
accumulation and a substantially increased rate of respiratory chain deficiency with age. 
Homozygote mice display an ageing phenotype from 25 weeks old which includes; weight 
loss, anaemia, osteoporosis, kyphosis, reduced subcutaneous fat, reduced fertility and a 
reduced lifespan <12 months, mirroring the phenotypes associated with human ageing 
(Trifunovic et al., 2004; Kujoth et al., 2005). The overwhelming majority of mutations that 
are acquired within PolγA(-/-) mice are point mutations, where for every 1000 mtDNA point 
mutations, there is 1 mtDNA deletion (Kraytsberg et al., 2009). Even though there is an 
increased rate of mtDNA point mutation accumulation within PolγA(-/-) mice, this was 
originally thought not to be associated with an increasing rate of ROS production and 
macromolecule oxidation with age, which provided evidence against the ‘vicious cycle’ 
hypothesis (Trifunovic et al., 2004; Kujoth et al., 2005). More recent studies have started to 
dispute these findings with one study showing that there exists increased oxidative damage 
within muscle from aged PolγA(-/-) mice (Kolesar et al., 2014). Another study has also showed 
that there exists an elevated level of hydrogen peroxide within aged PolγA(-/-) mice which has 
been hypothesised to have pro-apoptotic and pro-inflammatory effects (Logan et al., 2014). 
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1.8 THE COLON 
It is clear that mitochondrial dysfunction occurs within ageing tissues as has been previously 
described. However, the consequences of mitochondrial dysfunction within ageing tissues 
requires further investigation. As part of this thesis, the colon was used as a model tissue 
within both human and mouse to understand the impact of mitochondrial dysfunction on 
adult stem cells. The structure of the colon is unique and ideal for investigating stem cell 
dynamics and so is examined in greater detail below. 
1.8.1 Structure of the colon 
The colon is made up of four sections: the ascending, transverse, descending and sigmoid 
colon. Each section has four associated layers: the mucosa (epithelium containing crypts), the 
muscularis mucosae (thin muscle layer), the submucosa (connective tissue layer), and the 
muscularis externa (circular and longitudinal muscle responsible for peristalsis). The colonic 
epithelium is an array of millions of tubular shaped structures known as crypts. The structure 
of the crypt is shown in Figure 1-7. 
The epithelium of the colon regenerates at an extraordinarily fast rate, this has been shown to 
be approximately every day within mouse and every week within humans (Potten and 
Loeffler, 1990). The drivers of such fast regeneration are the multipotent stem cells that are 
contained at the base of crypts, which are able to generate all cell lineages required for crypts 
to perform their function (Schmidt et al., 1988; Potten, 1998). The cell lineages derived from 
stem cells includes: columnar enterocytes (colonocytes), goblet cells, and enteroendocrine 
cells (McKay, 2005). As all the cells of the crypt are derived from the stem cells at the base, 
any genetic mutations that exist within the stem cells will be transmitted to the progeny cells. 
The number of stem cells contained within colonic crypts still requires clarification due to the 
lack of robust stem cell markers. However, the consensus is that there is a low number of 
stem cells within human colonic crypts, possibly between 4 and 6 (Taylor et al., 2003; Baker 
et al., 2014). This is in good agreement with mouse studies that have shown there are ~7 stem 
cells within mouse colonic crypts (Kozar et al., 2013).  
 




1.8.2 Stem cell markers within crypts 
Identifying the stem cells contained within crypts has been a constantly evolving area of 
research over the last two decades. Potten and Loeffler first described the stem cell niche 
within crypts as highly dynamic, with individual cells possessing definitive levels of 
clonogenicity, with clonogenicity highly correlated with cell position within the crypt (Potten 
and Loeffler, 1990). Therefore, the ability to identify stem cells within crypts was based 
solely on the functional characteristics of the cells in question. It is now well established that 
the likely origin of tumour formation within colorectal and intestinal cancers are the stem 
cells themselves that have undergone malignant transformation, giving birth to the term 
‘cancer stem cells’ (Reya et al., 2001; Li and Neaves, 2006; Vermeulen et al., 2008; Barker 
et al., 2009). Therefore, the identification of stem cell markers is not only important for 
Figure 1-7 Structure of a colonic crypt 
Colonic crypts are located within the mucosal layer of the colon. They contain stem cells 
at the base which proliferate to generate stem cell progeny transit amplifying cells that go 
onto generate all the cell types present within the crypt. As cells divide, they migrate up 
the crypt axis until they are fully differentiated (goblet cells, colonocytes or 
enteroendocrine cells). They continue to migrate until they are eventually sloughed off 
into the gut lumen.  
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understanding stem cell biology, but could also be useful in understand the biology of cancer 
as well. Identifying stem cell markers within crypts requires the enrichment of highly 
clonogenic cells from the small intestinal and colonic epithelium, with subsequent gene 
expression profiling to determine what sets these cells apart. Many highly expressed genes 
within cells that display stem cell characteristics have been brought to light via this method.  
Within mouse colon, Lgr5, which encodes a leucine rich repeat containing G-protein coupled 
receptor (Lgr5), was investigated due to its involvement within the Wnt pathway 
(contributing to a cells ability to proliferate) and its abundance within cells at the base of 
crypts (Barker et al., 2007). The Lgr5-EGFP-Ires-CreERT2 mouse model was engineered 
which allowed a lineage tracing methodology to be used to determine the characteristics of 
cells with highly expressed Lgr5 (Barker et al., 2007). These cells had the ability to give rise 
to all differentiated cells lineages over time, suggesting that cells with highly expressed Lgr5 
were the functional stem cells within colonic epithelium. This was also shown to be the case 
within mouse small intestinal crypts as well (Snippert et al., 2010). Interestingly, another 
marker showed similar characteristics within small intestinal epithelium. Bmi1, which is a 
member of the Polycomb group gene family and has essential roles in chromatin silencing, 
was found to be highly expressed within cells that were, on average, 4 cell positions above 
the base of the crypt, unlike cells that had highly expressed Lgr5 which were located 
interspersed between Paneth cells. Using the Bmi1-EGFP-Ires-CreERT2 mouse model, these 
cells were also shown to give rise to all differentiated cell lineages over time (Sangiorgi and 
Capecchi, 2008). Furthermore, loss of Bmi1-expressing cells lead to crypt loss, indicating 
them to be another subset of stem cells within the small intestinal epithelium (Sangiorgi and 
Capecchi, 2008). More recently, Lgr5 and Bmi1 highly expressing cells have been identified 
as functionally distinct stem cell populations, postulated to provide contrasting functions to 
ensure homeostatic tissue maintenance (Yan et al., 2012). Lgr5 stem cells are mitotically 
active, ensuring normal tissue regeneration, whereas Bmi1 stem cells are mostly 
quiescent/slow cycling with minimal input to tissue maintenance under homeostatic 
conditions (Yan et al., 2012). Bmi1 cells are in the same +4 position as DNA label retaining 
cells that have previously been located (Potten et al., 1974; Potten et al., 2002), indicating 
that label retaining cells and quiescent/slow cycling Bmi1 stem cells are one and the same. 
Evidence suggests that Bmi1 stem cells function as a reserve intestinal stem cell pool upon 
tissue injury and Lgr5 stem cell ablation (Tian et al., 2011; Yan et al., 2012). 
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Lgr5 and Bmi1 stem cell populations also enrich distinct genes that can be further used for 
their characterisation. For instance Lgr5 stem cells enrich a Wnt target gene known as Ascl2 
(Achaete scute-like-2) which has been shown to control the Lgr5 stem cell fate, with its 
deletion resulting in the disappearance of Lgr5 stem cells (van der Flier et al., 2009). They 
also enrich Olfm4 which encodes a protein that acts as a BMP antagonist (Inomata et al., 
2008; Schuijers et al., 2014). However, deletion of Olfm4 does not result in any observable 
phenotype, questioning its potential role within Lgr5 stem cells (Schuijers et al., 2014). On 
the other hand, Bmi1 stem cells enrich Hopx which is an atypical homeodomain containing 
protein (Takeda et al., 2011). It was shown that Hopx expressing cells give rise to Lgr5 stem 
cells, but also Lgr5 stem cells give rise to Hopx/Bmi1 expressing label retaining cells, 
indicating an interconversion between the two stem cell populations (Takeda et al., 2011).  
At present, there is a paucity of literature about Bmi1 stem cells within colonic epithelium, 
unlike within small intestinal epithelium. However, the expression of Bmi1 within colorectal 
adenocarcinomas has been investigated in-depth with regards to the cancer stem cell 
hypothesis, with the inhibition of Bmi1 impairing the ability of colorectal cancer initiating 
cells from self-renewing (Kreso et al., 2014). CD133+ (Prominin-1 and AC133) cells have 
been described as having stem cell like qualities within the colonic epithelium, able to sustain 
long-term tumorigenesis within NOD/SCID mice (Shmelkov et al., 2008). However, it may 
be that this marker is not exclusive to stem cell populations and that its identification may 
only be possible under tumour growth conditions (O'Brien et al., 2007; Shmelkov et al., 
2008). The mammalian Musashi-1 homolog has been shown to be localised at the base of 
normal colonic crypts, which may indicate its potential use as a stem cell marker (Nishimura 
et al., 2003). Musashi is an RNA-binding protein thought to be involved in asymmetric 
divisions during Drosophila neural development (Nakamura et al., 1994). It is postulated that 
Musashi-1 is key for asymmetric stem cell divisions within the colonic epithelium, 
potentially allowing the identification of stem cells within the colon (Nishimura et al., 2003).  
1.8.3 The stem cell niche within crypts 
Multiple cellular markers have been identified within crypts which identify cells that can 
function as multipotent stem cells, as has been exemplified within the previous section 
(section 1.8.2). However, simply possessing cellular markers of stemness may not be 
sufficient for those cells to function as stem cells, adding to the complexity for investigating 
true functioning stem cells within crypts (Walther and Graham, 2014). A well accepted 
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school of thought now suggests that the stem cell niche is a dynamic interplay between the 
stem cell niche environment and the cells that occupy its space, with the goal of regenerating 
the crypt to maintain epithelium homeostasis (Walther and Graham, 2014). 
Experiments conducted by Ritsma and colleagues suggest that for a stem cell to remain and 
function as a stem cell, position within the stem cell niche is key (Ritsma et al., 2014). They 
used a novel intravital multiphoton imaging approach to track the migration of dividing 
Lgr5+ cells in situ. They classified each cell according to its initial position within the niche 
and saw that, upon division, cells that were closest to the base of the crypt, i.e. closest to the 
stem cell niche, were more likely to remain within the stem cell niche over time. As there is a 
competition for privileged stem cell niche space within crypts, the preferential retention of 
cells located in a particular position suggests extrinsic factors are contributing to stem cell 
homeostasis (Ritsma et al., 2014). It may be that there are many cells within the crypt that 
have the potential to function as a stem cell but are not exposed to the correct extracellular 
cues that are found within the stem cell niche to enable them to do this (Ritsma et al., 2014). 
Experiments conducted by Hua Tain and colleagues support this idea where Lgr5+ stem cells 
within mice were successfully ablated using the Cre recombinase induction of human 
diphtheria toxin (Tian et al., 2011). This would cause the temporary ablation of all Lgr5 
expressing cells within the stem cell niche. The subsequent regeneration of the stem cell 
niche by Bmi1 expressing cells would give rise to Lgr5 expressing cells, maintaining crypt 
homeostasis. This suggests that the stem cell niche was providing signalling cues to the 
occupying cells to function as stem cells. This could be explained by the environment within 
the stem cell niche itself influencing the gene expression profiles of the cells present within 
the stem cell niche. 
The stem cell niche within small intestinal crypts contains specialised cells known as Paneth 
cells which are interspersed between the crypt base columnar (CBC) cells that express Lgr5, 
i.e. the functional stem cells. These cells secrete factors EGF, TGF-alpha, Wnt3 and Notch 
ligand Dll4 (Sato et al., 2009). These factors are known to maintain the CBC cells as 
intestinal stem cells, with the ablation of Paneth cells subsequently ablating the CBC cells, 
providing evidence to suggest that Paneth cells contribute to the small intestinal stem cell 
niche (Sato et al., 2011).  
Crypt stem cell homeostasis is mainly controlled by the Wnt and BMP signalling pathways, 
constituents that allow intestinal crypt organoids to be grown in culture (Sato and Clevers, 
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2013). A concentration gradient of Wnt isoforms exists along the crypt axis, with the highest 
concentrations existing within the stem cell niche (Pinto et al., 2003). Once extracellular Wnt 
binds to the frizzled cell surface receptor, this triggers a signalling cascade which results in β-
catenin locating to the nucleus and triggering the gene expression that allows for stem cell 
self-renewal and proliferation. Abnormal activation of β-catenin results in adenomatous 
polyposis coli due to aberrant stem cell proliferation. 
However, Wnt signalling is not sufficient for self-renewal and proliferation of stem cells 
within the stem cell niche. BMP signalling inhibits stem cell renewal and proliferation by 
regulating PTEN activity, resulting in the inhibition of β-catenin activity within the nucleus 
(Scoville et al., 2008). BMP isoforms are expressed within the mesenchyme, allowing the 
self-renewal and proliferation of stem cells to be kept in check. In order to override the BMP 
signalling to allow stem cell self-renewal and proliferation to take place, the BMP antagonist 
“noggin” is required (He et al., 2004). Noggin is expressed in the submucosal region, next to 
the crypt base, thereby only allowing the cells in close proximity to the Noggin concentration 
gradient to self-renew and proliferate, making this location the true stem cell niche (He et al., 
2004; Scoville et al., 2008). Abnormal activation of BMP represses de novo crypt formation 
during development (Haramis et al., 2004).  
From this it would appear that the stem cell niche is just as important as the stem cells 
themselves, with a complex inter-relationship existing via signalling molecules, cell-cell 
interactions, and extracellular matrix components maintaining the controlled regenerative 
capacity that the stem cells provide. It seems logical that not only changes in stem cell 
characteristics cause perturbations that can result in tissue pathology and bowel disease in 
later life, but also perturbations to the stem cell niche has the potential to do this as well. 
1.8.4 Functions of the colon 
The main responsibility of the colon is to store and compact faecal matter before it is 
expunged via the anus in defecation. Before this happens, water and electrolytes (Ca2+, Mg2+) 
are absorbed. End stage digestion of dietary nutrients also takes place, producing short chain 
fatty acids, carbon dioxide and methane (Cummings, 1975). Urea is also broken down in the 
colon, producing ammonia which is absorbed, and carbonic acid (Cummings, 1975). The 
microflora (bacteria) that exist within the colon have an important role in end stage digestion 
as they break down dietary fibre allowing the synthesis of vitamin K, which is important for 
blood coagulation (Baron, 1996). In addition to the role of nutrient absorption, the microflora 
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act as an important immune barrier, protecting the mucosa from harmful pathogen 
colonisation (Berg, 1996). This barrier function is enhanced with the secretion of mucins 
from goblet cells, helping the microflora to maintain a protective barrier (Johansson et al., 
2008). Furthermore, colonocytes and goblet cells secrete anti-microbial proteins in response 
to microflora colonisation, enhancing the protective barrier (Peterson and Artis, 2014). With 
this it is clear that the colon is highly specialised for the end stages of digestion with roles in 
immune defence, as well as the processing and excretion of faeces. 
1.8.5 Mitochondrial dysfunction within the colon 
Human colonic epithelium has been shown to accumulate mitochondrial dysfunction, in the 
form of COX deficiency, exponentially with age (Taylor et al., 2003). Clonally expanded 
mtDNA point mutations have been shown to be the cause of the observed COX deficiency 
within human colon (Taylor et al., 2003; Greaves et al., 2009). Partially and fully COX 
deficient crypts can be observed within aged human colonic epithelium, suggesting COX 
deficiency as a potential stem cell lineage marker (Taylor et al., 2003). In a subsequent study, 
the mitochondrial genome was sequenced from COX deficient crypt cells undergoing fission 
and also neighbouring COX deficient crypts (Greaves et al., 2006). The same clonally 
expanded mtDNA mutation was present in the two arms of a bifurcating crypt and also in two 
adjacent crypts, suggesting that adjacent COX deficient crypts are clonally derived from the 
same founder stem cell clone and that their occurrence is via crypt fission (Greaves et al., 
2006). The minimal odds ratio of two adjacent crypts harbouring the same clonally expanded 
mtDNA point mutation by chance was calculated to be >2.48 x 109 :1 ([16,600:1 (genome 
size) x 3 (possible transition mutations)]2) (Greaves et al., 2006).  
The effects of mitochondrial dysfunction were investigated within aged human colon biopsies 
(Nooteboom et al., 2010). Crypt length, number of cells undergoing apoptosis, and number of 
proliferating cells were compared between normal and COX deficient crypts (Nooteboom et 
al., 2010). Respiratory deficient crypts showed an ~20% reduction in the number of stem cell 
progeny cells actively proliferating, indicating that COX deficiency was causing small but 
significant changes to cellular functions which could lead to imbalanced tissue homeostasis, 
potentially contributing towards the ageing process (Nooteboom et al., 2010). 
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1.8.6 Modelling stem cell dynamics within crypts 
Modelling stem cell dynamics within crypts is an active area of research that aims to 
understand all aspects behind the niche succession phenomenon under normal and perturbed 
conditions. Niche succession is the ability of a stem cell clone to become dominant within its 
niche. This has been carried out using a variety of mathematical and stochastic computational 
modelling methodologies along with experimental methods for acquiring the necessary 
biological data. 
Lopez-Garcia et al used an inducible labelling system that allowed the proliferative 
population within intestinal crypts to be targeted via Cre-mediated recombination within 
AhcreERt mice. It was assumed that labelled cell clones producing partially and fully labelled 
crypts are derived from single proliferative cells (Lopez-Garcia et al., 2010). Their aim was 
to determine whether the small intestinal long-lived stem cells were organised hierarchically 
or as an equipotent pool. A hierarchical organisation is described as having one master stem 
cell that gives rise to an additional pool of stem cells with a reduced proliferative potential 
that perform the role of regenerating the cells of the crypt (Griffiths et al., 1988; Winton and 
Ponder, 1990). An equipotent pool of stem cells means all stem cells are equal and have the 
same potential to generate stem cells and stem cell progeny alike (Potten and Loeffler, 1990). 
Intuitively, the equipotent organisation would mean loss of one stem cell would be corrected 
by the duplication of another to maintain homeostasis. A scaling form mathematical equation 
was used that allowed the hierarchical and equipotent stem cell organisations to be 
distinguished (Lopez-Garcia et al., 2010). There data exhibiting features of monoclonal 
conversion fitted the ‘scaling form’ mathematical equation, agreeing with an equipotent stem 
cell organisation where stem cells are being replaced laterally according to neutral drift 
dynamics. 
A similar study was conducted by Snippert et al who used an inducible labelling system that 
was able to express multiple fluorescent markers within Lgr5+ stem cells of the crypt also via 
Cre-mediated recombination (Snippert et al., 2010). They also used a version of the ‘scaling 
form’ mathematical equation to give some insight into their clone size distributions data over 
time. They found that Lgr5+ stem cells showed a convergence onto scaling behaviour over 
time, meaning Lgr5+ stem cells were following a pattern of neutral drift stem cell dynamics 
with stem cell clone loss compensated by stem cell clone gain. This study partially ruled out 
the existence of a hierarchical stem cell organisation over short time periods. This indicates 
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that the likely organisation of stem cells within crypts is of an equipotent stem cell population 
undergoing loss and replacement via a mechanism of neutral drift dynamics via symmetric 
stem cell division. 
In recent years, there has been much debate over the gene expression profile that defines the 
definitive stem cell population within crypts. This is due to the heterogeneity in gene 
expression profiles found within clonogenic cells at the crypt base. Lgr5 and Bmi1 are two of 
the most highly expressed genes within crypt base columnar (CBC) cells, with cells 
expressing high levels of these genes having the capacity to regenerate crypts (Sangiorgi and 
Capecchi, 2008; Munoz et al., 2012). The stem cell niche of crypts may well contain stem 
cells with varying degrees of clonogenicity and functional redundancy that cannot be 
compartmentalised. However, Lgr5 expression seems to be the most favoured stem cell 
marker within small intestine due to their ability to regenerate all cell types of the crypt, and 
that fact that they fully contribute to tissue maintenance under normal conditions (Barker et 
al., 2007; Sato et al., 2009). The Lgr5+ cell lineage has even been identified within mouse 
intestinal adenomas, indicating that not only can they regenerate crypts, but also are the 
driving cells involved in tumour growth (Sato et al., 2009; Schepers et al., 2012). Stem cell 
markers have been described in detail within section 1.8.2. 
Due to the uncertainty in stem cell markers within mouse small intestinal crypt, a study was 
recently carried out that used a stem cell independent method of continuous clonal labelling 
(Kozar et al., 2013). This was carried out using a mouse model with an out of frame SYNbglA 
reporter gene within the constitutively expressed Rosa26 housekeeping locus within mice. 
The reporter gene included a dinucleotide repeat tract ([CA]30) that was susceptible to 
frameshift mutation. Once a frameshift mutation occurred, this would bring the reporter gene 
into frame, allowing the expression of the detectable marker protein (EYFP). As stem cells 
are the only cells that are long lived within crypts over the lifetime of the mouse, the majority 
of partially and fully labelled crypts detected within the intestinal epithelium must be derived 
from the stem cells. A mathematical model was constructed which modelled the appearance 
of partially and fully labelled clones, taking into account a constant mutation rate that was 
determined for frameshift mutation to occur, allowing the expression of the marker. A model 
of neutral drift was developed. They were able to fit their data to a model where between 5-7 
stem cells are present with a stem cell replacement rate between 0.2-0.3 stem cells per day. 
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It is more difficult to understand stem cell dynamics within human crypts as reporter gene 
insertion is not an option. Therefore, one must rely on naturally occurring characteristics 
within cells to defer stem cell lineage. Methylation pattern analysis has previously been used 
to determine clonal populations within human colonic crypts (Yatabe et al., 2001). They 
showed that methylation within crypt cells increased with age. However, they saw that there 
were considerable differences in methylation patterns between crypts, and was dependent on 
inter-crypt distances. Even so, a crypt model was developed to explain their data. An 
immortal stem cell neutral drift model was developed. Methylation pattern data fitted a model 
of neutral stem cell drift within a defined stem cell niche that incorporated elements of both 
symmetric and asymmetric stem cell division.  
Somatic mtDNA mutations resulting in COX deficient cells are also acquired with age and is 
another naturally occurring process which can be used for identifying stem cell lineage within 
crypts (see section 1.8.4) (Taylor et al., 2003). Neighbouring crypts that share the same 
somatic mtDNA point mutation have been shown to have extremely divergent methylation 
patterns (Graham et al., 2011). Neighbouring crypts sharing the same somatic mtDNA point 
mutation by chance has been shown to be extremely unlikely, with an odds ratio of >=2.48 x 
109 : 1 (see section 1.8.4).  (Greaves et al., 2006). This indicates that the mtDNA mutation 
was acquired and was able to expand via crypt fission, whilst in that same time frame, 
methylation patterns had diverged considerably. This demonstrates that COX deficiency may 
be a better method of stem cell lineage tracing compared with methylation patterns to 
determine stem cell dynamics within human crypts.  
Using somatic mtDNA mutations that result in COX deficiency as a stem cell lineage marker 
has recently been investigated using a limited number of patient samples (Baker et al., 2014). 
They rationalise that the crypt is a cellular conveyor belt where cells are shuttled from the 
stem cells to the orifice where they are shed into the gut lumen (Wright and Alison, 1984). 
From their patient samples they identify partially COX deficient crypts which are then 
serially sectioned and reconstructed as a three-dimensional crypt image. Mapping 
longitudinal crypts shows increasing and decreasing clone width from the bottom to the top 
of the crypt. They hypothesised that an increase in clone width meant there was symmetric 
stem cell division of a COX deficient stem cell resulting in the replacement of a neighbouring 
COX normal stem cell. A decrease in clone width was taken to mean a COX normal cell has 
replaced a COX deficient stem cell. They tested this theory using a computational model of 
crypt cellular dynamics which was constructed by van Leeuwen et al (van Leeuwen et al., 
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2009). The model showed that their hypothesis was indeed correct for their specified 
parameters. The changes in clone width within normal crypts were shown to be balanced, 
indicating a neutral drift type process. Their data also indicated that there were between 4 and 
6 stem cells within normal crypts. They also looked at adenomatous crypts which indicated 
there was an increased number of stem cells present with an increased stem cell replacement 
rate compared to normal crypts (Baker et al., 2014). 
Mathematical and computational modelling are extremely powerful tools, allowing 
hypotheses to be tested against an array of biological data. Unlike biological data, which has 
often been captured at a single time-point for each sample acquired, modelling allows the full 
lifetime of the process to be simulated, providing invaluable insight into the process as a 
whole. The model constructed by van Leeuwen et al (van Leeuwen et al., 2009) and used to 
validate a hypothesis by Baker et al (Baker et al., 2014) is a good example of the interplay 
between experimental and computational modelling approaches.  
The model by van Leeuwen et al was based on a previous model by Meineke et al (Meineke 
et al., 2001). The original model treated a 3-dimensional crypt as an unfolded 2 dimensional 
rectangular surface with the introduction of cell boundaries. Each cell was modelled 
deterministically which responded to intra, inter and extra cellular cues. The Meineke model 
included cell division, differentiation, and apoptosis parameters, along with mechanical force 
determination on each cell boundary. Each cell boundary used Delaunay triangulation and 
Voroni tessellation to determine each cell’s centre, shape and size. The addition of the van 
Leeuwen model incorporated specific Wnt features (van Leeuwen et al., 2009). This included 
an extra-cellular Wnt concentration gradient. A cell-cell adhesion module which would be 
dependent on Wnt concentration due to β-catenin’s involvement with both the Wnt pathway 
(APC destruction complex) and cell-cell adhesion (binding to the cytosolic tail of the cell-cell 
interacting protein E-cadherin). A cell cycle module was also incorporated as Wnt has an 
effect on downstream gene transcription and translation, in particularly, those genes involved 
in cell cycle control. Therefore, making a more robust model of crypts as a whole. The 
project was part of an international endeavour for integrative biology which led to the 
modelling of other tissue types, for instance the heart (Gavaghan et al., 2005; van Leeuwen et 
al., 2007). This led to a fully engineered computational tool for biomedical applications and 
is no known as CHASTE (Cancer, Heart and Soft Tissue Environment) (Pitt-Francis et al., 
2008). 
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The van Leeuwen model simulated the propagation of COX deficiency within crypts and 
found that they could only achieve monoclonal conversion of a crypt when stem cell 
positions were not fixed. Indicating that symmetric division is taking place the majority of the 
time in order for monoclonal conversion to be achieved within their model (Meineke et al., 
2001; van Leeuwen et al., 2009). 
1.9 AIMS AND OBJECTIVES  
This thesis sets out to understand the mechanism by which mitochondrial dysfunction is able 
to accumulate within ageing colonic epithelium in conjunction with the potential impact of 
mitochondrial dysfunction on the stem cells themselves. 
 Determine the mechanism by which mitochondrial dysfunction is able to accumulate 
within: individual stem cells, individual crypts, and within colonic epithelium as a whole 
using computational modelling techniques by: 
 
o Acquiring experimental data sets of COX deficiency within human colonic 
epithelium to use as reference data. 
 
o Developing a model that incorporates known elements of mtDNA clonal 
expansion and stem cell niche succession. 
 
o Investigating whether COX deficiency is indeed a good marker of stem cell 
lineage tracing within colonic epithelium. 
 
o Determining optimum parameter sets that shed light on the mechanism by which 
COX deficient stem cells are able to accumulate within colonic epithelium. 
 
 Determine what the impact is of mitochondrial dysfunction on stem cell function by: 
 
o Validating a mouse model that allows the visualisation of stem cells in 
conjunction with accumulating feasible levels of mitochondrial dysfunction to 
investigate. 
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o Implement a method that can compare the cell cycle kinetics between normal and 
respiratory deficient stem cells and crypts as a whole. 
 






















Materials and Methods 
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Chapter 2 Materials and methods 
2.1 MATERIALS 
2.1.1 Equipment and computer software 
Antigen Retrieval Unit 2100 Retriever 
Axioimager Zeiss 
BX51 Stereology Microscope Olympus 
MATLAB R2015a MathWorks 
Microtome Microm 
Rotatest shaker R100 Luckham 
Stereoinvestigator MBF Bioscience 
Zen 2011 Carl Zeiss Microscopy 
2.1.2 Consumables 
2.1.2.1 General consumables 
5-Chloro-2-deoxyuridine thymidine (CldU) Sigma-Aldrich 
5-Iodo-2-deoxyuridine (IdU) Sigma-Aldrich 
Avidin/biotin blocking kit Vector Laboratories 
Colourcoat+ adhesion microscope slides CellPath 
Disodium hydrogen phosphate AnalaR 
Ethanol Fisher Scientific 




Formalin solution, neutral buffered, 10% Sigma-Aldrich 
Histoclear National Diagnostics 
Hoechst 33342, trihydrochloride, trihydrate Life Technologies 
Hydrochloric acid 37% VWR 
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Normal donkey serum Abcam 
Normal goat serum Sigma-Aldrich 
Paraformaldehyde solution 4% in PBS Santa-Cruz Biotechnology 
PBS tablets OXOID 
Potassium chloride Sigma-Aldrich 
Potassium dihydrogen phosphate AnalaR 
Prolong gold mounting medium Life Technologies 
Sodium chloride Sigma-Aldrich 
Tissue cassettes CellPath 
Tri-sodium citrate dihydrate VWR 
Trizma base Sigma-Aldrich 
Tween®-20 Sigma-Aldrich 
2.1.2.2 Antibodies 
Donkey anti-Mouse IgG H+L - AffiniPure TRITC Jackson ImmunoResearch 
Donkey anti-Rabbit IgG H+L - Alexa Fluor® 750 Abcam 
Donkey anti-Rat IgG H+L - AffiniPure Cy5 Jackson ImmunoResearch 
Goat anti-GFP (biotin) antibody Abcam 
Goat anti-Mouse IgG1 (biotin) Life Technologies 
Goat anti-Mouse IgG2a - Alexa Fluor® 546 Life Technologies 
Goat anti-Mouse IgG2b - Alexa Fluor® 488 Life Technologies 
Mouse anti-IdU antibody BD Bioscience 
Mouse anti-MTCO1 IgG2a antibody Abcam 
Mouse anti-NDUFB8 IgG1 antibody Abcam 
Mouse anti-VDAC1 IgG2b antibody Abcam 
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Rabbit anti-Ki67 Abcam 
Rat anti-CldU antibody Novus Biologicals 
Streptavidin, Alexa Fluor® 488 Life Technologies 
Streptavidin, Alexa Fluor® 647 Life Technologies 
2.1.3 Solutions 
TBST pH 7.4 5 mM Trizma base 
 100 mM Sodium chloride 
 0.1% (v/v) Tween®-20 
  
PBS pH 7.4 137 mM sodium chloride 
 2.7 mM potassium chloride 
 10 mM disodiuum hydrogen 
phosphate 
 
 1.8 mM potassium dihydrogen 
phosphate 
  
EDTA antigen retreival buffer pH 8.0 1 mM EDTA 
  
Sodium citrate antigen retrieval buffer pH 6.0 10 mM tri-sodium citrate 
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2.2 METHODS 
2.2.1 Subjects and colorectal mucosal samples 
Human colorectal mucosal samples were collected from the same anatomical site (10 cm 
from the anal verge) from patients (n=148, age range 17-78 years) undergoing colonoscopy 
for disturbed bowel function in whom no evidence of bowel disease was identified (BORICC 
1 Study). Ethical approval was obtained from the Northumbria NHS Trust Local Research 
Ethics Committee. 
2.2.2 Mouse models  
2.2.2.1 PolγA(-/-) mitochondrial mutator mice 
Mitochondrial mutator mice (PolγA(-/-)) were generated with a knock-in missense mutation 
(D257A) that changes the amino acid from aspartic acid to alanine within the second 
proofreading domain of the PolγA catalytic subunit of the mtDNA polymerase gamma 
(Trifunovic et al., 2004). PolγA(-/-) male mice (n=4) were originally obtained from a well-
established colony kindly donated by Tomas Prolla, Department of Genetics and Medical 
Genetics, University of Wisconsin, Madison, USA. PolγA(-/-) male mice were mated with 
female C57Bl/6J wild-type mice (Charles River Laboratories). The resulting PolγA(+/-) female 
and PolγA(+/-) male mice were mated to propagate our own colony of PolγA(-/-) mice (Figure 
2-1). All mice were maintained within the comparative biology centre at Newcastle 
University where they were kept in individually ventilated cages with RM3 expanded chow 
provided by special diet services. Mice were kept in a room with a constant temperature of 
25˚C with a 12 hour light/dark cycle. 




2.2.2.2 Lgr5-EGFP-Ires-CreERT2 mice and PolγA(-/-) mitochondrial mutator mice 
Lgr5-EGFP-Ires-CreERT2 (Lgr5(+/-)) mice were generated by homologous recombination in 
embryonic stem cells targeting an EGFP-Ires-CreERT2 cassette to the ATG of Lgr5. This 
resulted in the constitutive expression of the EGFP fluorescent reporter protein within cells 
that normally express Lgr5, with the abolishment of Lgr5 gene expression (Barker et al., 
2007). Lgr5(-/-) mice were embryonic lethal, indicating the importance of Lgr5 during 
development. Lgr5(+/-) were backcrossed with C57Bl/6J mice for at least 4 generations before 
being donated to Jackson Laboratories, where they were mated with C57Bl/6J inbred mice. 
Lgr5-EGFP-Ires-CreERT2 were kindly donated by Karen Vousden, Beatson Institute for 
Cancer Research, Glasgow, UK. PolγA(+/-) male mice were mated with female Lgr5(+/-) mice. 
The resulting PolγA(+/-)Lgr5(+/-) female and PolγA(+/-)Lgr5(+/+) male mice were mated to 
propagate our own colony of mice (Figure 2-2). All mice were maintained within the 
comparative biology centre at Newcastle University where they were kept in individually 
Figure 2-1 Mitochondrial mutator mouse breeding scheme 
PolγA( -/-) male mice were mated with wild type C57Bl/6J female mice. The resulting PolγA(+/- ) 
female and PolγA(+/- ) male mice were mated to propagate the colony of  PolγA( -/-), PolγA(+/-) and 
PolγA(+/+) mice. 
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ventilated cages with RM3 expanded chow provided by special diet services. Mice were kept 
in a room with a constant temperature of 25˚C with a 12 hour light/dark cycle. 
  
2.2.3 Double thymidine analogue labelling 
Thymidine analogue labelling allows cells undergoing DNA replication to be identified via 
immunohistochemical and immunofluorescence techniques. With the help of Dr Elizabeth 
Stoll (Newcastle University), a method was adapted for thymidine analogue labelling of cells 
within the gut (Stoll et al., 2011). CldU (Sigma Aldrich) and IdU (Sigma Aldrich) were made 
up at a concentration of 5mg/ml in PBS and then filter sterilised. The dissolution of IdU 
required 55°C for 8 hours followed by dropwise addition of 2M NaOH. The IdU solution was 
then set to pH7.4. The in vivo concentration was 50mg/kg, therefore, the injection volume 
was 10µl per gram of animal weight. Thymidine analogues were administered via 
intraperitoneal injection. The injection schedule was as follows: 
 
Figure 2-2 Lgr5 and mitochondrial mutator mouse breeding scheme 
PolγA(+/-) male mice were mated with Lgr5(+/-) female mice. The resulting PolγA(+/-)Lgr5(+/-) female 
and PolγA(+/-)Lgr5(+/-) male mice were mated to propagate the colony of  PolγA( -/-)Lgr5(+/-), 
PolγA(+/-)Lgr5(+/-) and PolγA(+/+)Lgr5(+/-) mice. 
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Day 1 
Injection 1 10am CldU 50 mg/kg 
Injection 2 6pm CldU 50 mg/kg 
Day 2 
Injection 3 10am CldU 50 mg/kg 
Injection 4 6pm CldU 50 mg/kg 
Day 3 
Injection 5 10am CldU 50 mg/kg 
Injection 6 6pm CldU 50 mg/kg 
Day 4 
Injection 7 10am CldU 50 mg/kg 
Injection 8 6pm IdU 50 mg/kg 
Day 5 
Animal sacrificed between 8-10am (~15 hours after IdU injection). 
2.2.4 Mouse tissue harvesting 
Mice were killed by cervical neck dislocation. All tissues were harvested. Mouse colons were 
removed and flushed with phosphate buffered saline (PBS), pH7.4 to remove any faeces and 
pellets. The colon was then cut longitudinally, placed onto a paraffin wax dish and splayed 
open before pins were inserted around the edge. All tissues were fixed using 10% neutral 
buffered formalin for 24 hours. After fixing, the colon was rolled up into a coil with a pin 
inserted to keep the orientation. All tissues were then transferred to 70% ethanol to await 
tissue processing and paraffin embedding. 
2.2.5 Immunofluorescence for mitochondrial dysfunction 
Formalin fixed paraffin embedded mouse colon blocks were cut at a thickness of 3µm using 
the microtome. Tissue sections were floated out at 40˚C and lifted onto glass slides. They 
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were dried in the 37˚C incubator overnight before immunofluorescence was carried out. 
Sections were deparaffinised and rehydrated via a 20 minute incubation at 60˚C followed by 
2 x 10 minute submersions in Histoclear (National Diagnostics), 2 x 5 minute submersions in 
100% Ethanol, 1 x 5 minute submersion in 95% Ethanol, 1 x 5 minute submersion in 70% 
Ethanol, 1 x 5 minute submersion in distilled water. Antigen retrieval was carried out via 
submersing the sections in 1mM EDTA for 40 minutes within the antigen retrieval unit (2100 
Retriever). Sections were then washed 3 x 5 minutes in TBST on the shaking incubator, all 
subsequent wash steps were performed this way. The sections were then incubated with 10% 
normal goat serum (NGS) (Sigma Aldrich) for 1 hour at room temperature followed by a 
wash step. An Avidin/Biotin blocking kit (Vector Laboratories) was used due to the types of 
antibodies that were being used. Avidin was added to the sections for 15 minutes at room 
temperature followed by a wash step. Biotin was added to the sections for 15 minutes at room 
temperature followed by a wash step. Primary antibodies were added to the sections and 
incubated at 4˚C overnight followed by a wash step. Primary antibodies included mouse α-
NDUFB8 IgG1 (Abcam) at a 1:50 dilution, mouse α-MTCO1 IgG2a (Abcam) at a 1:200 
dilution, and mouse α-VDAC1 IgG2b (Abcam) at 1:200 dilution. Secondary antibodies were 
added to the sections and incubated in the dark at 4˚C for 2 hours followed by a wash step. 
Secondary antibodies included goat α-mouse IgG1 biotin (Life Technologies) at a 1:400 
dilution, goat α-mouse IgG2a-TRITC (Life Technologies) at a 1:400 dilution, and goat α-
mouse IgG2b-FITC (Life Technologies) at a 1:400 dilution. Streptavidin conjugated Cy5 
(Life Technologies) was added to the sections at a dilution of 1:200 and incubated in the dark 
at 4˚C for 2 hours followed by a wash step. Hoechst (Life Technologies) was added to the 
sections as a nuclear counterstain at a dilution of 1:1200 and incubated in the dark at room 
temperature for 15 minutes followed by a wash step. The sections were mounted in Prolong 
gold (Life Technologies) using a coverslip and placed in the -20° freezer until ready to be 
viewed by fluorescence microscopy. 
2.2.6 Immunofluorescence for cell cycle kinetics 
Formalin fixed paraffin embedded mouse colon blocks were cut at a thickness of 3µm using 
the microtome. Tissue sections were floated out at 40˚C and lifted onto glass slides. They 
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were dried in the 37˚C incubator overnight before immunofluorescence was carried out. 
Sections were deparaffinised and rehydrated via a 20 minute incubation at 60˚C followed by 
2 x 10 minute submersions in Histoclear (National Diagnostics), 2 x 5 minute submersions in 
100% Ethanol, 1 x 5 minute submersion in 95% Ethanol, 1 x 5 minute submersion in 70% 
Ethanol, 1 x 5 minute submersion in distilled water. Antigen retrieval was carried out via 
submersing the sections in sodium citrate antigen retrieval buffer for 40 minutes within the 
antigen retrieval unit (2100 Retriever). Further antigen retrieval was carried out by 
submersing the sections in 1.5M HCl at room temperature for 40 minutes. Sections were then 
washed 3 x 5 minutes in TBST on the shaking incubator, all subsequent wash steps were 
performed this way. The sections were then incubated with 10% normal donkey serum (NDS) 
(Abcam) for 1 hour at room temperature followed by a wash step. An Avidin/Biotin blocking 
kit (Vector Laboratories) was used due to the types of antibodies that were being used. 
Avidin was added to the sections for 15 minutes at room temperature followed by a wash 
step. Biotin was added to the sections for 15 minutes at room temperature followed by a wash 
step. Primary antibodies were added to the sections and incubated at 4˚C overnight followed 
by a wash step. Primary antibodies included rabbit α-Ki67 IgG (Abcam) at a 1:50 dilution, rat 
α-CldU IgG (Novus Biologicals) at a 1:200 dilution, mouse α-IdU IgG (BD Biosciences) at a 
1:100 dilution, and goat α-GFP IgG biotin (Abcam) at a 1:100 dilution. Secondary antibodies 
were added to the sections and incubated in the dark at 4˚C for 2 hours followed by a wash 
step. Secondary antibodies included streptavidin conjugated FITC (Life Technologies) at a 
1:400 dilution, donkey α-mouse IgG (H+L) TRITC (Jackson ImmunoResearch) at a 1:200 
dilution, donkey α-rat IgG (H+L) Cy5 (Jackson ImmunoResearch) at a 1:100 dilution, and 
donkey α-rabbit IgG (H+L) Cy7 (Abcam) at a 1:50 dilution. Hoechst (Life Technologies) was 
added to the sections as a nuclear counterstain at a dilution of 1:1200 and incubated in the 
dark at room temperature for 15 minutes followed by a wash step. The sections were mounted 
in Prolong gold (Life Technologies) using a coverslip and placed in the -20° freezer until 
ready to be viewed by fluorescence microscopy. 
2.2.7 Fluorescence microscopy and image analysis 
An Axioimager (Zeiss) microscope was used to image the tissue sections that had undergone 
immunofluorescence (described in section 2.2.5 and 2.2.6). Axiovision software was used in 
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conjunction with the Axioimager microscope to take fluorescence images. Using the 
monochrome camera, no primary control sections were used to optimise exposure times to 
eliminate autofluorescence and secondary antibody non-specific binding. With those 
exposure times, a large tiled fluorescence image of the whole tissue section was constructed 
from individual 10x images for those sections that had primary antibodies applied. Large tiled 
images were used to count crypts that had COX-1 (Complex IV) and NDUFB8 (Complex I) 
loss of expression. Large tiled images were also used to identify crypts that contained cells 
that were EGFP+, indicating their Lgr5+ status. Individual crypts that were EGFP+ had 40x 
images taken from serial sections that had undergone immunofluorescence for mitochondrial 
dysfunction and cell cycle kinetics. Therefore, the OXPHOS status, cell cycle kinetics, and 
Lgr5+ stem cells were identified for each crypt and for each cell within that crypt. Analysis 
of OXPHOS status, cell cycle markers, and Lgr5+ stem cells was conducted using the ZEN 
2011 software with its graphical user interface console.  
2.2.8 COX/SDH histochemistry 
COX/SDH histochemistry was carried out on patient biopsy sections by Dr Laura Greaves in 
2006 using the following protocol: 
Normal human colonic mucosal biopsies were attained from patients ranging between 17 – 
78 years of age. Colon samples were mounted for sectioning and frozen in isopentane, 
previously cooled to -160°C in liquid nitrogen. A dual histochemical assay was used to 
determine the cytochrome c oxidase activity (proxy for respiratory deficiency) of the crypts. 
Cryostat sections (12 µm) were first incubated in cytochrome c oxidase medium (100 µM 
cytochrome c, 4 mM diaminobenzidine tetrahydrochloride, and 20 µg / ml catalase in 0.2 M 
phosphate buffer, pH 7.0) at 37°C for 50 minutes. Sections were then washed in PBS (3 x 5 
minutes) and incubated in succinate dehydrogenase (SDH) medium (130 mM sodium 
succinate, 200 µM phenazine methosulphate, 1 mM sodium azide, 1.5 mM nitroblue 
tetrazolium in 0.2M phosphate buffer, pH7.0) at 37°C for 40 minutes. Sections were washed 
in PBS, pH 7.4 (3 x 5 minutes) dehydrated in graded ethanol series (70%, 95%, 2 x 100%), 
cleared in Histoclear (National Diagnostics, Atlanta, Georgia, USA), and mounted in DPX 
(BDH Laboratory Supplies, Poole, United Kingdom). The same protocol was used in (Taylor 
et al., 2003). 
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2.2.9 COX/SDH histochemical analysis 
The Olympus BX51 microscope was used in conjunction with the Stereoinvestigator software 
(MBF Biosciences) to view the tissue sections that had previously undergone COX/SDH 
histochemistry. The slides were placed on the microscope stage and the 10x magnification 
lens was selected. Using the software programme, an auto-white balance was performed and 
a point of origin was selected for each tissue sample. The proportion of COX deficiency 
within every crypt exhibiting COX deficiency was calculated using the software’s contour 
option, which allowed the area to be calculated, allowing a percentage COX deficiency to be 
determined. For each patient biopsy, the number of partially and fully COX deficient crypts 
was recorded (Craig Stamp MRes 2012). Crypts which appeared to be undergoing fission 
were also counted and were also recorded as being normal or COX deficient. Furthermore, 
the number of COX deficient crypt colonies was recorded along with the number of COX 
deficient crypts within those colonies. The total number of crypts within the tissue section 
was counted in order for the data to be normalised. 
2.2.10 Computational modelling of respiratory deficient stem cells  
2.2.10.1 Mouse stem cell population model 
A stem cell model that simulated mtDNA relaxed replication and mtDNA random 
segregation within a population of rapidly dividing stem cells was developed within 
MATLAB (MathWorks). MtDNA mutation rate upon replication was modelled using a 
probability of acquiring a new mutated mtDNA molecule during replication of a normal 
mtDNA molecule. In the case of a mutation event, the number of mutated mtDNA molecules 
would be increased by one. The number of mtDNA molecules per cell was set at 200 based 
on previous simulations of mitotic cells (Coller et al., 2001). A parameter scan was 
conducted to determine the optimum mutation rate that matched experimentally observed 
COX deficiency data from wild-type C57Bl/6J, PolγA(+/-) and PolγA(-/-) mice when a level of 
>75% mutated mtDNA signified a COX deficient stem cell. Other parameters included the 
division rate which was once per day, hence 1080 divisions were used to account for a 
simulation time of 36 months. One-thousand cells were simulated to measure the percentage 
of cells harbouring COX Deficiency at each time point. Model code is included in the 
appendices (appendix 1.3.1) 
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2.2.10.2 Human stem cell niche model 
A more biologically relevant model of stem cell dynamics, mtDNA relaxed replication and 
mtDNA random segregation was developed within MATLAB (MathWorks) in order to test 
hypothesis of stem cell dynamics using human colon COX deficiency data as a reference. 
The computational multi- level model that was developed simulates the occurrence of mtDNA 
mutations within the human colon and their subsequent expansion/disappearance over the 
average human lifespan of 80 years. In the model, the colon is divided into individual crypts 
of approximately 2500 cells (Yatabe et al., 2001; Nicolas et al., 2007; Nooteboom et al., 
2010), of which all but the stem cells are constantly being lost and replaced by stem cell 
symmetric and asymmetric division. It’s assumed that only mutations occurring/expanding in 
the stem cells (but also present in the other cells of the crypt) survive for long enough to 
allow clonal expansion to take place in order for COX deficiency to be observed. Therefore, 
only the stem cells of the crypt are explicitly modelled. The model can simulate any fixed 
number of stem cells and any fixed number of mtDNA molecules throughout the simulation 
time of 80 years. Asynchronous stem cell division takes place approximately once per week 
(Potten et al., 1992; Kim and Shibata, 2002). For each stem cell upon division, the number of 
mtDNA doubles via relaxed replication, followed by random segregation of the mtDNA into 
2 groups, each representing a daughter cell compartment. The division can either be 
asymmetric, in which case one of the daughter cells is a stem cell and the other daughter cell 
is lost, or symmetric, in which case both or none of the daughter cells are stem cells. To keep 
the number of stem cells in the crypt constant, in case the number of stem cells in the crypt is 
different from the starting number after division, a randomly chosen stem cell either divides 
or is deleted. 
The stem cells are simulated to undergo 4171 asynchronous divisions during the lifetime of 
the crypt, based on the division rate being once every 7 days and the crypt being simulated 
for 80 years ((365/7)*80). Therefore, within an individual crypt simulation, there is a record 
of the number of mutated mtDNA molecules at each time point for each stem cell simulated. 
Before each division for each stem cell, the model simulates the acquisition of de novo 
mtDNA mutations according to the mutation rate specified and the use of a random number 
generator that generates a number between 0 and 1. Random doubling of mtDNA molecules 
occurs before division to simulate random genetic drift via relaxed replication. This was 
carried out using the following transition matrices which were designed by Dr Anze Zupanic 
(Eawag aquatic research) and then implemented into the model code. 
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A) Transition matrix for mtDNA molecule clonal expansion in a stem cell 
In each division cycle there are Ntot mtDNA molecules in the cell, out of which any number 
can carry a mutation. In the doubling step, N mtDNAs are chosen to replicate, however some 
of them can replicate more than once and some not at all (the choice is a random N-
combination with repetitions from a set of size Ntot). The transition matrix gives the 
probability that i mtDNA molecules carrying the mutation will be picked j times, and the 
non-mutant carrying mtDNA molecules N-j times. Each element of the matrix can be 
calculated by: 





















where i  [0,Ntot] is the number of mtDNA molecules carrying a mutation in the stem cells 
before mtDNA replication and  j  [0,Ntot]  is the number of mtDNA molecules carrying the 
mutation gained in the process of replication. If we insert N = Ntot = 200 into the equation 























For easier construction of the complete transition matrix, we can transform T1A into a 
201x401 size matrix T1B by moving each matrix row of T1A i columns to the right (which is 
equivalent to adding the number of mtDNA molecules carrying the mutation before 
replication to the new mtDNA molecules – the columns of T1B now represent the probability 
of getting a certain number of mtDNA molecules with a mutation after replication):  
 
𝑇1𝐵 (𝑖, 𝑗𝑗 + 𝑖) = 𝑇1𝐴 (𝑖, 𝑗) 
 
B) Transition matrix for mtDNA molecule segregation upon division 
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After replication of mtDNA, the Ntot + N mtDNA molecules are divided into two sets of the 
same size (the choice is a random (Ntot + N)/2-combination without repetitions). The 
transition matrix gives the probabilities that out of the k mtDNA molecules carrying the 
mutation in the mother stem cell, m will be chosen for one daughter cell. The transition 



























; (𝑚> 𝑘) 𝑜𝑟 (𝑚 < 𝑘 − (𝑁+𝑁𝑡𝑜𝑡)/2
; 𝑘,𝑚 = 0 𝑜𝑟 𝑘 = 400,𝑚 = 200
;𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒
 
where k  [0,Ntot+N] is the number of mtDNA molecules carrying a mutation before division 
in the mother stem cell and m  [0,(Ntot+N)/2] is the number of mtDNA molecules carrying 
the mutation in one of the daughter cells after division. If we insert N = Ntot = 200 into the 
equation above, we get: 
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Model code and transition matrices generation code are included within appendix 1.3.2 
(model code), 1.3.3.5 (relaxed replication transition matrices), and 1.3.3.6 (random 
segregation transition matrices). 
A figure of the model has been added to appendix 1.1. 
2.2.10.3 COX deficient stem cell distribution model 
The stem cell niche model simulates the emergence of COX deficient stem cells and their 
expansion and extinction over time. However, the biological data attained from human 
colonic tissue biopsies is a measure of COX deficiency percentage of individual crypts when 
viewed in transverse cross sections. Depending on where the tissue was cut will determine at 
which level the crypt is observed. As the majority of the crypt is made up of stem cell 
progeny and differentiated cells, it is highly likely that it is these cells that are observed as 
opposed to the stem cells at the base of the crypt. Therefore, a method for determining how 
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the number of COX deficient stem cells translates to the COX deficiency percentage higher 
up the crypt was required in order for the model data to be comparable with the biological 
data. 
‘Functional’ stem cells divide to produce stem cell progeny that rapidly divide and 
differentiate while they are being shuttled up the crypt due to expansion in cell numbers. This 
is analogous to a ‘conveyor belt’ of cells that are eventually shed off into the gut lumen. It is 
reasonable to assume that there is a scaling up of the number of cells that are clonally derived 
from a single ‘functional’ stem cell due to expansion in cell numbers. As it has been shown 
previously (Baker et al., 2014), within partially COX deficient human colonic crypts there is 
a ‘wiggle’ of COX deficiency from the base to the top of the crypt. This was explained by 
increased and decreased activity of COX deficient stem cell clones dividing symmetrically, 
creating a ribbon imprint of COX deficiency on the crypt wall. However, as there will also be 
competition between the stem cell progeny (derived from asynchronous stem cell divisions) 
that are rapidly dividing, it is likely that this will also contribute to the ‘wiggle’ that is 
observed within human colonic crypts. With this rationale, for each number of COX deficient 
stem cells that are present within the stem cell niche, there must be an associated probability 
distribution for the likely COX deficiency percentage observed.  
Therefore, a model was developed that assumes there is a doubling of the number of cells 
until a certain number of cells is surpassed (to replicate the cell expansion process), starting 
with the number of ‘functional’ stem cells. For each of the ‘functional’ stem cells that are 
COX deficient, random replication is simulated until the number of cells at the next level is 
reached. This process is repeated for each cell expansion level. The number of COX deficient 
cells at the top level is recorded (observation level). The simulation was run 100,000 times to 
determine a distribution for the number of COX deficient cells there are at the observation 
level (appendix 1.3.4.1). The data is then transformed into a probability distribution and used 
to convert the biological data into the number of likely COX deficient stem cells it likely 
represents (appendix 1.3.4.2 to 1.3.4.5). This probability distribution can also be reversed to 
relate COX deficient stem cell number to likely % COX deficiency (appendix 1.3.4.6). 
A method of random replication of cells to reach the subsequent level of the crypt was used 
to simulate the competition between equally fit competing populations within the crypt. The 
iterative equation used to carry out this random replication of COX deficient cells is 
described in Equation 2-1. 
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Equation 2.1 – Crypt Cell Expansion Equation 
Iterative equation describes how the probability is calculated to determine how many COX 
deficient stem cells will occupy the successive level in order to relate number of stem cells to 
number of potential transit amplifying cells that are COX deficient at the observation level. p = 
probability of COX deficient stem cell dividing to take up a place in the successive level, m = 
number of mutated stem cells, t = total number of cells at current level and r = replication event 
number where r = 1: t-1. The probability is recalculated for each dividing cell until the total 
number of cells at the current level is reached. The process is started again for each subsequent 
level with m initially set to the value it was at the end of the previous level. 
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Chapter 3 Mitochondrial dysfunction within human colon 
3.1 INTRODUCTION 
3.1.1 Mitochondrial dysfunction and ageing  
Ageing is characterised by the decline in an organism’s ability to function, manifesting with 
an increased likelihood of developing diseases and disabilities leading to the organism’s 
eventual death. This is caused by intracellular and extracellular damage accumulation 
(Kirkwood, 2005).   
Ageing was initially thought to be the result of normal cellular metabolism generating free 
radicals that go onto damage cellular constituents and connective tissues (Harman, 1956). It 
was later refined to involve mitochondria when it was discovered that they were the main 
source of reactive oxygen species (ROS) when the rate of oxygen consumption was linked to 
the accumulation of mitochondrial damage by radical oxygen species (ROS) (Harman, 1972). 
Therefore the free radical theory of ageing was transformed into the mitochondrial free 
radical theory of ageing (MFRTA). ROS inflict damage upon mitochondrial respiratory chain 
complexes and the mtDNA due to their close proximity to the site of ROS generation, leading 
to mitochondrial dysfunction (Fleming et al., 1982; Linnane et al., 1989). Mitochondrial 
dysfunction is a commonly observed feature within a variety of ageing tissues, for example 
prostate (Blackwood et al., 2011), liver (Fellous et al., 2009), stomach (McDonald et al., 
2008), and colon (Taylor et al., 2003). Morphological changes of dysfunctional mitochondria 
include size increase and decreased ultrastructural organisation within the cell (Miquel et al., 
1980; Beregi et al., 1988). They also exhibit decreased membrane potential, decreased ATP 
production and increased ROS generation (Ozawa, 1997; Kushnareva et al., 2002). Somatic 
mtDNA mutations that cause mitochondrial dysfunction have been linked to a variety of age-
related diseases which include macular degeneration (Blasiak et al., 2013), diabetes mellitus 
(Sivitz and Yorek, 2010) and certain neurodegenerative diseases such as Alzheimer’s and 
Parkinson’s disease (Reeve et al., 2008). 
3.1.2 Mitochondrial dysfunction within human colon 
Human colon is made up of millions of crypt-like structures, each containing approximately 
2000-5000 cells (Kim and Shibata, 2002). They contain multiple stem cells at the base which 
continually proliferate throughout life to renew the stem cell pool and generate stem cell 
progeny which regenerate the colonic epithelium (Loeffler et al., 1997). Unfortunately, there 
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are no robust markers for human colonic stem cells at present as current markers like CD44+ 
and CD133+ which enrich colon cancer initiating cells are too broadly expressed (see section 
1.8.2) (Haraguchi et al., 2008).  
Clonally expanded point mutations have been shown to cause mitochondrial dysfunction 
within human colonic crypts with age (Taylor et al., 2003). Through the histochemical 
reaction for COX activity, mitochondrial dysfunction can be observed within individual 
crypts and has been shown to increase exponentially with age (Taylor et al., 2003). Full and 
partially COX deficient crypts have been observed within these tissue sections. 3D 
reconstruction of a partial crypt shows a ribbon pattern emanating from the base of the crypt, 
demonstrating that respiratory deficiency is transferred from stem cells at the base of the 
crypts to their progeny. COX deficiency is essentially an irreversible marker of the 
respiratory deficient stem cell lineage (Taylor et al., 2003). Due to the stochastic nature of 
how the stem cell progeny migrate upwards through the crypt axis, it can be seen that there 
will be a range for the proportion of the crypt that is COX deficient, when viewed as a 
transverse cross section. 
However, even though there is an increase in mitochondrial dysfunction within human colon 
with age, due to the vast pool of functional redundancy (i.e. a vast array of crypts that have 
normal mitochondrial function when assessed via COX/SDH histochemistry) the colon is still 
able to carry out its function, if not to a reduced capacity. It is still debated as to the specific 
impact mitochondrial dysfunction has on crypts but it has been shown to have a mild effect 
on the proliferative capacity within the stem cell progeny (Nooteboom et al., 2010). 
3.1.3 Monoclonal conversion of crypts 
Human colonic crypts have been shown to be clonal in nature, meaning that over time all the 
cells originate from the same founding stem cell clone. This has been shown in patients with 
the XO/XY genetic background whereby their crypts either contain wholly XY sex 
chromosomes, or wholly XO sex chromosomes (Novelli et al., 1996). This phenomenon was 
explored using the R26R-Confetti/Cre recombinase reporter mouse where random expression 
of different fluorescent proteins could be induced within mouse small intestinal crypts 
(Snippert et al., 2010). At first, each crypt contained multiple fluorescent colours; however, 
after 30 weeks, each crypt contained a single fluorescent colour, highlighting the process of 
monoclonal conversion over time within individual crypts. Kozar et al. investigated stem cell 
lineage tracing within mouse small intestinal crypts. They constructed a mouse that had a 
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[CA]30 dinucleotide repeat unit in the promoter region of a reporter gene, which was 
susceptible to frameshift mutation due to strand slippage during replication. Upon frameshift 
mutation, the gene would be brought into frame allowing expression of the reporter gene. 
Mice were killed at different time points and the expression of the reporter was analysed 
within the small intestine. Partially and fully labelled crypts were observed. Levels of 
partially labelled crypts remained constant with age, whereas levels of fully labelled crypts 
increased linearly with age (Kozar et al., 2013). This further highlights the process of 
monoclonal conversion over time within individual crypts. As fully and partially COX 
deficient crypts can be observed within human colon, this suggests that, like the examples 
above, they are in a state of undergoing monoclonal conversion. At present, the number of 
functional stem cells within human colonic crypts is an active area of research. Estimates 
within mouse studies suggest there are approximately 16 stem cells within mouse small 
intestinal crypts (Snippert et al., 2010), whereas estimates range between 4 and 7 stem cells 
for mouse and human colonic crypts (Kozar et al., 2013; Baker et al., 2014). 
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3.2 AIMS OF STUDY 
This study aimed to quantify the extent of mitochondrial dysfunction (COX deficiency) 
within human colon tissue biopsies at a depth that has not been achieved previously. This was 
in order to possess a robust data set that would allow further investigation into the process of 
monoclonal conversion within human colonic epithelium tissue. The in-depth quantification 
included: 
1. Number of partially / fully COX deficient crypts (Craig Stamp MRes Dissertation 
2012). 
2. Percentage COX deficiency of each individual crypt (Craig Stamp MRes Dissertation 
2012). 
3. Number of normal / COX deficient crypts undergoing crypt fission. 
a. Percentage COX deficiency of each crypt undergoing fission. 
4. Number of COX deficient crypt colonies. 
5. Number of COX deficient crypts making up each colony. 
a. Percentage COX deficiency of each crypt within a colony. 
This chapter forms the in-depth quantification and analysis of human colon biological data 
that was necessary to carry out further work into understanding the mechanism of 
monoclonal conversion that allows mitochondrial dysfunction to accumulate within human 
colonic epithelium. 
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3.3 METHODOLOGY 
3.3.1 COX deficiency quantification within human colonic mucosa 
148 slides containing human colon tissue sections had already undergone COX/SDH 
histochemistry by Dr Laura Greaves (Newcastle University) in order to visualise focal 
respiratory chain enzyme deficiency (cytochrome c oxidase (COX) deficiency at Complex 
IV), which was the result of clonally expanded mtDNA point mutations (section 2.2.8). COX 
deficiency was quantified using the Olympus BX51 microscope (section 2.2.9). The 
percentage fraction of partially and fully COX deficient crypts for each individual crypt was 
quantified (Craig Stamp MRes Dissertation). The number of normal and COX deficient 
crypts undergoing fission was quantified. The number of COX deficient crypt colonies or 
patches was quantified, together with the number and percentage fraction of COX deficienc y 
of each crypt within each colony. Data was normalised as a percentage of the total number of 
crypts present within the tissue section. 
3.3.2 Relating COX deficiency observed to fraction of stem cells  
COX deficiency fractions were quantified for transverse COX deficient crypts. However, the 
accumulation of COX deficiency would be modelled purely within the stem cell compartment 
(section 2.2.10.2). Stem cell dynamics have been well characterised within mouse models 
using the assumption that the fraction of stem cell progeny cells displaying a stem cell 
lineage marker represents the same fraction of stem cells with that marker (Lopez-Garcia et 
al., 2010; Snippert et al., 2010; Kozar et al., 2013). Within this study however, a relationship 
between the fraction of COX deficient stem cells present within the stem cell niche and the 
fraction of COX deficient stem cell progeny cells was sought. This would allow model and 
biological data to be comparable. The model that was developed relating the number of stem 
cells COX deficient and the observed COX deficiency fraction has been described (section 
2.2.10.3) with model code contained within appendix 1.3.4.  
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3.4 RESULTS 
3.4.1 Characteristics of human colon epithelium after COX/SDH histochemistry 
There are a range of features present within human colonic epithelium after COX/SDH 
histochemistry has been performed. Features include partially and fully COX deficient crypts, 
patches of COX deficient crypts and crypts undergoing fission. The identification and 
quantification of these features forms the majority of this chapter. It was important to be able 
to identify these features in order to achieve the most reliable data set that shows how COX 
deficiency within human colon changes with age. Figure 3-1A shows a crypt that is 
completely brown following COX/SDH histochemistry. Therefore, all the cells/stem cell 
progeny observed in this crypt’s transverse cross section have normal cytochrome c oxidase 
activity and are deemed respiratory normal or COX positive (COX+ve). Figure 3-1B shows a 
crypt that is partially blue with the rest being brown following COX/SDH histochemistry. 
Only a fraction of the cells/stem cell progeny observed in this crypt’s transverse cross section 
have deficient cytochrome c oxidase activity and are deemed respiratory deficient or COX 
deficient (COX-ve), making this a partially COX deficient crypt. Figure 3-1C shows a crypt 
that is completely blue following COX/SDH histochemistry. This means that all the 
cells/stem cell progeny observed in this crypt’s transverse cross section have deficient 
cytochrome c oxidase activity, making this a fully COX deficient crypt. Figure 3-1D shows 
two respiratory normal crypts in the process of fission. Crypt fission is important for growth 
and repair of the colon and to keep the tissue in a homeostatic balance between crypt death 
and crypt renewal and is an important feature that must be taken into account. Figure 3-1E 
shows two COX deficient crypts undergoing fission, highlighting the fact that crypt fission 
occurs in both normal and COX deficient crypts. Figure 3-1F shows a colony of four COX 
deficient crypts and are thought to arise from one COX deficient stem cell clone. The 
majority of crypts that contribute towards a COX deficient crypt colony are fully COX 
deficient, however, where this was not the case, the percentage COX deficiency of each 
individual crypt that contributes towards a COX deficient crypt colony was ascertained. 
  





Figure 3-1 Characteristics of Human colon after COX/SDH histochemistry 
The percentage COX deficiency of individual crypts was quantified from human colon 
tissue biopsies that had been sectioned and subjected to COX/SDH histochemistry. 148 
human colon biopsies were included within this patient cohort with ages ranging from 17-
78 years. A variety of features are present within patient biopsies after COX/SDH 
histochemistry. (A) Respiratory normal crypts (cytochrome c oxidase activity present). (B) 
Partially COX deficient crypts (cytochrome c oxidase activity is only present in a fraction 
of cells observed). (C) Fully COX deficient crypt (cytochrome c oxidase is completely 
absent from all cells observed). (D) Respiratory normal crypts undergoing fission. (E) 
Respiratory deficient crypts undergoing fission. (F) COX deficient crypt colony of four 
fully COX deficient crypts. 
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3.4.2 Partially COX deficient crypts and stem cell number within human colon 
Partially COX deficient crypt percentages were pooled together from all patient samples to 
see the spread of the data as a whole. Figure 3-2A shows a schematic of partially COX 
deficient crypts with their associated percentage COX deficiency and is an example of how 
the pooled crypts were segregated into their nearest groups. Figure 3-2B shows the 
distribution of partially COX deficient crypts when they are grouped into 5% COX 
deficiency fractions. There is an increasing number of crypts in each fraction up until the 
20% fraction. After this, we see a gradual decrease until we reach the 95% fraction. This 
suggests that partially COX deficient crypts are more likely to exist with a low COX 
deficiency fraction compared to those with a high COX deficiency fraction. One explanation 
is that the frequency for a certain fraction is equivalent to the average amount of time that a 
partially COX deficient crypt can exist as that fraction. If this is the case, there must be a 
biological mechanism acting on this system to produce this result. The mechanism 
responsible for this effect has been investigated and is contained within chapter 4. 
As there is a peak in the data at the 0.2 COX deficiency fraction, this may represent the point 
at which the first COX deficient stem cell is acquired within the stem cell niche. If we say 
COX deficiency fraction peak is equal to 1/N (N = Number of stem cells present within a 
human colonic crypt). Then this would mean that there are approximately 5 stem cells 
contained within human colonic crypts. This is an emergent property when looking at pooled 
COX deficiency percentages within human colonic epithelium. A small number of stem cells 
within crypts, in line with approximately 5 has been corroborated within recent publicatio ns 
(Kozar et al., 2013; Baker et al., 2014). Therefore, for simplicity, the biological data was 
segregated into 6 fractions (0.0, 0.2, 0.4, 0.6, 0.8, 1.0) from now on to represent the presence 
of 5 stem cells within human colonic crypts  
  




Figure 3-2 Pooled partially COX deficient crypts 
The percentage COX deficiency of individual crypts was quantified from human colon 
tissue biopsies that had been sectioned and subjected to COX/SDH histochemistry. 148 
human colon biopsies were included within this patient cohort with ages ranging from 17-
78 years. Partially COX deficient crypt percentages were pooled from all patient samples 
of all ages. (A) Example schematic of transverse cross sections of crypts allocated to a 
specific percentage of COX deficiency from exact percentage data. (B) Graph showing the 
distribution of pooled partially COX deficient crypts separated into 5% COX deficiency 
fractions.  
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3.4.3 COX deficiency within human colon samples 
The percentage COX deficiency of each individual crypt from each individual patient biopsy 
section was quantified previously (Craig Stamp MRes 2012). The number of partially and 
fully COX deficient crypts along with the total number of crypts was also counted for each 
patient sample. Figure 3-3A shows that there is an exponential increase in partially COX 
deficient crypts with age (non-linear regression exponential doubling time 17.65 years, R2 = 
0.39). Figure 3-3B shows that there is an even greater exponential increase in fully COX 
deficient crypts with age (non-linear regression exponential doubling time 12.5 years, R2 = 
0.38). Figure 3-3C shows that there is a statistically significant increase in the ratio between 
fully and partially COX deficient crypts with age (linear regression R2 = 0.19, p < 0.001). 
This means that with increasing age, fully COX deficient crypts make up an increasing 
majority of COX deficient crypts present within human colon tissue. This indicates that a 
fully COX deficient crypt becomes fixed, with regards to a biological end-point, and persists 
within human colonic epithelium. This is what one would expect with monoclonal conversion 
of a single crypt. Figure 3-3D shows the data when the COX deficiency fraction of individual 
crypts is taken into account. Here, the data is grouped within 10 year age brackets and split 
into 6 COX deficiency fractions. What becomes clear from this graph is that with an 
increasing COX deficiency fraction, there is a decreasing frequency of COX deficient crypts 
for all age brackets up to fraction 0.8. This is then followed by a large increase in fully COX 
deficient crypts within fraction 1.0. It would also appear that the exponential increase we see 
in partially COX deficient crypts with age (Figure 3-3A) is also mirrored for each partially 
COX deficient fraction (Figure 3-3D). 
  




Figure 3-3 Human colon COX deficiency 
The percentage COX deficiency of individual crypts was quantified from human colon 
tissue biopsies that had been sectioned and subjected to COX/SDH histochemistry. 148 
human colon biopsies were included within this patient cohort with ages ranging from 17-
78 years. (A) Percentage of total crypts that are partially COX deficient correlated with 
age of sample (exponential curve doubling time = 17.65 yrs, R2=0.39). (B) Percentage of 
total crypts that are fully COX deficient correlated with age of sample (exponential curve 
doubling time = 12.50 yrs, R2=0.38). (C) Ratio between fully and partially COX deficient 
crypts correlated with age of sample (linear regression R2 = 0.17, P<0.0001). Line at y=1 
represents the point at which the number of fully and partially COX deficient crypts are 
equal. (D) COX deficient crypt percentage segregated based on the nearest COX 
deficiency fraction and split into 10 year age brackets. Error bars represent SEM. 
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3.4.4 Crypt fission occurrence within human colon 
Another feature that was present within human colon tissue samples was crypt fission. As can 
be seen in Figure 3-1D/E, this occurs within both normal and COX deficient crypts. As crypt 
fission has the potential to influence the number of COX deficient crypts within human 
colon, it was prudent to quantify the extent of crypt fission for both normal and COX 
deficient crypts. Figure 3-4A shows the percentage of total crypts that were undergoing 
fission, grouped for both normal and COX deficient crypts. The majority of COX deficient 
crypt fission events were those where both crypts observed within the fission event were fully 
COX deficient. Where this was not the case, the percentage COX deficiency of each 
individual crypt contributing towards crypt fission was recorded. For simplicity, all crypts 
harbouring any fraction of COX deficiency were labelled as COX deficient crypts undergoing 
fission. There were no instances where one crypt taking part in fission was normal and the 
other was COX deficient. This highlights the fact that crypt fission is essentially a transfer of 
the older crypts phenotype to the new crypt. This is most likely via stem cell duplication of 
existing stem cells, with the subsequent migration into new stem cell niche space, triggering 
the crypt fission event (Loeffler et al., 1993; Park et al., 1995; Loeffler et al., 1997; Garcia et 
al., 1999; Greaves et al., 2006). Figure 3-4A shows crypt fission events as a percentage of the 
total number of crypts within the tissue sections. The data has been grouped into 10 year age 
brackets and segregated based on whether normal or COX deficient crypt fission is taking 
place. Due to the large standard deviation, there seems to be a lot of variance within this data 
set. However, the mean value for each 10 year age bracket appears to be approximately 1% 
for normal crypt fission events. This is in contrast to COX deficient crypt fission events 
which have a smaller variance for each 10 year age bracket and an apparent increase with 
age. However, this may be due to there being more COX deficient crypts present within older 
human colon samples, meaning more chance of observing a COX deficient crypt fission 
event in the higher age brackets. Figure 3-4B shows crypt fission events as a percentage of 
either normal crypts or COX deficient crypts. Therefore, the influence of increasing number 
of COX deficient crypts with age was negated. Unsurprisingly, we still see normal crypts 
undergoing crypt fission at approximately 1% because they make up the overwhelming 
majority of crypts present. However, it does appear that there is an increase in the proportion 
of COX deficient crypts undergoing fission with increasing age. Furthermore, there seems to 
be a difference in the means between normal and COX deficient crypts in the higher age 
groups (56-65 years and 66-75 years) in Figure 3-4B. Therefore, this data was extracted for 
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the two groups and compared using a Mann Whitney U test for non-parametric data to see if 
there was a truly statistically significant difference between the two groups for both age 
brackets (Figures 3-4C/D). This test showed that there was a difference between normal and 
COX deficient percentage in the higher age groups only, indicating that in the higher age 
groups, crypts were more likely to undergo crypt fission if they were COX deficient. Linear 
regression was carried out on the fraction of normal crypts undergoing fission and the 
fraction of COX deficient crypts undergoing fission (Figure 3-4E/F). Normal crypts didn’t 
show any increase with age (linear regression R2 = 0.023, p = 0.0613), whereas COX 
deficient crypts show a statistically significant increase with age when a linear regression 
model with a Poisson distribution for non-parametric data was fitted to the data (p < 0.001). 
  















Figure 3-4 Crypt fission frequency between normal and COX deficient crypts  
Crypt fission occurrence was recorded from human colon tissue biopsies that had been 
sectioned and subjected to COX/SDH histochemistry. 148 human colon biopsies were 
included within this patient cohort with ages ranging from 17-78 years. Occurrence was 
segregated depending on whether the crypt was normal or COX deficient. (A) Crypt 
fission data was split into 10 year age brackets and graphed separately for normal and 
COX deficient crypts. Error bars represent standard deviation (B) Crypt fission data was 
grouped into either normal or COX deficient groups to determine the percentage of crypt 
fission occurring within the two groups. The data was split into 10 year age brackets and 
graphed separately for the normal and COX deficient groups. Error bars represent standard 
deviation. (C) The data from the 56-65 age bracket was extracted so normal vs COX 
deficient crypt fission could be compared. A Mann Whitney U test was performed for non-
parametric data and showed that there was a statistically significant difference between the 
two groups (p = 0.0096). (D) The data from the 66-75 age bracket was extracted so normal 
vs COX deficient crypt fission could be compared. A Mann Whitney U test was performed 
for non-parametric data and showed that there was a statistically significant difference 
between the two groups (p = 0.0361). (E) The percentage of crypts undergoing fission in 
the normal group from each patient sample was graphed in an x-y scatter plot and 
subjected to linear regression. There was no statistically significant increase with age (R2 = 
0.023, p = 0.0613). (F) The percentage of crypts undergoing fission in the COX deficient 
group from each patient sample was graphed in an x-y scatter plot and subjected to a 
generalised linear regression model with a Poisson distribution for non-parametric data. 
There was a statistically significant increase with age (p < 0.001). 
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3.4.5 COX deficient crypt colonies within human colon 
The last feature examined within human colonic epithelium were COX deficient crypt 
colonies. These are exemplified in Figure 3-1F. It has previously been shown that patches of 
fully COX deficient crypts within human colon are clonally related, with those crypts 
harbouring the same mtDNA mutation (Greaves et al., 2006). The overwhelming majority of 
COX deficient crypt colonies contained only fully COX deficient crypts. If there were 
colonies that harboured partially COX deficient crypts, the percentage COX deficiency of 
those crypts was recorded. For simplicity, the subsequent analysis counted partially COX 
deficient crypts as COX deficient and no distinction between partially and fully COX 
deficient was made. Figure 3-5A shows that there is an exponential increase in the number of 
COX deficient crypt colonies with age (exponential curve doubling time = 17.03 yrs, 
R2=0.21). When the COX deficient crypt colony data is split into 10 year age brackets and 
linear regression is conducted, there is a statistically significant increase in the number of 
COX deficient crypt colonies with age (linear regression R2 = 0.79, p = 0.0073) (Figure 3-
5B). The next question that was addressed was whether there was an increase in the average 
number of COX deficient crypts that contribute to a colony. It has been shown that there is an 
increase in the mean COX deficient patch size with age (Greaves et al., 2006). Figures 3-
5C/D address if this data set replicates this finding. It was determined from Figure 3-5C that 
the data contributing to this plot was not normally distributed as the smallest number of 
crypts that contribute to a colony is 2, which make up the majority of crypt colonies. 
Therefore, a method of non-parametric data analysis to determine whether there was an 
increase in the number of COX deficient crypts that contribute towards a colony was 
required. In order to do this, the median colony size was plotted for each patient sample 
(Figure 3-5D) and this data was subject to a generalised linear regression model with a 
Poisson distribution to test for a statistically significant increase in the median colony size 
with age. The result showed that there was not a statistically significant increase in the 
median colony size with age (R2 = 0.09, p = 0.157). 
  


















Figure 3-5 COX deficient crypt colonies within human colon 
The frequency of COX deficient crypt colonies and the number of crypts within each 
colony was recorded from human colon tissue biopsies that had been sectioned and 
subjected to COX/SDH histochemistry. 148 human colon biopsies were included within 
this patient cohort with ages ranging between 17-78 years. The percentage COX 
deficiency of each crypt contained within a COX deficient crypt colony was recorded. A 
crypt was included in the analysis of colonies if >20% of the crypt was COX deficient. 
(A) The number of COX deficient crypt colonies from each colon biopsy was correlated 
with age (exponential curve doubling time = 17.03 yrs, R2=0.21). (B) The number of COX 
deficient crypt colonies were grouped into 10 year age brackets and correlated with age. 
There was a statistically significant increase with age (linear regression R2 = 0.79, p = 
0.0073). Error bars represent standard deviation. (C) The distribution of the number of 
COX deficient crypts that contribute to a COX deficient crypt colony. (D) The number of 
COX deficient crypts within each colony was recorded and graphed according to age of 
sample. (E) The median number of crypts within a COX deficient crypt colony was 
graphed according to age of sample and fitted to a generalised linear regression model 
with a Poisson distribution for non-parametric data. There was not a statistically 
significant increase with age (R2 =0.09, p = 0.157). 
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3.4.6 Removal of crypt colonies from biological data 
We have assumed from previous literature that the emergence of COX deficient crypt 
colonies are the result of COX deficient crypt fission (Greaves et al., 2006). In chapter 4 it 
was necessary to model the accumulation of COX deficiency within human colonic 
epithelium with age. In order to have a wide variety of biological data to model, an additional 
data set that would remove the impact that COX deficient colony formation via crypt fission 
has on the biological data was required. The additional data set would contain only the de 
novo COX deficient crypts, thereby providing a data set that removed the effect of crypt 
fission. Figure 3-6A is a depiction of how the human colon COX deficiency data was 
manipulated. In the case of a crypt colony made up of purely fully COX deficient crypts, this 
would now only represent one fully COX deficient crypt in order to emphasise the de novo 
COX deficient crypts. However, as previously mentioned, a small minority of crypt colonies 
contained partially COX deficient crypts. In this case, the most frequent COX deficiency 
fraction was used to represent the colony. In the case of a colony being made up purely by 
partially COX deficient crypts, the mean COX deficiency fraction was used to represent the 
colony. Figure 3-6B shows the biological data before manipulation and Figure 3-6C shows 
the biological data after manipulation. Both data sets have been split into 10 year age brackets 
and according to COX deficiency fraction. From comparing the difference between the two 
data sets, we see that removing COX deficient colonies has impacted fully COX deficient 
crypts the most, highlighting the fact that the majority of crypts within COX deficient crypt 
colonies are fully COX deficient. 
  




Figure 3-6 Crypt colony correction for human colon COX deficiency data. 
The percentage COX deficiency of individual crypts along with the number of colonies 
and the number of COX deficient crypts within those colonies was quantified from human 
colon tissue biopsies that had been sectioned and subjected to COX/SDH histochemistry. 
148 human colon biopsies were included within this patient cohort with ages ranging from 
17-78 years. (A) Schematic representation of data manipulation that takes into account the 
presence of COX deficient crypt colonies. A COX deficient crypt colony was reduced to 
one COX deficient crypt with its percentage COX deficiency equal to that of the mode of 
the entire colony, in the majority of cases this was equal to 100%. If the colony was made 
up of partially COX deficient crypts only, the percentage COX deficiency was equal to the 
mean of the entire colony. (B) COX deficient crypt percentage segregated based on the 
nearest COX deficiency fraction and split into 10 year age brackets. Error bars represent 
SEM. (C) COX deficient crypt percentage segregated based on the nearest COX 
deficiency fraction and split into 10 year age brackets after the COX deficient crypt colony 
correction was performed. Error bars represent SEM. 
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3.4.7 Relating COX deficiency percentage to number of COX deficient stem cells  
In chapter 4, it was necessary to model the accumulation of COX deficiency within human 
colonic epithelium with age. This was done by assuming there is a relationship between the 
percentage COX deficiency that is observed within transverse cross sections of crypts, and 
the fraction of stem cells that are COX deficient within the stem cell niche of crypts. 
However, it can be assumed that there will be a distribution for the percentage COX 
deficiency observed for each fraction of COX deficient stem cells contained within the stem 
cell niche due to stochastic variation in the migration of COX deficient stem cell progeny. 
Therefore, a model was developed to simulate this stochastic variation in order to generate 
probability distributions that can be used for any number of stem cells that are said to be 
contained within the stem cell niche of human colonic crypts (appendix 1.3.4). Figure 3-7A 
depicts how the probability distributions can be used to relate number of COX deficient stem 
cells to percentage COX deficiency observed, and vice versa. Figures 3-7B-G shows the 
constructed probability distributions for 3 to 8 stem cells present in the stem cell niche, 
respectively. These generated probability distributions can be used to convert the COX 
deficiency data attained from human colon epithelium in the form of percentages per crypt 
into number of stem cells that are COX deficient within individual crypts when the total 
number of stem cells is assumed. These probability distributions can also be used to relate the 
number of stem cells COX deficient to a percentage COX deficiency observed at the 
transverse cross section. It can be seen that the more stem cells that are assumed to be present 
within the crypt, the narrower the probability distribution becomes for each number of stem 
cells within a crypt.  
  




















Figure 3-7 Model relating percentage COX deficiency observed to likely number of 
COX deficient stem cells 
A model was developed that stochastically simulated the propagation of COX deficient 
stem cell progeny as they migrate to the level at which the COX deficiency can be 
observed (appendix 1.3.4.1). Probability distributions were generated that allow the 
conversion of % COX deficiency observed to the likely number of COX deficient stem 
cells the percentage represents (appendix 1.3.4). (A) Schematic representation of a 
probability distribution where a crypt contains 5 stem cells. A probability distribution will 
be associated to each number of COX deficient stem cells, between 1 and 4 in this case. 0 
and 5 stem cells will have a probability of 1 for being associated with 0% and 100% 
observed, respectively. Probability distributions have been generated for crypts containing 
(B) 3 stem cells (C) 4 stem cells (D) 5 stem cells (E) 6 stem cells (F) 7 stem cells (G) 8 
stem cells. 
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3.4.8 Biological data converted to stem cell number 
In chapter 4, it was necessary to model the accumulation of COX deficiency within human 
colonic epithelium with age. The probability distributions generated in section 3.4.7 were 
used to convert COX deficiency percentage observed to number of stem cells COX deficient 
in order for subsequent modelling work to be comparable. Figures 3-8(A-F) shows the 
biological data represented as crypts containing a total of 3-8 stem cells, respectively. It can 
be seen that the probability distribution manipulation does not affect fully COX deficient 
crypts as they were initially represented as 100% COX deficiency, which will always 
correspond to the total number of stem cells contained within the stem cell niche being COX 
deficient. The same is true for 0% COX deficient (normal crypts), as these will always 
represent 0 stem cells being COX deficient, therefore probability distributions are not 
required for manipulating 0% and 100% COX deficiency to stem cell number. 
  




Figure 3-8 Distributional binning for COX deficient stem cell number 
Probability distributions were generated in order to relate the percentage COX deficiency 
observed at the transverse cross section of a crypt to the likely number of COX deficient 
stem cells that were present at the base of a crypt. Probability distributions can be 
generated for any number of stem cells specified to be present within the stem cell niche. 
The COX deficiency data from human colon was converted to number of stem cells using 
the probability distributions for (A) 3 stem cells, (B) 4 stem cells, (C) 5 stem cells, (D) 6 
stem cells, (E) 7 stem cells and (F) 8 stem cells being present within the stem cell niche of 
human colonic crypts. 
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3.5 DISCUSSION 
The quantification of COX deficiency within human colon tissue biopsies has previously 
been assessed (Taylor et al., 2003). However, this study classed a COX deficient crypt as 
those containing >50% COX deficiency. All other crypts were classified as normal for COX 
activity. Furthermore, the COX deficiency fraction of individual crypts was not taken into 
account, meaning the data obtained within this study has more depth and can be more useful 
when assessing the mechanism that allows the accumulation of COX deficiency within 
human colon. On the other hand, Taylor et al also showed that there was an exponential 
increase in COX deficient crypts with age, reaching ~16% at >80 years of age (Taylor et al., 
2003). 
The assessment of partially COX deficient crypts within this study has showed some 
interesting features. For instance, not only is there an exponential increase in the number of 
fully COX deficient crypts with age, but there is also an exponential increase in the number 
of partially COX deficient crypts as well, but to a lesser extent. This has important 
implications as in order to achieve this exponential in partially COX deficient crypts with 
age, there must be something driving an increase in the rate of partially COX deficient crypt 
acquisition. This is in contrast to what is shown in (Kozar et al., 2013) where they see a 
constant level of partially labelled crypts with age using there system. Granted, we are not 
comparing like for like between these two systems, for instance, mouse small intestine using 
a fluorescent reporter marker as a stem cell lineage marker vs human colon using COX 
deficiency as a stem cell lineage marker.  
Another interesting feature is the distribution of partially COX deficient crypts. For instance, 
the decreasing frequency of crypts with increasing COX deficiency fraction with a substantial 
frequency peak at the 0.2 COX deficiency fraction. This indicates that there are 
approximately 5 stem cells present within human colonic crypts and that partially COX 
deficient crypts spend more time in their small fraction form compared to their large fraction 
form. Baker et al corroborate that 4-6 functional stem cells reside within human colonic 
crypts also (Baker et al., 2014). Unfortunately, it was not possible to split the data up into 10 
year age brackets to determine whether the peak at the 0.2 COX deficiency fraction was 
present at all ages. This was because there was a substantial reduction and an unequal skew 
for the number of COX deficient crypts available within each age bracket. The only option 
was to pool the data from all 148 patient samples, which represented ~140,000 partially COX 
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deficient crypts, and determine the distribution for all age groups. If there were an infinite 
number of partially COX deficient crypts available, one should expect equal peaks at varying 
frequencies, with each peak being equal to the number of stem cells that are COX deficient at 
the base of the crypt, hence making it clearer as to the number of stem cells contained within 
human colonic crypts. The distribution of partially COX deficient stem cells is something that 
needs to be replicated when modelling accumulation of COX deficiency within human colon. 
Crypt fission has also been observed within this study. The data shows that when looking at 
the proportion of normal and COX deficient crypts undergoing fission, there is a statistically 
significant increase in the proportion of COX deficient crypts undergoing fission with age 
(Figure 3-4F). The data also shows a statistically significant difference between the fraction 
of normal crypts undergoing fission (around 1%) and the fraction of COX deficient crypts 
undergoing fission (around 3%) within age groups >56 years of age. This indicates that there 
is a greater chance of COX deficient crypts undergoing fission compared to normal crypts. 
As crypt fission is likely triggered by the actions of the stem cells contained at the base of 
crypts (Loeffler et al., 1993; Park et al., 1995; Loeffler et al., 1997; Garcia et al., 1999; 
Greaves et al., 2006), it is likely that stem cell perturbations caused by COX deficiency result 
in the increased likelihood of COX deficient crypts to undergo fission. Crypt fission is an 
important mechanism that has the potential to facilitate the increase in COX deficiency 
within the colon. This is an important feature that needs to be taken into account when 
modelling COX deficiency accumulation within the colon. 
COX deficient crypt colonies have also been observed within this study. We see there is an 
exponential increase in the number of COX deficient crypt colonies with age. This correlates 
well with the exponential increase in COX deficient crypts with age. However, unlike in a 
previous study (Greaves et al., 2006), this data does not show a statistically significant 
increase in COX deficient crypt colony size with age. The majority of COX deficient crypt 
colonies exist as 2 crypts. This adds weight to the hypothesis that crypt fission takes a 
substantial amount of time to complete and the chance of having many crypt fission events 
taking place within the same colony within the average human lifespan is small. 
3.6 CONCLUSION 
Conducting an in-depth investigation of COX deficiency within human colon from such a 
large cohort of patient samples has provided the framework for further work that sets out to 
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understand the processes involved in monoclonal conversion, which can account for the 
accumulation of COX deficiency within normal human colon tissue. 
Data sets have been generated which are comparable to data that can be produced from 
modelling the process of niche succession within individual crypts, with and without the 
influencing factor of crypt fission. This has been achieved by characterising crypt fission and 
COX deficient crypt colonies within human colonic epithelium. This has been further 
elucidated by accounting for the variation in COX deficiency percentage data and its 
relationship to the potential number of stem cells the COX deficiency percentage represents. 
This was an essential piece of data that was required before anything else and is why the first 
results chapter of this thesis is dedicated to the acquisition of the biological data from human 
colonic epithelium. 
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Chapter 4 Modelling stem cell dynamics within colonic epithelium 
4.1 INTRODUCTION 
Gut epithelium is one of the most attractive tissue types for studying the complex 
relationships that exists between many different cell types due to its defined stem cell niche 
and hierarchical structure. Small intestinal epithelium and colonic epithelium are the most 
widely looked at when investigating these relationships. The study of other tissue types is 
possible, however these often have an undefined stem cell niche, making it harder to study 
the complex interactions taking place between stem cells and their progeny (Morrison and 
Spradling, 2008). 
Intestinal and colonic epithelium harbour an array of millions of crypt-like structures that 
reside within the mucosal layer and is supported by the muscularis mucosae and muscularis 
externa muscle layers. Whereas the colonic epithelium is made up only of crypts, the small 
intestine contains additional protrusions into the lumen, called villi, in order to increase the 
epithelial surface area for maximum absorption of nutrients. As crypts are the independent 
units common to both tissue types, they have become the focus of many investigations that 
try to understand the mechanisms that drive the regeneration of the epithelium. This is not 
only to understand the mechanism that drives homeostasis within crypts, but also to 
understand how these mechanisms become perturbed, for instance during tumour formation 
and cancer progression. Crypt architecture makes these tissues ideally suited for the 
investigation of stem cell dynamics. 
It is widely known that multiple stem cells are present at the base of crypts (Scoville et al., 
2008) which function to regenerate the cells of the crypt throughout life, and hence the 
epithelium. This has been demonstrated by the fact that individual crypts can manifest 
multiple phenotypes (Griffiths et al., 1988; Winton et al., 1988; Park et al., 1995). There are 
many studies that have documented the process of monoclonal conversion of crypts from one 
phenotype, often a native state, to an altered phenotype, either induced or natural. As it has 
become widely known, the phenotype of the crypt is derived from the phenotype of the stem 
cells themselves. Monoclonal conversion of a crypt occurs due to the existence of competing 
phenotypes within the stem cell pool which are passed on to the stem cell progeny, and hence 
the crypt itself. All stem cells derived from a single founder are termed stem cell clones. With 
this in mind, it is reasonable to assume that the clone width (i.e. the number of cells observed 
within a crypt with an altered phenotype), as a percentage of the whole crypt, serves as a 
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fraction of stems cell clones present within the crypt (Lopez-Garcia et al., 2010; Snippert et 
al., 2010; Kozar et al., 2013). When all the stem cells within a niche become derived from the 
one stem cell clone, this is termed niche succession. It is assumed niche succession is the 
result of the complex stem cell dynamics that take place within the stem cell niche of crypts, 
which are influenced by both cell intrinsic and cell extrinsic factors. When stem cell 
dynamics are referred to, this takes into account the type of division event a stem cell 
undergoes and the resulting effect on the other stem cells within the same stem cell niche. 
Stem cell division events can be asymmetric (renewed stem cell and stem cell progeny) or 
symmetric (either two renewed stem cells or two stem cell progeny) in nature. Monoclonal 
conversion rules out purely asymmetric stem cell division tissue maintenance. Stem cell 
replacement via symmetric stem cell division allows stem cell clones to expand within their 
niche and explains the emergence of monophenotypic crypts over time. 
Aged human colonic epithelium contains both partially and fully COX deficient crypts 
(Taylor et al., 2003). Due to the presence of partially COX deficient crypts, this suggests that 
COX deficiency could be used as a stem cell lineage marker (Taylor et al., 2003). This is akin 
to studies conducted within mice that investigate stem cell dynamics using either inducible or 
stochastic markers for cell lineage tracing (Lopez-Garcia et al., 2010; Snippert et al., 2010; 
Kozar et al., 2013). Recently, COX deficiency was used to investigate stem cell dynamics 
within aged human colon (Baker et al., 2014). However, the use of COX deficiency as a 
neutral stem cell lineage marker requires more in-depth investigation as, unlike markers of 
mouse stem cell lineage, COX deficiency is by definition a pathogenic alteration to the stem 
cells cellular function. 
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4.2 AIMS OF STUDY 
This study aimed to investigate the mechanism by which COX deficiency accumulates within 
human colonic epithelium with age. A robust computational model would be developed that 
sheds light on the intra-crypt accumulation of COX deficiency with age  
In order to be as biologically accurate as possible, the acquisition of COX deficiency within 
individual stem cells would be stochastically simulated via relaxed replication and random 
segregation of mutated mtDNA molecules. Using biological data from human patients 
described in chapter 3, hypotheses would be tested as to the mechanism by which COX 
deficiency accumulates within colonic epithelium. 
Hypothesis were tested as variable parameters which included: 
1. Stem cell division dynamics (asymmetric vs symmetric stem cell division) 
2. Number of stem cells present within human colonic crypts 
3. Mitochondrial DNA mutation rate 
4. Crypt fission occurrence 
5. COX deficient stem cell advantage/disadvantage  
Using the most robust biological data in conjunction with the most biologically accurate 
model, optimum parameter sets were sought in order to explain how the process of niche 
succession, monoclonal conversion and hence, COX deficiency accumulation takes place 
within normal human colonic epithelium. 
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4.3 METHODOLOGY 
4.3.1  Computational model of human colonic stem cell dynamics  
A model simulating the accumulation of COX deficiency within a population of crypts was 
designed and constructed within MATLAB (MathWorks). It can be described as a multi-scale 
model simulating the acquisition and subsequent clonal expansion of mutated mtDNA 
molecules within individual stem cells, whilst simultaneously simulating the stem cell 
dynamics (asymmetric/symmetric stem cell division) within a stem cell niche, potentially 
leading to niche succession. A detailed description of the model is contained within section 
2.2.10.2. The model has been developed over the course of my MRes and PhD. A model 
development timeline is shown in Table 4-2. Each model has additional parameters that either 
allow hypothesis testing to be carried out, or make the model more biologically relevant. 
Models 1 and 2 were constructed during my MRes degree (Craig Stamp MRes Dissertation). 
Models 3-10 were constructed during my PhD and represent major enhancements. Table 4-1 
describes each parameter and enhanced functionality that is incorporated into the model. 
Table 4-1 Table of parameters and functionality 
Parameter Description 
numRuns The number of crypts being simulated within simulated 
colon. 
mutThreshold The fraction of mutated mtDNA (heteroplasmy) within 
individual stem cells that denotes a COX deficient stem 
cell. 
numDiv The number of division events per crypt. 
mtDNA The number of mtDNA molecules that are contained 
within each stem cell. 
initS The number of stem cells that are simulated within each 
crypt. 
P(asymmetric) The probability that a stem cell will undergo 
asymmetric stem cell division. The probability for 
symmetric division (P(symmetric)) is therefore 1-
P(asymmetric). P1(symmetric) is the probability that a stem cell 
will divide to produce 2 new stem cells. P2(symmetric) is 
the probability that a stem cell will divide to produce 2 
stem cell progeny cells. For each type of symmetric 
division (P1(symmetric) and P2(symmetric)) the probability is 1-
P(asymmetric)/2. 
P(CO XDefSC) The probability that a dividing stem cell will mutate 
into a COX deficient stem cell. 
Adv(CO XDefSC) The symmetric division advantage conveyed to COX 
deficient stem cells. Therefore, the probability that a 
COX deficient stem cell will divide symmetrically to 
produce 2 new stem cells is P1(symmetric)*Adv(COXDefSC). 
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With this, asymmetric stem cell division is reduced by 
this increased amount. Pnew(asymmetric) = P(asymmetric) - 
((P1(symmetric)*Adv(COXDefSC)) - P1(symmetric)). 
mutationRate For each mtDNA replication, a mutation rate as a 
probability that a mtDNA replication event will lead to 
the acquisition of a pathogenic mutation effecting COX 
activity if clonal expansion occurs. 
mutationRateFold The mutation rate fold increase from the first stem cell 
division to the stem cell division that represents an 80 
year lifespan of a human. 
cryptNormalPercentage The probability that crypt fission will be initiated at 
each stem cell division step. 
cryptFissionFactor The probability increase (cryptNormalPercentage * 
cryptFissionFactor) that determines the crypt fission 
probability for COX deficient crypts at each stem cell 
division step. 
mtDNASpeciesTracking1 The ability to track each newly acquired mtDNA 
mutation as an individual mtDNA species. Once a 
mtDNA molecule has acquired a mutation, no more 
mutations can be added. 
mtDNASpeciesTracking2 The ability to track each newly acquired mtDNA 
mutation as an individual mtDNA species. Multiple 
mutations can be acquired for each simulated mtDNA 
molecule. 
COXCorrectionFactor The number of stem cell divisions that occur for normal 
stem cells before COX deficient stem cells incorporate 
an additional division. 
COXDefCycleRepeats The number of additional divisions COX deficient stem 
cells undergo at the time point determined by 
COXCorrectionFactor. 
DivisionSegregationAdvantage The ability of mutated mtDNA molecules to incorporate 
a segregation bias upon asymmetric stem cell division. 
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4.4 RESULTS 
4.4.1 Human niche succession model 
A model of COX deficiency accumulation within human colon epithelium was developed and 
is described in section 2.2.10.2 with model code contained within appendix 1.3.2. The model 
simulates a population of crypts (numRuns). Each crypt contains a specified number of stem 
cells (initS), with each stem cell containing a specified number of mtDNA molecules 
(mtDNA). Asynchronous stem cell division occurs once per week, making the total number 
of divisions per stem cell equal to 4171 over 80 years (numDivs). Asymmetric (stem cell 
divides to replicate itself and produce a stem cell progeny cell) and symmetric (stem cell 
divides to produce two renewed stem cells or two stem cell progeny cells) stem cell division 
can take place at division and is determined by the probability of asymmetric division 
occurring (Pa). If Pa<1, then symmetric stem cell division probability is 1-Pa, with each form 
of symmetric division having a probability of occurring equal to ½(1-Pa). The base model 
simulates relaxed replication and random segregation of mtDNA molecules upon division. 
More simply, each stem cell division results in the stochastic doubling of the mtDNA pool 
with their subsequent stochastic segregation into two groups (i.e two daughter cells). Figure 
4-1 depicts the fate outcomes for each type of division that can take place within the model. 
Once the simulation is complete, an algorithm (appendix 1.3.3.4) takes the model data and 
converts it into COX deficiency frequency using 75% mutated mtDNA to confer a stem cell 
as COX deficient (mutThreshold). This allows the model data to be comparable to the 
biological data acquired. The model allows the emergence of partially and fully COX 
deficient crypts, therefore allowing the niche succession phenomenon to be investigated 
within human colon epithelium. 
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4.4.2 Human niche succession model testing 
Once the model was constructed, the model was tested by varying each parameter and 
determining the effect this has on the model output. The model output was in the form of 
COX deficiency frequency within simulated colon, segregated into 10 year age brackets, akin 
to the biological data. All model testing was performed assuming 5 stem cells were contained 
within the stem cell niche (section 3.4.2). Table 4.3 gives section references for each 
parameter tested. 
Table 4-3 Parameters tested with corresponding section reference 
Parameter Section 
Asymmetric division probability 4.4.2.1, 4.4.2.5 and 4.4.2.6 
De novo mutation rate 4.4.2.2 
Crypt fission 4.4.2.3 
COX deficient stem cell advantage  4.4.2.4 
mtDNA copy number 4.4.2.5 and 4.4.2.6 
4.4.2.1 Asymmetric division probability 
The first parameter that was tested was the effect of changing the asymmetric stem cell 
division probability. Figure 4-2 exemplifies the effect of changing the asymmetric stem cell 
division probability. When the probability of asymmetric stem cell division is increased, there 
is an increased frequency of partially COX deficient crypts and a decreased frequency of 
fully COX deficient crypts. It would appear that in order to achieve partially COX deficient 
crypts at a frequency seen within human colonic epithelium, the probability of asymmetric 
stem cell division needs to be >0.97. However, when the probability of asymmetric stem cell 
division is high enough (Figure 4-2F/G), partially COX deficient crypt frequency becomes 
too high and fully COX deficient crypt frequency becomes too low, effectively reaching an 
inversion threshold. A model where purely asymmetric stem cell division is simulated 
(Figure 4-2H) results in the emergence of purely partially COX deficient crypts. If symmetric 
stem cell division is absent, niche succession and monoclonal conversion cannot occur to 
result in a fully COX deficient crypt. The acquisition of a fully COX deficient crypt in this 
scenario would be extremely rare, requiring an extremely high mtDNA mutation rate, 
resulting in a COX deficiency frequency that does not match the biological data. 
  




Figure 4-2 Asymmetric division probability 
The effect of changing asymmetric division probability within the human niche succession 
model was ascertained. 5000 crypts were simulated, 75% mutated mtDNA conferred COX 
deficiency to a stem cell. 5 stem cells were simulated, each with 100 mtDNA molecules 
present. A constant de novo mutation rate was set to 3 x 10-5 mutated mtDNA/mtDNA 
replication. Simulations were carried out with asymmetric division probabilities (A) 0.75 
(B) 0.90 (C) 0.95 (D) 0.97 (E) 0.99 (F) 0.995 (G) 0.999 (H) 1.00. 
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4.4.2.2 De novo mtDNA mutation rate 
The effect of altering the de novo mtDNA mutation rate was ascertained. Figure 4-3 
exemplifies the effect of changing the de novo mtDNA mutation rate. When the mutation rate 
is increased, there is an increased frequency of both partially and fully COX deficient crypts. 
It would appear that in order to achieve partially and fully COX deficient crypts at a 
frequency seen within human colonic epithelium, the mutation rate must be between 1 x 10 -5 
and 5 x 10-5 mutated mtDNA/mtDNA replication. This would be equivalent to 3.02 x 10-7 and 
6.04 x 10-8 mutations per bp per generation, which is similar to the estimated mtDNA 
mutation rate quoted by Coller et al of between 3x10-7 – 3 x 10-8 mutations per bp per 
generation (Coller et al., 2001). Once the mutation rate is high enough, there is a plateauing 
effect where there is a reduction in the number of partially COX deficient crypts with age 
along with and a decreasing rate of accumulation of COX deficient crypts (Figure 4-3E/F). 
The acquisition of a de novo mutation, which is controlled by the mutation rate, is the start of 
the clonal expansion process, be it destined for extinction or fixation. Once the mutation rate 
is high enough, clonal expansion of mutated mtDNA becomes less important due to the shear 
rate of de novo mutation acquisition resulting in a stem cell’s COX deficiency. This explains 
the COX deficiency frequency in the scenario within Figures 4-3E/F.  
The effect of increasing de novo mtDNA mutation rate with age was also investigated. Figure 
4-4 exemplifies the effect of changing the de novo mtDNA mutation rate with age. Increasing 
the de novo mutation rate increased the frequency of both partially and fully COX deficient 
crypts with age. The greater the increase in de novo mtDNA mutation rate with age, the 
greater the increase in COX deficient crypts with age. 
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Figure 4-3 Constant de novo mutation rate 
The effect of changing the de novo mutation rate within the human niche succession 
model was ascertained. 5000 crypts were simulated, 75% mutated mtDNA conferred COX 
deficiency to a stem cell. 5 stem cells were simulated, each with 100 mtDNA molecules 
present. Asymmetric division probability was set to 0.99. Simulations were carried out 
with a constant de novo mutation rate of (A) 5 x 10-6 (B) 1 x 10-5 (C) 5 x 10-5 (D) 1 x 10-4 
(E) 5 x 10-4 (F) 1 x 10-3 mutated mtDNA/mtDNA replication. 




Figure 4-4 Increasing de novo mutation rate 
The effect of increasing the de novo mutation rate with age within the human niche 
succession model was ascertained. 5000 crypts were simulated, 75% mutated mtDNA 
conferred COX deficiency to a stem cell. 5 stem cells were simulated, each with 100 
mtDNA molecules present. Asymmetric division probability was set to 0.99. Simulations 
were carried out with a starting de novo mutation rate of 3 x 10-5 mutated mtDNA/mtDNA 
replication. The de novo mutation rate was increased linearly (A) 1x (B) 2x (C) 3x (D) 4x 
(E) 5x (F) 6x over 80 simulated years.  
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4.4.2.3 Crypt fission  
The effect of crypt fission within the model was ascertained. The model had to be adapted for 
crypt fission integration. The model code is contained within appendix 1.3.2. The probability 
of a crypt undergoing fission during its lifetime was added as a parameter (cryptFisProb). If 
crypt fission occurred at any point during its lifetime, an additional crypt was simulated from 
the timepoint at which crypt fission occurred. A COX deficiency advantage was also included 
(cryptFisFactor) which would increase the probability of a crypt undergoing fission if it was 
harbouring COX deficiency and was included based on findings from chapter 3. Figure 4-5 
exemplifies the effects of changing the cryptFisProb and cryptFisFactor parameters. 
Changing the cryptFisProb on its own had no effect on COX deficiency frequency. There had 
to be a substantial advantage endowed upon COX deficient crypts to undergo crypt fission in 
order for an exponential increase in fully COX deficient crypts with age to be observed. 
However, this did not result in a similar exponential increase in partially COX deficient 
crypts with age. Unfortunately, parameters that were much higher than those observed within 
the biological data were required to produce an effect within the model. For example, from 
the biological data, there appears to be a 1% chance of crypt fission occurring for normal 
crypts at the higher age groups, with COX deficient crypts having a 3% chance of fission. 
This would translate to a CryptFisProb of 1% with a cryptFisFactor of 3. However, a 
cryptFisProb of 2.5% with a cryptFis Factor of 10 (Figure 4-5A/B) does not significantly 
alter the model output. 
  




Figure 4-5 Crypt fission 
The effect of crypt fission occurring within the human niche succession model was 
ascertained. 5000 crypts were simulated, 75% mutated mtDNA conferred COX deficiency 
to a stem cell. 5 stem cells were simulated, each with 100 mtDNA molecules present. 
Asymmetric division probability was set to 0.99. A constant de novo mutation rate was set 
at 3 x 10-5 mutated mtDNA/mtDNA replication. Simulations were carried out with an 
overall crypt fission occurrence probability of 0.025 (A,B), 0.050 (C,D) 0.100 (E,F). The 
presence of COX deficiency increasing the chance of crypt fission was simulated for x2 
(A,C,E) and x10 (B,D,F). 
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4.4.2.4 COX deficient stem cell advantage 
As an unrealistic advantage for COX deficient crypts to undergo fission more often than 
normal crypts was required in order to increase the frequency of COX deficient crypts within 
the model output, a COX deficiency advantage at the stem cell level was investigated. As 
crypt fission is thought to be initiated following an increase in stem cell number (Greaves et 
al., 2006), which is a result of symmetric stem cell divisions (2 stem cells), perhaps it is an 
increase in symmetric stem cell divisions that triggers crypt fission. Therefore, an advantage 
being conveyed to COX deficient stem cells for them to undergo symmetric stem cell 
division (two renewed stem cells) more often was incorporated into the model. This would 
allow hypothesised perturbations to stem cell dynamics caused by respiratory deficiency to be 
simulated. The model had to be adapted to take this into account. The model code is 
contained within appendix 1.3.2. Figure 4-6 exemplifies the effect of increasing COX 
deficient stem cell advantage. Increasing the advantage that is conferred to COX deficient 
stem cells increased both partially and fully COX deficient crypt frequency. Once a stem cell 
acquires COX deficiency, it is more likely to remain and expand within the stem cell niche. 
The greater the COX deficiency advantage, the greater the COX deficiency frequency within 
simulated colonic epithelium. As long as there are sufficient de novo mtDNA mutations that 
are able to clonally expand to the point where the stem cell becomes COX deficient, this 
remains the case. Figure 4-6F shows that there is a decrease in partially COX deficient crypts 
after the 31-40 years age bracket. This indicates a plateau has been reached where the de 
novo mtDNA mutation rate can no longer provide enough mutations that go onto clonally 
expand, to maintain the increase in partially COX deficient crypts with age, with increasing 
advantage. There is also a corresponding decrease in the rate of fully COX deficient crypts 
with age in this case. 
  




Figure 4-6 Increasing COX deficient stem cell advantage 
The effect of COX deficient stem cell advantage within the human niche succession model 
was ascertained. 5000 crypts were simulated, 75% mutated mtDNA conferred COX 
deficiency to a stem cell. 5 stem cells were simulated, each with 100 mtDNA molecules 
present. Asymmetric division probability was set to 0.99. A constant de novo mutation rate 
was set at 5 x 10-6 mutated mtDNA/mtDNA replication. Simulations were carried out with 
a COX deficient stem cell advantage of (A) 1 (B) 2 (C) 5 (D) 10 (E) 20 (F) 50. 
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4.4.2.5 mtDNA copy number and asymmetric division probability – part 1 
The human niche succession model was constructed so that the probability of a de novo 
mtDNA mutation going onto become fixed within a stem cell and also the time taken for 
fixation to occur could be recorded. It was also constructed so that the probability of a de 
novo COX deficient stem cell going onto become fixed within the stem cell niche and also 
the time taken for niche succession to occur could be recorded. This provided the model with 
metrics that allowed each simulation to be fully quantifiable. Figure 4-7 exemplifies the 4 
metrics that can be extremely useful for characterising changes in parameter sets. Figure 4-
7A shows how mtDNA copy number impacts on the clonal expansion success probability. It 
shows that with increasing mtDNA copy number, there is a reduction in the clonal expansion 
probability and is roughly equal to 1/mtDNA copy number, which is indicative of a Moran 
type process when all stem cell divisions are asymmetric (Moran, 1962). Figure 4-7B shows 
how mtDNA copy number impacts on the number of stem cell divisions it takes for a mutated 
mtDNA to reach fixation. It shows that with increasing mtDNA copy number, there is an 
increase in the time it takes for mutated mtDNA to reach fixation. The number of stem cell 
divisions for it to reach fixation is roughly equal to 2 x mtDNA copy number when all stem 
cell divisions are asymmetric. Figure 4-7C shows how the asymmetric stem cell division 
probability impacts on the niche succession probability of a de novo COX deficient stem cell. 
It shows that with increased probabilities of asymmetric stem cell division, there is a decrease 
in the probability of a de novo COX deficient stem cell becoming fixed within the stem cell 
niche, meaning less chance of niche succession occurring. Figure 4-7D shows how 
asymmetric stem cell division probability impacts on the number of stem cell divisions it 
takes for a de novo COX deficient stem cell to reach fixation within the stem cell niche. It 
shows that with increasing asymmetric stem cell division probability, there is an increase in 
the time it takes for a de novo COX deficient stem cell to reach fixation, hence niche 
succession and monoclonal conversion within the crypt. 
  




Figure 4-7 Clonal expansion probability and niche succession success 
The effect of mtDNA copy number and asymmetric division probability within the human 
niche succession model was ascertained. The effect of mtDNA copy number was 
determined when purely asymmetric division was simulated by (A) measuring the 
probability of a mutated mtDNA fixation event (B) measuring the number of stem cell 
divisions it takes for mutated mtDNA fixation to occur. The effect of asymmetric division 
probability was ascertained when 100 mtDNA molecules were simulated per stem cell by 
(C) measuring the probability of a successful niche succession event by a COX deficient 
stem cell (D) Measuring the number of stem cell divisions it takes for fixation of a COX 
deficient stem cell to occur. 
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4.4.2.6 mtDNA copy number and asymmetric division probability – part 2 
The metrics described in section 4.4.2.5 were used to determine the impact of symmetric 
stem cell division in conjunction with mtDNA copy number within the human niche 
succession model. The mutated mtDNA clonal expansion fixation probability and time taken 
for mutated mtDNA were used to determine its effects on the model as whole. Figure 4-8 
shows the effects symmetric stem cell division and mtDNA copy number have on the model. 
Figure 4-8A shows the COX deficiency frequency within a model where purely asymmetric 
stem cell division and 400 mtDNA molecules per stem cell are being simulated. We see that 
the majority of the crypts within simulated colon epithelium are normal, with a decrease in 
normal crypts with age. Figure 4-8B shows the effect mtDNA copy number has on the 
percentage of normal crypts at the 11-20 age bracket. With increasing mtDNA copy number 
there is an increase in normal crypts in this age bracket. It is a small difference, for example, 
a ~100 fold increase in the mtDNA copy number results in a ~6% increase in normal crypts 
within this age bracket. Even so, this indicates that with increasing mtDNA copy number, 
mutated mtDNA fixation time is increased due to the reduction in COX deficient crypts. This 
concurs with Figure 4-7B. Figures 4-8C/D show the mutated mtDNA fixation time and 
probability between a purely asymmetric stem cell division model and a model where 1% 
symmetric division is being simulated, with both models simulating 5 mtDNA molecules per 
stem cell. Figure 4-8C shows that with the introduction of a 0.01 symmetric stem cell 
division probability, there is a larger distribution of fixation times, resulting in a reduced 
median fixation time. The majority of fixation times are the result of a normal stem cell being 
taken over by a COX deficient stem cell where mutated mtDNA has already become fixed. 
Figure 4-8D shows that the probability of mutated mtDNA becoming fixed within a stem cell 
is also reduced within a model where symmetric stem cell division is simulated. This is due 
to symmetric stem cell division allowing a COX deficient stem cell to be replaced by a 
normal symmetrically dividing stem cell. This finding is also replicated in models where 400 
mtDNA molecules are simulated (Figure 4-8E/F), however, the difference in mutated 
mtDNA fixation probability in this case is marginal. This indicates that with increasing 
mtDNA copy number within stem cells, symmetric stem cell division has a decreasing effect 
on mutated mtDNA fixation probability. Figures 4-8G/H show the difference between a 
model where 5 mtDNA molecules are simulated per stem cell and one with 400 mtDNA 
molecules. The model where 400 mtDNA molecules are simulated per stem cell (Figure 4-
8H) shows a gradual increase in partially COX deficient crypts until the 31-40 age bracket. 
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This is compared to the model where 5 mtDNA molecules are simulated per stem cell (Figure 
4-8G) where there is no gradual increase in partially COX deficient crypts with age. This 
reflects the time it takes for mutated mtDNA molecules to reach fixation between 5 and 400 
mtDNA molecules (Figures 4-8E and 4-8G). There is also a slight reduction in COX 
deficiency frequency in the model with 400 mtDNA molecules being simulated when 
compared to the model with 5 mtDNA molecules being simulated. This reflects the difference 
in mutated mtDNA fixation probability. 
  

















Figure 4-8 Interplay between symmetric division and mtDNA clonal expansion 
success 
The effect of mtDNA copy number in conjunction with asymmetric stem cell division was 
assessed. 5000 crypts were simulated, 75% mutated mtDNA conferred COX deficiency to 
a stem cell. 5 stem cells were simulated. A constant de novo mutation rate was set to 5 x 
10-5 mutated mtDNA/mtDNA replication. (A) 100% asymmetric stem cell division. (B) 
Effect of increasing mtDNA copy number on the percentage of normal crypts at 11-20 
years of age. (C) Clonal expansion fixation time between a model with purely asymmetric 
division and one with 99% asymmetric division when 5 mtDNA molecules are simulated. 
(D) Mutated mtDNA fixation probability between a model with purely asymmetric 
division and one with 99% asymmetric division when 5 mtDNA molecules are simulated. 
(E) Clonal expansion fixation time between a model with purely asymmetric division and 
one with 99% asymmetric division when 400 mtDNA molecules are simulated. (F) 
Mutated mtDNA fixation probability between a model with purely asymmetric division 
and one with 99% asymmetric division when 400 mtDNA molecules are simulated. (G) 
The percentage COX deficiency present within a model where 99% asymmetric stem cell 
division and 5 mtDNA molecules per stem cell is simulated. (H) The percentage COX 
deficiency present within a model where 99% asymmetric stem cell division and 400 
mtDNA molecules per stem cell is simulated. 
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4.4.3 Multiple mtDNA mutations 
4.4.3.1 Multiple mtDNA mutations detected within aged human colon 
It has previously been shown that cells within human colonic epithelium can contain multiple 
clonally expanded mtDNA point mutations with the majority being the cause of the cells 
COX deficiency (Taylor et al., 2003; Greaves et al., 2006; Greaves et al., 2010). Data has 
been provided by Dr Laura Greaves on the numbers of mtDNA mutations that have clonally 
expanded within aged human colonic epithelium cells and has been plotted in Figure 4-9. 
Data has been grouped based on whether the cells are normal or COX deficient. The majority 
of mutations found in normal cells were synonymous non-pathogenic mutations, where this 
was not the case, low heteroplasmy was detected. The majority of mutations found in COX 
deficient cells were non-synonymous pathogenic mutations. This data indicates that a model 
that simulates mutated mtDNA verses normal mtDNA may be too simplistic compared to the 
biology of the process which may have multiple mutations clonally expanding 
simultaneously within the same cell. Therefore, a more biologically relevant model was 
developed. 
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Figure 4-9 Number of mtDNA mutations detected within aged human colonic cells  
Data kindly provided by Dr Laura Greaves showing the number of mtDNA mutations 
detected within aged (>70 years) human colonic cells (Taylor et al., 2003; Greaves et al., 
2006; Greaves et al., 2010) was attained via laser microdissection of individual cells from 
whole mount tissue sections that had undergone COX/SDH histochemistry followed by 
mtDNA sequencing. 
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4.4.3.2 Tracking multiple mtDNA mutations within human niche succession model 
The human niche succession model was further developed to allow each de novo mtDNA 
species to be tracked. The model was adjusted so that each mtDNA molecule is able to 
acquire multiple mutations upon replication to make it more biologically robust. Newly 
acquired de novo mtDNA mutations were given a new species ID, with all clones given the 
same species ID. Each mtDNA species ID was linked to the number of mutations that were 
present on those mtDNA clones. Figure 4-10 is a crypt map showing each individual stem 
cell with each individual mtDNA species ID as a different colour throughout the crypts life. It 
is possible to see that at certain time points, individual stem cells contain multiple mtDNA 
species, indicating the presence of >1 mutations present within the stem cell. However, due to 
each species being able to harbour multiple mutations, the number of mutations within that 
stem could be much more than the number of mtDNA species present within the crypt map. 
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4.4.3.3 Parameter effects on multiple mutations 
Key parameters within the model were investigated to see how varying their values would 
influence the number of mutations that were present within individual stem cells. The key 
parameters included mtDNA copy number, asymmetric stem cell division probability and 
mutation rate. Figure 4-11 shows how key parameter alterations influence the mutation 
distribution. Changes to mtDNA copy number and asymmetric division probability (Figure 4-
11A/B) did not have any observable effect on the distribution of number of mutations present 
within individual stem cells. However, changes to de novo mtDNA mutation rate showed a 
dramatic effect between parameter values 1 x 10-4 and 5 x 10-4 mutated mtDNA/mtDNA 
replication. Increasing the mutation rate allows for a broader range of mutations within 
individual stem cells, meaning stem cells are more likely to contain a greater number of 
individual mutations  
  





Figure 4-11 Influencing number of mutations within individual cells  
A parameter scan was conducted with mtDNA copy number, asymmetric stem cell 
division probability and mutation rate to determine how the number of mutations within 
individual cells would be influenced by altered parameters. Unless stated within the 
graphs, 5000 crypts were simulated, 75% mutated mtDNA conferred COX deficiency to a 
stem cell. 5 stem cells were simulated, each with 100 mtDNA molecules present. 
Asymmetric division probability was set to 0.99. A constant de novo mutation rate was set 
at 2 x 10-4 mutated mtDNA/mtDNA replication. Number of mutations within individual 
cells was measured with changing (A) mtDNA copy number (B) Asymmetric stem cell 
division probability (C) Mutation rate. 
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4.4.4 Impact of altered mtDNA segregation upon division 
4.4.4.1 Mutation distribution spectra with random mtDNA segregation upon division 
Model simulations were carried out to determine how the COX deficiency frequency and the 
number of mutations within individual stem cells corresponded with each other. Figure 4-12 
exemplifies the effect of increasing the de novo mtDNA mutation rate 10-fold. Figure 4-
12A/B shows the COX deficiency frequency and number of mutations with a mutation rate of 
5 x 10-5 mutated mtDNA/mtDNA replication. Fully COX deficient crypts reach ~15% within 
the simulated colon at the 71-80 year age bracket (Figure 4-12A). However, when we 
examine the mutation distribution, ~90% contain only one mutation, with <10% harbouring 
multiple mutations (Figure 4-12B). Figure 4-12C/D shows the COX deficiency frequency and 
number of mutations with a mutation rate of 5 x 10-4 mutated mtDNA/mtDNA replication. 
Fully COX deficient crypts reach ~80% within simulated colon at the 71-80 year age bracket 
(Figure 4-12C). However, when we examine the mutation distribution, ~35% contain only 
one mutation, with the remainder harbouring multiple mutations with quite a broad 
distribution (Figure 4-12D). A mutation rate of 5 x 10-4 mutated mtDNA/mtDNA replication 
gives a COX deficiency frequency that is twice that compared with the biological data 
(Figure 3-8C) but gives a mutation distribution that does not correspond to the number of 
mutations detected within cells from human colon epithelium (Figure 4-9). It is clear to see 
from these results that relaxed replication and random segregation of mutated mtDNA will 
not allow both the COX deficiency frequency and the number of mutations within individual 
cells from human colon epithelium to be matched simultaneously. 
  




Figure 4-12 Random segregation and number of mutations detected 
Mutation rate was assessed when looking at COX deficiency frequency and the number of 
mutations present within individual cells simultaneously. 5000 crypts were simulated, 
75% mutated mtDNA conferred COX deficiency to a stem cell. 5 stem cells were 
simulated, each with 100 mtDNA molecules present. Asymmetric division probability was 
set to 0.99. (A) COX deficiency when a model is simulated with a de novo mutation rate 
set to 5 x 10-5 mutated mtDNA/mtDNA replication. (B) Number of mutations within 
individual cells when a model is simulated with a de novo mutation rate set to 5 x 10-5 
mutated mtDNA/mtDNA replication. (C) COX deficiency when a model is simulated with 
a de novo mutation rate set to 5 x 10-4 mutated mtDNA/mtDNA replication. (D) Number 
of mutations within individual cells when a model is simulated with a de novo mutation 
rate set to 5 x 10-4 mutated mtDNA/mtDNA replication. 
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4.4.4.2 Biasing mutated mtDNA segregation upon division 
Relaxed replication and random segregation have been shown to explain the emergence of 
respiratory deficiency computationally within post-mitotic muscle tissue and mitotic 
epithelial tissue (Coller et al., 2001; Elson et al., 2001). However, there is still debate over 
the exact mechanism of clonal expansion and could be subject to the characteristics of the 
tissues in which the cells inhabit. Katajisto et al have data that suggests asymmetrically 
dividing mammary stem cells apportion their aged vs young mitochondria asymmetrically 
(Katajisto et al., 2015). They used a photoactivatable GFP system which incorporated a 
specific mitochondrial organelle localisation signal. They activated the GFP with a UV laser 
pulse, aged the cells and imaged the apportioning of aged vs new mitochondria between 
daughter cells. Upon asymmetric division, 80% of the old mitochondria were segregated into 
one cell and 20% into the other. This is achieved by old mitochondrial organelles being 
restricted to the perinuclear region of the mother cell (Katajisto et al., 2015). If there is 
evidence suggesting that mitochondria are apportioned asymmetrically, this may be true for 
the apportioning of mtDNA upon asymmetric stem cell division as well. For instance, newly 
replicated mtDNA (most likely to harbour mtDNA replication errors) may be more likely to 
be segregated into the stem cell progeny cell in order to reduce mtDNA mutation 
accumulation within the stem cell pool. 
A new algorithm was constructed that would generate new division transition matrices 
according to there being an increased likelihood of mutated mtDNA being segregated out into 
the stem cell progeny cell upon asymmetric stem cell division (appendix 1.3.3.7). Division 
matrices were generated with varying degrees of bias for mutated mtDNA molecules to be 
segregated out of the stem cell pool upon asymmetric stem cell division. Figure 4-13 shows 
the impact that a mutated mtDNA segregation bias has upon mutated mtDNA fixation 
probability. A division segregation factor of 1 means that segregation is random. A division 
segregation factor of 2 means mutated mtDNA molecules are twice as likely to be segregated 
out of the stem cell pool upon asymmetric stem cell division. A small increase in bias results 
in a large decrease in mutated mtDNA fixation probability with all de novo mtDNA mutation 
rates tested. 
  




Figure 4-13 Biasing mutated mtDNA segregation upon asymmetric stem cell division 
The mutated mtDNA segregation advantage was assessed using the mutated mtDNA 
fixation probability. 5000 crypts were simulated, 75% mutated mtDNA conferred COX 
deficiency to a stem cell. 5 stem cells were simulated, each with 100 mtDNA molecules 
present. Asymmetric division probability was set to 0.99. The de novo mutation rate was 
changed as shown in the figure to determine its effect. A division segregation factor of 2 
means a mutated mtDNA molecule is twice as likely to be segregated out of the stem cell 
pool upon asymmetric stem cell division. 
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4.4.4.3 Mutation distribution spectra with biased mtDNA segregation upon division. 
Model simulations were carried out to determine how COX deficiency frequency 
corresponded with number of mutations within individual stem cells with a division 
segregation factor of 1.03. Figure 4-14 exemplifies the effect of increasing de novo mtDNA 
mutation rate 10-fold. Figure 4-14A/B shows the COX deficiency frequency and number of 
mutations with a mutation rate of 5 x 10-5 mutated mtDNA/mtDNA replication. This time, 
fully COX deficient crypts fail to reach even 1% within the simulated colon at the 71-80 year 
age bracket (Figure 4-14A). When we examine the mutation distribution, ~97% contain only 
one mutation, with <3% harbouring multiple mutations (Figure 4-14B). Figure 4-14C/D 
shows the COX deficiency frequency and number of mutations with a mutation rate of 5 x 10 -
4 mutated mtDNA/mtDNA replication. Fully COX deficient crypts reach ~5% within 
simulated colon at the 71-80 year age bracket (Figure 4-14C). When we examine the 
mutation distribution, ~60% contain only one mutation, with the remainder harbouring 
multiple mutations with quite a broad distribution (Figure 4-14D). A mutation rate of 5 x 10-4 
gives a COX deficiency frequency that is much more biologically relevant (Figure 3-8C) and 
gives a mutation distribution that does correspond to the number of mutations detected within 
cells from human colonic epithelium (Figure 4-9). 
  




Figure 4-14 Biased segregation and number of mutations detected 
Mutation rate was assessed when looking at COX deficiency frequency and the number of 
mutations present within individual cells simultaneously. A segregation bias was 
introduced into the model code. The results detailed here are from a model where mutated 
mtDNA were more likely to be segregated into the stem cell progeny during asymmetric 
division by a factor of 1.03. 5000 crypts were simulated, 75% mutated mtDNA conferred 
COX deficiency to a stem cell. 5 stem cells were simulated, each with 100 mtDNA 
molecules present. Asymmetric division probability was set to 0.99. (A) COX deficiency 
frequency when a model is simulated with a de novo mutation rate set to 5 x 10-5 mutated 
mtDNA/mtDNA replication. (B) Number of mutations within individual cells when a 
model is simulated with a de novo mutation rate set to 5 x 10-5 mutated mtDNA/mtDNA 
replication. (C) COX deficiency frequency when a model is simulated with a de novo 
mutation rate set to 5 x 10-4 mutated mtDNA/mtDNA replication. (D) Number of 
mutations within individual cells when a model is simulated with a de novo mutation rate 
set to 5 x 10-4 mutated mtDNA/mtDNA replication. 
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4.4.4.4 Effects of biasing mtDNA segregation upon division 
The effect of using a segregation bias was further investigated by examining the mutated 
mtDNA fixation probability and time taken with a bias of 1.03. Figure 4-15 highlights the 
difference between random and biased segregation with a mutation rate of 5 x 10 -5 mutated 
mtDNA/mtDNA replication (Figure 4-15A/B) and 5 x 10-4 mutated mtDNA/mtDNA 
replication (Figure 4-15C/D). As has been shown previously, there is a decrease in the 
mutated mtDNA fixation probability (Figure 4-13). What can also be seen is that there is a 
reduced number of mutated mtDNA molecules undergoing fixation for both mutation rates 
tested. From this we can say that the bias acts to reduce the probability of mutated mtDNA 
becoming fixed within a cell by their removal from the stem cell pool. This can be overcome 
by increasing the mutation rate which, in so doing, increases the number of different types of 
mtDNA present within the stem cell. 
  




Figure 4-15 Biased segregation impact on mutated mtDNA clonal expansion 
A segregation bias was introduced into the model code. The results detailed here compare 
the difference between a model where random mtDNA segregation take place with one 
where mutated mtDNA were more likely to be segregated into the stem cell progeny 
during asymmetric division by a factor of 1.03. 5000 crypts were simulated, 75% mutated 
mtDNA conferred COX deficiency to a stem cell. 5 stem cells were simulated, each with 
100 mtDNA molecules present. Asymmetric division probability was set to 0.99. (A) 
Compares the mutated mtDNA fixation probability between a model with random 
segregation and a model with biased segregation when a mutation rate is set to 5 x 10 -5 
mutated mtDNA/mtDNA replication. (B) Compares the mutated mtDNA fixation time 
between a model with random segregation and a model with biased segregation when a 
mutation rate is set to 5 x 10-5 mutated mtDNA/mtDNA (C) Compares the mutated 
mtDNA fixation probability between a model with random segregation and a model with 
biased segregation when a mutation rate is set to 5 x 10-4 mutated mtDNA/mtDNA 
replication. (D) Compares the mutated mtDNA fixation time between a model with 
random segregation and a model with biased segregation when a mutatio n rate is set to 5 x 
10-4 mutated mtDNA/mtDNA.  
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4.4.5 Model optimisation 
Now that the model was fully characterised and made as biologically robust as possible, a 
parameter scan was conducted to determine the optimum parameters that would allow the 
trend in human COX deficiency frequency and the number of mutations detected within 
human colonic epithelium to be matched. This was done for model simulations with between 
3-8 stem cells per crypt. Fixed parameters included COX deficiency threshold and mtDNA 
copy number. Parameters which were optimised included asymmetric stem cell division 
probability, advantage to COX deficient stem cells (divide symmetrically more often), 
division segregation factor and mutation rate. 
Figures 4-17 and Figure 4-18 contained best fit COX deficiency frequency graphs for models 
simulated with 3-8 stem cells with the corresponding number of mutations distribution graphs 
as an inset. Figure 4-18 contained best fit graphs for models with an advantage endowed to 
COX deficient stem cells. All best fit parameters are contained within section 4.4.5.3 as 
Tables 4.4 and 4.5. 
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4.4.5.1 COX deficiency frequency from human colon 
 
Figure 4-16 COX deficiency frequency within human colon epithelium 
Probability distributions were generated in order to relate the percentage COX deficiency 
observed at the transverse cross section of a crypt to the likely number of COX deficient 
stem cells that were present at the base of a crypt. Probability distributions can be 
generated for any number of stem cells specified to be present within the stem cell niche. 
The COX deficiency data from human colon was converted to number of stem cells using 
the probability distributions for (A) 3 stem cells, (B) 4 stem cells, (C) 5 stem cells, (D) 6 
stem cells, (E) 7 stem cells and (F) 8 stem cells being present within the stem cell niche of 
human colonic crypts. 
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4.4.5.2 Best fit COX deficiency frequency and number of mutations 
 
   
Figure 4-17 Best fit data 
A parameter scan was conducted in order to optimise the COX deficiency frequency and 
the number of mutations within cells that would provide the closest match to the biological 
data. This was done with models containing (A) 3 (B) 4 (C) 5 (D) 6 (E) 7 (F) 8 stem cells 
per crypt. Parameters used for each fit are contained in Table 4-4. 




Figure 4-18 Best fit data with COX deficient stem cell advantage 
A parameter san was conducted in order to optimise the COX deficiency frequency and 
the number of mutations within cells that would provide the closest match to the biological 
data. An advantage was introduced into the model that would make COX deficient stem 
cells more likely to undergo symmetric stem cell division. This was done with models 
containing (A) 3 (B) 4 (C) 5 (D) 6 (E) 7 (F) 8 stem cells per crypt. Parameters used for 
each fit are contained in Table 4-5. 
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4.4.5.3 Best fit data tables 



















3 75% 100 0.9975 1 1.03 3.0 x 10-4 
4 75% 100 0.996 1 1.03 2.5 x 10-4 
5 75% 100 0.99 1 1.03 2.5 x 10-4 
6 75% 100 0.985 1 1.03 2.0 x 10-4 
7 75% 100 0.99 1 1.03 2.5 x 10-4 
8 75% 100 0.98 1 1.03 2.4 x 10-4 
 
 



















3 75% 100 0.9995 150 1.05 4.5 x 10-4 
4 75% 100 0.997 120 1.05 3.0 x 10-4 
5 75% 100 0.99 30 1.05 2.5 x 10-4 
6 75% 100 0.985 15 1.05 2.5 x 10-4 
7 75% 100 0.95 10 1.05 2.5 x 10-4 
8 75% 100 0.75 7 1.05 2.5 x 10-4 
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4.4.5.4 Stem cell number validation from human niche succession model 
The optimum number of stem cells contained within human colonic crypts was determined 
using the best-fit data from models simulated with parameters from Table 4-5. In chapter 3, 
partially COX deficient crypts were used to determine how many stem cells were contained 
within human colonic crypts. The same was done from a modelling perspective. Each model 
with different numbers of stem cells had their partially COX deficient crypts pooled. The data 
was transformed using the distribution model described in chapter 3 using the algorithm 
contained within appendix 1.3.4. This allowed the biological and model data to be in the 
same format for a probability density curve to be plotted for each. Figure 4-19 shows that 
with increasing number of stem cells simulated, there is an increasing ratio between crypts 
that have low partial COX deficiency fraction compared to those that have a high partial 
COX deficiency fraction. This ratio best fitted with a model that had 5-6 stem cells present. 
Least squares analysis of the probability density curves show that a model with 5 stem cells 
fits the biological data the best (Table 4-6). 





















Figure 4-19 Stem cell number validation via partially COX deficient crypts. 
The distribution of partially COX deficient crypts from human colon was compared with 
the distribution of partially COX deficient crypts generated from the optimised models 
with varying number of stem cells simulated (Table 4-5). The distribution model described 
in section 3.4.7 (model code and conversion algorithm contained in appendix 1.3.4) were 
used to transform number of COX deficient stem cells into observed COX deficiency 
percentage. Each distribution was plotted as a probability density curve for comparison. 
Each model was compared with the biological data via method of least squares. Least 
squares goodness of fit values are contained within Table 4-6. A value of 0 represents a 
perfect match to the biological data. 
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Table 4-6 Least squares value for model fits with varying stem cell number 
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4.5 DISCUSSION 
The human niche succession model developed during my PhD is an advancement to the one 
that was developed during my MRes (development timeline section 4.3.1). The major step 
forward was being able to explicitly simulate individual mtDNA molecules within stem cells, 
with a mutation rate acting upon each mtDNA replication. More adaptations have been 
introduced into the human niche succession model during my PhD, all in order to make the 
model as biologically accurate as possible. These include introducing; a variable slope 
mutation rate with age (constant or linear), the process of crypt fission, individual mtDNA 
species tracking, and the incorporation of a mutated mtDNA segregation advantage upon 
stem cell division. 
There are a considerable number of parameters that influence the human niche succession 
model output. The effects of each parameter on the model have been depicted and described 
within the results section. Briefly, increasing the constant de novo mtDNA mutation rate 
within the human niche succession model (Figure 4-3) increases the COX deficiency 
frequency observed. An increasing de novo mtDNA mutation rate (Figure 4-4) results in an 
increasing frequency of partially COX deficient crypts with age along with an increasing rate 
of fully COX deficient crypt accumulation. Increasing the constant de novo mtDNA mutation 
rate also increases the number of individual mutations present within aged stem cells (Figure 
4-11, Figure 4-12, and Figure 4-14). A previous study using the Random Mutation Capture 
(RMC) assay to assess low level mutation frequency which excludes clonally expanded 
mutations (proxy for mutation rate) provides evidence that there is not a statistically 
significant difference in low level mtDNA mutation frequency with age within human 
colonic mucosa (p = 0.343, one way ANOVA) (Greaves et al., 2014). However, although the 
RMC assay is the closest measurement of mtDNA mutation rate currently available, it cannot 
measure mtDNA mutation rate as a dynamic process, and the assay is intrinsically noisy, 
therefore a minor increase in mtDNA mutation rate with age cannot be definitively ruled out. 
An increasing mtDNA mutation rate would fit in with the reactive oxygen species ‘vicious 
cycle’ hypothesis (Harman 1972). 
Within the human niche succession model, increasing mtDNA copy number decreases the 
probability and increases the amount of time it takes for a mutated mtDNA molecule to 
become fixed (Figure 4-7). However, with a 100-fold difference in mtDNA copy number, the 
resulting COX deficiency frequency difference is marginal (Figure 4-8).  
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Asymmetric stem cell division probability is a parameter that has a considerable effect on the 
COX deficiency frequency. This parameter has the effect of deciding the ratio between 
partially and fully COX deficient crypt frequencies with the most dramatic effect observed at 
a probability >0.95 (Figure 4-2). This is because with increasing asymmetric stem cell 
division probability, there is a decreasing probability of de novo COX deficient crypt niche 
succession, with an associated increase in the time it takes niche succession to occur (Figure 
4-7).  
Crypt fission was also introduced into the human niche succession model as this was 
observed within human colonic crypt biopsy sections and has been hypothesised to aid the 
expansion of COX deficient crypts within human colonic epithelium (Greaves et al., 2006). 
However, when crypt fission is simulated with different probabilities of occurrence, there was 
no significant difference (Figure 4-5). A difference was observed when an advantage for 
COX deficient crypts to undergo crypt fission was introduced into the model. Within human 
colon epithelium, there is a 1% occurrence of normal crypts undergoing fission in all age 
brackets (Figure 3-4). However, in aged samples, there is a 3% occurrence of COX deficient 
crypts undergoing fission. This would suggest that there is an advantage for COX deficient 
crypts to undergo crypt fission more often, if only just in aged samples. Unfortunately, the 
human niche succession model required a considerable crypt fission probability in 
conjunction with a much larger advantage conveyed to COX deficient crypts to undergo crypt 
fission than was biologically conceivable. Therefore, as COX deficient crypt colonies are 
thought to be the result of crypt fission (Greaves et al., 2006), the biological data set had the 
effect of crypt fission removed (section 3.4.6). This new data set would serve as the 
biological reference data allowing crypt fission to be ignored within the model.  
Perturbed stem cell dynamics was also incorporated into the human niche succession model 
as a mechanism for crypt fission induction. This was in the form of an advantage conveyed to 
COX deficient stem cells to undergo symmetric stem cell division (2 renewed stem cells) 
more often than normal stem cells. It has been suggested that respiratory deficiency would 
alter the stem cells metabolism considerably via ROS mediated alteration, shifting its cell fate 
decision (Ryu et al., 2015). Increasing the COX deficient stem cell advantage within the 
human niche succession model increases both partially and fully COX deficient crypt 
frequency at all ages (Figure 4-6). This was dependent on there being a large enough de novo 
mtDNA mutation rate present for large advantages conveyed to COX deficient stem cells.  
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Finally, a bias was introduced into the human niche succession model that would allow 
mutated mtDNA to be preferentially segregated into the stem cell progeny cell upon 
asymmetric stem cell division. This was due to the observation that new mitochondria, hence 
newly replicated mtDNA, are segregated asymmetrically within dividing mammary epithelial 
stem cells (Katajisto et al., 2015). Relaxed replication and random segregation would not 
allow COX deficiency frequency and number of mutations to match the trend in the 
biological data simultaneously (Figure 4-12). Increasing the division segregation factor was 
shown to reduce the probability of mutated mtDNA molecules becoming fixed due to their 
segregation out of the stem cell pool (Figure 4-13). This was true for all mutation rates 
(Figure 4-15). This allowed the number of mtDNA mutations within simulated aged stem 
cells to be matched to the number of mtDNA mutations found within human colonic mucosa. 
The optimised simulations show there exists an advantage for mutated mtDNA to be 
segregated out of the stem cell pool. This is true for all models with varying stem cell number 
being simulated within crypts (Figure 4-17). In order to observe an increase in partially COX 
deficient crypts with age, as is shown within the biological data, there needs to be an 
advantage conferred to COX deficient stem cells for them to undergo symmetric stem cell 
division more often (Figure 4-18). With this scenario, there also needs to be a greater division 
segregation bias conferred to mutated mtDNA. Optimised models have also reinforced the 
notion that there are an average of 5 functional stem cells contained within human colonic 
crypts (Figure 4-19 and Table 4-6). 
Mouse studies have shown that the emergence of partially and fully labelled crypts follow a 
pattern of neutral drift dynamics (Lopez-Garcia et al., 2010; Snippert et al., 2010; Kozar et 
al., 2013). This is exemplified by there being a constant frequency of partially labelled crypts 
with a linearly increasing frequency of fully labelled crypts throughout the mouse’s lifetime. 
Human colon COX deficiency data shows that there is an increasing rate of accumulation for 
both partially and fully COX deficient crypts with age. This suggests that human COX 
deficient stem cells do not follow a pattern of neutral drift. This is reinforced by the human 
niche succession model which shows that biologically relevant partially COX deficient crypts 
can only be achieved with an advantage conferred to COX deficient stem cells. This is further 
reinforced by the fact that a mutated mtDNA segregation bias is required in order to match 
both COX deficiency frequency and number of mutations present within aged stem cells. 
Therefore, mutated mtDNA upon stem cell division are not following random segregation 
Chapter Four  Modelling stem cell dynamics within human colon 
139 
and COX deficient stem cells are not following a pattern of neutral drift, though the 
perturbation from neutrality is relatively mild. 
The human niche succession model explicitly simulates stem cells within their niche, 
overcoming many obstacles involved in simulating the entire crypt. Simulating the entire 
crypt involves understanding the cell dynamics of all cell types within the crypt, for example, 
cell division times, migration, differentiation, apoptosis, and also the assumption of 
geometric architecture of the crypt. Most models of crypt cell dynamics have to map 3 
dimensional crypts as 2 dimensional surfaces (Meineke et al., 2001; van Leeuwen et al., 
2009; Fletcher et al., 2012). Extra assumptions and parameter estimations to build such a 
model adds to its complexity, with its complexity hindering its ability to produce novel 
findings. 
The van Leeuewen model was used to validate an assumption within a study conducted by 
Baker et al (van Leeuwen et al., 2009; Baker et al., 2014). The assumption was that the 
expansion and contraction of COX deficient stem cell clones within the stem cell niche 
produces a chronological COX deficiency imprint on the cell wall. An expansion of a COX 
deficient stem cell clone via symmetric stem cell division would result in a larger COX 
deficiency imprint on the cell wall. The fact that a larger fraction of COX deficient stem cells 
within the niche results in an increased COX deficiency imprint on the crypt wall is in 
agreement with the COX deficiency distribution model described (section 3.4.7). However, I 
propose that changes in COX deficiency clone width may have additional factors than those 
stated in Baker et al. For example, as there are a particular number of ‘functional’ stem cells 
within the stem cell niche of crypts, there has to be an expansion of stem cell progeny to the 
numbers that are observed in transverse cross-sections of crypts, especially if there are 5 
‘functional’ stem cells, which our data shows (section 3.4.2 and section 4.4.5.4) and the 5-7 
‘functional’ stem cells stated in Baker et al. This must be achieved via stem cell progeny 
rapidly proliferating and differentiating further up the crypt as they migrate, which highly 
likely results in lateral displacement of the COX deficient cells, thereby increasing and 
decreasing the COX deficiency imprint on the cell wall. It is also highly likely that the 
‘functional’ stem cells within crypts divide asynchronously. Asymmetric asynchronous stem 
cell divisions along with expansion in stem cell progeny must greatly influence the dispersion 
of the COX deficiency imprint on the cell wall. Furthermore, COX deficiency may not result 
from a cell having a completely fixed mtDNA mutation within the cell. A heteroplasmy 
threshold level may exist, depending on the type of mutation present. The expansion and 
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contraction of the COX deficiency imprint on the crypt wall may be the result of the cells 
heteroplasmy level falling below the level at which COX deficiency is observed via 
COX/SDH histochemistry. Therefore, the expansion and contraction of the COX deficiency 
imprint on the crypt wall can be explained with additional factors and may not be solely 
influenced by stem cell dynamics. Another important consideration is the regeneration time 
of human colonic crypts compared with the stem cell division time. It has been shown that 
human colonic epithelium is regenerated weekly (Potten et al., 1992) with colonic stem cells 
dividing every 3-5 days (Potten et al., 1992). If this is the case, then a 3-dimensional crypt 
observed at a single time-point only represents the stem cells that have divided within the 
previous week. Each stem cell would have only undergone a limited number of stem cell 
divisions in that time, which limits the insights that can be made about the stem cell dynamics 
taking place within crypts from this data set. Baker et al used 9 patients’ colon biopsies with 
11 en face serial sections to construct 3 dimensional crypts to gain insight into the ‘wiggle’ 
COX deficiency pattern on the crypt wall. With such a limited number of partially COX 
deficient crypts analysed, it is highly likely that the other factors described influence the size 
of the COX deficiency imprint on the crypt wall, potentially biasing interpretations of this 
data type. 
The study conducted in this thesis examined 148 human colon biopsy samples from patients 
ranging between 17 and 78 years of age. This study quantified the COX deficiency present 
within ~140,000 transverse partially COX deficient crypts from single sections. As so many 
partially COX deficient crypts were quantified from each age bracket, together with the COX 
deficiency distribution model constructed, the effects of other factors having an effect on the 
size of the COX deficiency imprint on the crypt wall were accounted for. This allowed a 
simpler model of human colon stem cell dynamics to be constructed as opposed to the van 
Leeuwen model. Number of COX deficient stem cells within the model could be assigned to 
the COX deficiency fraction observed within transverse crypts using the COX deficiency 
distribution model. 
Even though the human niche succession model is a simpler model than having to simulate 
an entire crypt, it is still made complex by the incorporation of additional parameters. With 
each additional parameter added to make the model more biologically realistic, it becomes 
substantially harder to optimise to biological reference data. With the addition of an extra 
parameter being optimised, many more simulation had to be run. The most up to date human 
niche succession model simulated with biologically relevant parameters required ~6 seconds 
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per crypt simulation to complete, meaning a population of 5000 crypts would take ~8 hours 
to simulate. Therefore an automatic parameter optimisation algorithm was not possible. 
Parameter scanning was conducted by trial and error and is how the optimised models were 
established (Figure 4-17 and Figure 4-18). Optimisation was based on similar trends in data 
when comparing model results and biological reference data. 
At present the model can incorporate a variable de novo mutation rate with age. All other 
parameters had to be fixed throughout the lifetime of a crypt due to the way the model was 
constructed in MATLAB. For instance, replication and segregation matrices had to be 
constructed for each number of mtDNA molecules being simulated within stem cells. 
Matrices could not be constructed for mtDNA copy number >400 due to insufficient 
computer random access memory (RAM) that would be required to construct them. However, 
given the size of stem cells and the low nuclear:cytoplasmic volume, >400 mtDNA copies is 
unlikely. The ability to vary each parameter with age would be beneficial because ageing, 
which is associated with a decline in cellular function, may result in variable parameter 
values as well. 
4.6 CONCLUSION 
It is true that no biological model can truly replicate the processes that occur within 
biological systems as they are a simplification of the processes being investigated. However, 
the human niche succession model, in conjunction with the human colon COX deficiency 
data, shows that COX deficiency has the potential to confer altered stem cell dynamics to a 
stem cell, allowing COX deficiency to accumulate via a non-neutral drift manner within the 
colon. Investigating the way in which COX deficiency confers an advantage to stem cells 
should be investigated in vivo. 
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Chapter 5 Development and validation of a mouse model to investigate 
stem cell dynamics 
5.1 INTRODUCTION 
Mitochondrial dysfunction within ageing human colon has been well studied over the past 
decade (Taylor et al., 2003; Greaves et al., 2006; Greaves et al., 2010). Furthermore, the 
similarities and differences between mouse and human mitochondrial dysfunction has been 
investigated in depth in order to discover a good mouse model of mitochondrial ageing within 
the colon (Greaves et al., 2011; Baines et al., 2014). It has been shown that aged wild type 
C57Bl/Icrfa1 mice don’t accumulate mitochondrial dysfunction in the form of COX 
deficiency to the same extent as in aged humans (Greaves et al., 2011). For instance, humans 
at 85 years accumulate ~15% COX deficiency within their colonic epithelium, whereas mice 
at 36 months, which was deemed equivalent to 85 year old humans, only accumulate ~1%. 
Contrastingly, the ciliary epithelium within mouse intraocular tissue accumulates ~30% COX 
deficiency at 36 months, whereas humans only accumulate ~12%. This exemplifies the 
differences in the rate of COX deficiency accumulation within the same tissues between mice 
and humans. Furthermore, this demonstrates the reason why ageing wild type mice can’t be 
used as a model of human intestinal ageing with regards to mitochondrial dysfunction. COX 
deficiency determined by COX/SDH histochemistry is a good marker of Complex IV 
deficiency caused by mtDNA mutations. This has been shown within a variety of human 
tissues, which include; prostate (Blackwood et al., 2011), liver (Fellous et al., 2009), stomach 
(McDonald et al., 2008) and colon (Taylor et al., 2003). However, as mtDNA contains genes 
that encode protein subunits for 3 other respiratory chain complexes, it may be the case that 
other complexes may be deficient whilst normal COX activity for Complex IV is present. 
This is brought to light by the observation showing multiple respiratory complexes becoming 
deficient during normal human ageing within the colon (Greaves et al., 2010). 
Mouse models are an important tool in order to understand the link between mitochondrial 
dysfunction and age related phenotypes. TFAM knockout mice are one such mouse model 
that can be used to investigate this link. TFAM is a transcriptional activator within 
mitochondria and is also important for mitochondrial DNA replication (Reyes et al., 2002). 
As such, TFAM knockout mice (Tfam(+/-)) have reduced mtDNA copy number with 
associated respiratory chain complex deficiency. TFAM knockout mice have been discussed 
in detail in section 1.7.4.1. 
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MtDNA mutator mice are another mouse model that can be used to investigate the link 
between mitochondrial dysfunction and ageing. They are associated with a progressive 
accumulation of mtDNA mutations along with the development of age-related phenotypes. 
Mitochondrial mutator mice are discussed in detail in section 1.7.4.2.  
COX deficiency within the colons of mitochondrial mutator PolγA(+/-) mice show a similar 
level of COX deficiency within their colons (~15%) when compared to humans at an 
equivalent age, with a similar pattern for the types of mtDNA mutations present as well 
(Baines et al., 2014). It was also determined that mutations within genes other than MT-CO 
genes can result in COX deficiency, adding weight to the respiratory supercomplex 
hypothesis (Schagger and Pfeiffer, 2000). This corroborates the finding that patients with 
mutations in Complex I genes show multiple respiratory chain deficiency (Hinttala et al., 
2006). 
Multiple respiratory complex deficiency has been shown within colonic epithelium within 
normal human ageing (Greaves et al., 2010). For instance, of the total number of crypts that 
were tested for Complex I, III and IV deficiency, 11.2% harboured some form of complex 
deficiency (Greaves et al., 2010). Of the 11.2%, 29.9% of crypts had a deficiency in one 
complex, 19.1% had a deficiency in two complexes, and 51% had a deficiency within all 
three complexes (Greaves et al., 2010). Furthermore, the majority of deficient crypts (>95%) 
harboured either Complex I or Complex IV deficiency, with ~70% of those crypts harbouring 
both Complex I and Complex IV deficiency together (Greaves et al., 2010).  
As the cause of the respiratory deficiency of any particular complex can be due to mutations 
in the genes of another complex, it is important to assess multiple respiratory complexes 
when determining the respiratory status of a cell or tissue. As mitochondrial mutator 
PolγA(+/-) mice have been shown to be a good mouse model of ageing (Baines et al., 2014), it 
would be interesting to assess whether multiple complexes are deficient within these mice as 
well. 
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5.2 AIMS OF STUDY 
The aim of this study was to validate the use of the PolγA mice with the Lgr5 mice in order to 
investigate stem cell dynamic perturbations caused by respiratory deficiency. This would be 
done by examining multiple respiratory chain loss of expression within 11-12 month old mice 
with varying degrees of mitochondrial polymerase proofreading deficiency. The majority of 
mtDNA base pairs within protein encoding genes contribute towards subunits of Complex I 
and Complex IV (82%), therefore these respiratory chain complexes were chosen. The 
frequency of both Complex I (NDUFB8 subunit) and Complex IV (MTCO1 subunit) 
expression loss within Lgr5(+/-)PolγA(+/+), Lgr5(+/-)PolγA(+/-)and Lgr5(+/-)PolγA(-/-) mice at 
similar ages would be investigated. Therefore, the effect of increasing level of mitochondrial 
polymerase proofreading deficiency upon replication would be ascertained. 
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5.3  METHODOLOGY 
5.3.1 Modelling focal respiratory chain deficiency within mouse colon 
Wild-type C57Bl/6J, PolγA(+/-) and PolγA(-/-)  mitochondrial mutator mice were bred within the 
comparative biology centre (Newcastle University) (section 2.2.2.1). Mouse colon COX 
deficiency frequency data from both mitochondrial mutator mouse species at discrete age 
steps was provided by Dr Holly Baines (Newcastle University) (Baines et al., 2014). Wild-
type C57Bl/6J mouse colon COX deficiency frequency data was provided by Dr Laura 
Greaves (Newcastle University) (Greaves et al., 2010). A model that simulated the clonal 
expansion of mutated mtDNA molecules within a population of stem cells was constructed 
(section 2.2.10.1) in order to determine whether mtDNA mutation rate could explain the 
difference in COX deficiency accumulation between the three mouse genotypes. The main 
assumption was that a stem cell was likened to a fully COX deficient crypt. 
5.3.2 Quantifying mitochondrial dysfunction within mouse colon 
Lgr5-EGFP-Ires-CreERT2 (Lgr5+) mice were crossed with heterozygote mitochondrial 
mutator PolγA(+/-) mice within the comparative biology centre (Newcastle University) 
(section 2.2.2.2). Lgr5(+/-)PolγA(+/+) (n=4), Lgr5(+/-)PolγA(+/-) (n=5) and Lgr5(+/-)PolγA(-/-) (n=4) 
were aged to 11-12 months and then killed (section 2.2.4). Mouse colons were removed for 
tissue processing at 11-12 months (section 2.2.4). Immunofluorescence was carried out to 
determine the expression levels of cytochrome c oxidase subunit 1 (MTCO1) of Complex IV 
and the NDUFB8 subunit of Complex I within mouse colon (section 2.2.5). Fluorescence 
microscopy and image analysis was conducted on mouse colon sections that had undergone 
immunofluorescence for mitochondrial OXPHOS subunit expression (section 2.2.7). This 
allowed the viability of the cross between Lgr5+ and mitochondrial mutator mice to be 
determined. It would also allow the pattern of mitochondrial dysfunction within their colon 
tissue to be quantified before further work could be carried out. 
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5.4 RESULTS 
5.4.1 Mitochondrial mutator mouse phenotype 
The observable phenotype for each mouse included within this study was recorded as can be 
seen in Table 5.1. All Lgr5(+/-)PolγA(+/+) mice showed a normal phenotype for 12 month old 
C57Bl/6J mice. PolγA(+/-) mice show no observable phenotype associated with ageing due to 
mitochondrial dysfunction (Trifunovic et al., 2004). Within this study, the majority of 
Lgr5(+/-)PolγA(+/-) mice appeared normal when compared to Lgr5(+/-)PolγA(+/+) mice, however, 
there were a couple of mice that showed some characteristics associated with its genotype, 
this included a marginally grey coat. PolγA(-/-) mice show an ageing phenotype from 6 months 
which includes; weight loss, anaemia, osteoporosis, kyphosis, and reduced subcutaneous fat 
(Trifunovic et al., 2004). Within this study, an ageing phenotype was also observed with 
Lgr5(+/-)PolγA(-/-) mice. The most obvious phenotype was greying of the fur and low weight. 
However, unlike the PolγA(-/-) used within the study by Trifunovic et al, the kyphosis 
phenotype was not as severe. The difference in phenotype severity is likely due to the nuclear 
background as the mitochondrial mutator mice within this study have a C57Bl/6J background 
(Kujoth et al., 2005), as opposed to C57Bl/6N (Trifunovic et al., 2004) within the study by 
Trifunovic et al. This may suggest that there is slower clonal expansion of mutated mtDNA 
within C57Bl/6J mice. Therefore, it would appear that the nuclear background significantly 
impacts on the severity of observable phenotypes within mitochondrial mutator mice. 
5.4.2 COX deficiency frequency within mitochondrial mutator mice  
A model was developed that was able to replicate the accumulation of COX deficiency within 
mouse colonic epithelium. In particularly, the accumulation of COX deficiency within mouse 
models of mitochondrial dysfunction, also known as PolγA mice. These mice have a 
proofreading deficiency within the mitochondrial DNA polymerase (D257A substitution) 
which means they are more likely to incorporate the wrong nucleotide upon replication, 
leading to mtDNA point mutation accumulation. COX/SDH histochemistry allows the 
visualisation of respiratory deficient crypts caused by clonal expansion of pathogenic de novo 
mtDNA mutations. Figure 5-1 shows the accumulation of COX deficiency within colonic 
epithelium of both PolγA+/- (heterozygote) and PolγA-/- (homozygote) mice and has kindly 
been provided by Dr Holly Baines (Baines et al., 2014). PolγA homozygote mice develop an 
ageing phenotype between 6 and 9 months (Trifunovic et al., 2004) and have a reduced 
lifespan compared to wild-type mice which is why there are no data points after 12 months of 
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age. PolγA homozygote mice accumulate COX deficiency within the colon at a faster rate 
compared to PolγA heterozygote. Wild-type mice also accumulate COX deficiency with age, 
but this only reaches ~1.5% by 36 months of age (Greaves et al., 2011). A model was 
developed in order to determine whether mutation rate alone could explain the difference in 
COX deficiency frequency between wild-type, PolγA heterozygote and PolγA homozygote 
mice, in order to validate their use. 
 







wild-type    
LPA446 f 54.0 Normal 
LPA457 f 54.0 Normal 
LPA497 f 52.3 Normal 
LPA499 f 52.3 Normal 
PolgA het    
LPA187 f 51.9 Greying coat 
LPA245 f 51.7 Normal 
LPA281 m 51.7 Normal 
LPA247 f 52.0 Normal 
LPA280 f 51.7 Normal 
PolgA hom    
LPA278 f 48.0 Slight kyphosis, greying coat, low weight 
LPA242 f 47.1 Slight kyphosis, greying coat, thining fur, low weight 
LPA213 m 49.3 Slight kyphosis, greying coat, thining fur 
LPA219 m 48.1 Slight kyphosis, fully grey coat, thining fur 
  





Figure 5-1 COX deficiency within mitochondrial mutator mice with age 
Data kindly provided by Dr Holly Baines showing the trend in respiratory deficiency 
(COX deficiency) within colonic epithelium of mice that have a proofreading deficiency 
within their mitochondrial polymerase gamma subunit (PolγA). The proofreading 
deficiency makes replicated mtDNA prone to acquiring point mutations. Both 
heterozygote and homozygote data is shown (Baines et al., 2014). 
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5.4.2.1 MtDNA mutation clonal expansion model 
A model of COX deficiency accumulation within mouse colon was developed and is 
described in section 2.2.10.1 with model code contained within appendix 1.3.1. A population 
of 1000 crypts within the colon was likened to a population of 1000 stem cells within the 
model, each with a specified mtDNA copy number. Each stem cell undergoes 1080 
asymmetric divisions and are simulated independently. Figure 5-2 depicts the clonal 
expansion of mutated mtDNA molecules within 5 individual stem cells. 
 
Figure 5-2 Mutated mtDNA clonal expansion within individual stem cells  
The clonal expansion model simulates the clonal expansion of mutated mtDNA molecules 
over time via relaxed replication and random segregation within a population of purely 
asymmetrically dividing stem cells. 1000 stem cells are simulated with each stem cell 
containing, in this case, 200 mtDNA molecules. A mutation rate (mutated 
mtDNA/replicated mtDNA) can be set which introduces de novo mtDNA point mutations 
into the system. Number of mutated mtDNA molecules verses number of stem cell 
divisions is shown for 5/1000 stem cells simulated to exemplify the stochastic clonal 
expansion of mutated mtDNA within individual stem cells. Only stem cell 3 reaches 
fixation. A more detailed explanation of the model is given in section 2.2.10.1 and the 
model code is contained within appendix 1.3.1. 
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5.4.2.2 Mutation rate and mtDNA copy number within stem cells 
The effects of mtDNA copy number and de novo mutation rate were assessed within the 
clonal expansion model. Figure 5-3 shows that with different numbers of mtDNA copy 
number, increasing the constant de novo mutation rate does increase the rate at which COX 
deficiency accumulates within a population of stem cells, likened to the colon epithelium.  
Figure 5-4 shows how mtDNA copy number changes the accumulation of COX deficiency 
within a population of stem cells. With a smaller mtDNA copy number, there is a slightly 
faster rate at which COX deficiency accumulates within a population of asymmetrically 
dividing stem cells. This difference is more pronounced with a low mutation rate, however, 
with an increased mutation rate, there is only a smaller difference in the rate of COX 
deficiency accumulation. 
  






















































































































































































































































































































































Figure 5-4 MtDNA copy number within the clonal expansion model 
The effects of increasing mtDNA copy number were ascertained within the clonal 
expansion model. 75% mutated mtDNA within individual stem cells conferred COX 
deficiency and was used when determining the percentage COX deficiency within the 
population. Simulations were also carried out with varying mutation rate. Simulations 
were run with mutations rates (A) 1.75 x 10-4, (B) 4.00 x 10-4, (C) 1.50 x 10-3, (D) 3.00 x 
10-3, (E) 5.00 x 10-3, and (F) 1.00 x 10-2 mutated mtDNA/mtDNA replication 
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5.4.2.3 Population model best fits with mitochondrial mutator mouse models  
As mtDNA copy number did not impact significantly on the rate of COX deficiency 
accumulation, a copy number of 200 was chosen for the best fit optimisation (Coller et al., 
2001). The mutation rate was optimised for wild-type, PolγA heterozygote and PolγA 
homozygote mice by using COX deficiency reference points from each animal (Figure 5-5). 
The reference point for wild type animals was 1.5% COX deficiency at 36 months. This was 
matched with a mutation rate of 7 x 10-6 mutated mtDNA/mtDNA replication. The reference 
point for PolγA heterozygote animals was 15% COX deficiency at 20 months. This was 
matched with a mutation rate of 7 x 10-4 mutated mtDNA/mtDNA replication. The reference 
point for PolγA homozygote animals was 60% at 9 months. This was matched with a 
mutation rate of 1 x 10-2 mutated mtDNA/mtDNA replication. This indicates there is a 100x 
and 1428x increase in the chance of a mutation occurring within PolγA heterozygote and 
homozygote animals compared with wild type animals, respectively. Also, PolγA homozygote 
animals acquire mutations 14x faster than PolγA heterozygote animals. This indicates that 
mtDNA mutation rate can be the main difference between mouse species that varies the rate 
of accumulation of focal respiratory deficiency. 
 
Figure 5-5 Optimised clonal expansion model  
Mutation rates were optimised in order to match COX deficiency frequency within wild-
type, PolγA(-/+) and PolγA(-/-) mice. 7 x 10-6 mutated mtDNA/replicated mtDNA best 
matched wild-type mice. 7 x 10-4 mutated mtDNA/replicated mtDNA best matched PolγA(-
/+) mice. 1 x 10-2 mutated mtDNA/replicated mtDNA best matched PolγA(-/-) mice. 200 
mtDNA molecules were simulated per stem cell. 
 
Chapter Five   Development and validation of mouse model 
155 
5.4.3 Observed mitochondrial dysfunction within mouse colon 
Quadruple immunofluorescence and fluorescence microscopy was conducted on 
Lgr5(+/-)PolγA(+/+), Lgr5(+/-)PolγA(+/-)and Lgr5(+/-)PolγA(-/-) mouse colons in order to determine 
the frequency of crypts with MTCO1 (Complex I) and NDUFB8 (Complex IV) loss at 48-54 
weeks of age (Table 5.1). Figures 5-6, 5-7 and 5-8 show images for Complex I, Complex IV, 
VDAC1 (Porin) (mitochondrial mass marker) and DAPI (nuclear counterstain), along with a 
merged image. There was a clear distinction between expression and loss of expression for 
each respiratory complex subunit, with no partial down-regulation observed within mouse 
colon. Therefore, crypts were grouped according to them being normal for Complex I and 
Complex IV expression, Complex I loss of expression, Complex IV loss of expression, and 
both Complex I and Complex IV loss of expression. Complex I expression appears red, 
Complex IV expression appears green, Porin expression appears orange and the cell nucleus 
appears blue. A merged image provides a clear picture of the mitochondrial OXPHOS status 
for Complex I and IV. Yellow crypts exemplify the expression of both Complex I and 
Complex IV. Red crypts exemplify the expression of Complex I only. Green crypts 
exemplify the expression of Complex IV only. Crypts that do not have a colour exemplify the 
loss of both Complex I and Complex IV. Figure 5-6 shows an example of what is observed 
within Lgr5(+/-)PolγA(+/+) mice. As can be seen within the merged image, all the crypts are 
yellow, indicating the presence of Complex I and Complex IV. As can be seen in the graph in 
Figure 5-6F. There is very little Complex I and Complex IV loss across all Lgr5(+/-)PolγA(+/+) 
mice observed. There is a slightly higher level of Complex I loss (~1%) compared to 
Complex IV (~0.1%) within Lgr5(+/-)PolγA(+/+) mice. Figure 5-7 shows an example of what is 
observed within Lgr5(+/-)PolγA(+/-) mice. As can be seen within the merged image, there is a 
mosaic pattern of yellow, green and red crypts. This indicates that crypts can either be normal 
for mitochondrial OXPHOS complex expression, Complex I deficient, Complex IV deficient, 
or harbour multiple complex deficiency (not shown in image). There is much more Complex 
I (~40%) and Complex IV (~20%) loss within Lgr5(+/-)PolγA(+/-) compared to 
Lgr5(+/-)PolγA(+/+) animals. Figure 5-8 shows an example of what is observed within 
Lgr5(+/-)PolγA(-/-) mice. As can be seen within the merged image, there is substantial 
mitochondrial OXPHOS complex loss for both Complex I and Complex IV. Most of the 
Complex I (~95%) expression within the colon epithelium is absent with a significant 
fraction of Complex IV (~60%) expression absent as well. Porin was included within the 
immunofluorescence assays to determine whether there was an associated decrease in 
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mitochondrial mass with loss of respiratory chain complex expression. As can be seen within 
the images for respiratory deficient crypts (Figures 5-7 and 5-8), there was no observable 
decrease in Porin intensity, indicating that crypts with respiratory chain complex deficiency 
within mitochondrial mutator mice are not associated with a reduction in mitochondrial mass. 
  




Figure 5-6 Mitochondrial dysfunction within Lgr5(+/-)PolγA(+/+) mouse colon 
Immunofluorescence for mitochondrial OXPHOS subunits NDUFB8 (Complex I) and 
MTCO1 (Complex IV) was performed on Lgr5(+/-)PolγA(+/+) mice (n=4) according to the 
protocol in section 2.2.5. (A) NDUFB8 (Complex I) image (B) MTCO1 (Complex IV) 
image (C) VDAC1 (Porin) image (D) DAPI image (E) NDUFB8 and MTCO1 merged 
image (F) Comparison of Complex I and Complex IV loss within Lgr5(+/-)PolγA(+/+) 
mouse colon. 




Figure 5-7 Mitochondrial dysfunction within Lgr5(+/-)PolγA(+/-) mouse colon 
Immunofluorescence for mitochondrial OXPHOS subunits NDUFB8 (Complex I) and 
MTCO1 (Complex IV) was performed on Lgr5(+/-)PolγA(+/-) mice (n=5) according to the 
protocol in section 2.2.5. (A) NDUFB8 (Complex I) image (B) MTCO1 (Complex IV) 
image (C) VDAC1 (Porin) image (D) DAPI image (E) NDUFB8 and MTCO1 merged 
image (F) Comparison of Complex I and Complex IV loss within Lgr5(+/-)PolγA(+/-) mouse 
colon. 




Figure 5-8 Mitochondrial dysfunction within Lgr5(+/-)PolγA(-/-) mouse colon 
Immunofluorescence for mitochondrial OXPHOS subunits NDUFB8 (Complex I) and 
MTCO1 (Complex IV) was performed on Lgr5(+/-)PolγA(-/-) mice (n=4) according to the 
protocol in section 2.2.5. (A) NDUFB8 (Complex I) image (B) MTCO1 (Complex IV) 
image (C) VDAC1 (Porin) image (D) DAPI image (E) NDUFB8 and MTCO1 merged 
image (F) Comparison of Complex I and Complex IV loss within Lgr5(+/-)PolγA(-/-) mouse 
colon. 
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5.4.4 Comparison of mitochondrial dysfunction between mouse genotypes  
The expression levels of both NDUFB8 (Complex I) and MTCO1 (Complex IV) were 
assessed and compared within Lgr5(+/-)PolγA(+/+), Lgr5(+/-)PolγA(+/-)and Lgr5(+/-)PolγA(-/-) 
mice. Figure 5-9 shows the comparisons for all types of crypts in relation to their 
mitochondrial respiratory complex status. Figure 5-9A shows the frequency of normal crypts 
for all mice being investigated. Around 99% of crypts are normal within Lgr5(+/-)PolγA(+/+) 
mice, ~50% are normal within Lgr5(+/-)PolγA(+/-) mice, and <1% are normal within 
Lgr5(+/-)PolγA(-/-). Figure 5-9B shows the frequency of crypts with Complex IV loss for all 
mice being investigated. Less than 1% of crypts have Complex IV loss within 
Lgr5(+/-)PolγA(+/+) mice, ~20% of crypts have Complex IV loss within Lgr5(+/-)PolγA(+/-) mice, 
and ~60% of crypts have Complex IV loss within Lgr5(+/-)PolγA(-/-) mice. Figure 5-9C shows 
the frequency of crypts with Complex I loss for all mice being investigated. Less than 2% of 
crypts have Complex I loss within Lgr5(+/-)PolγA(+/+) mice, ~40% of crypts have Complex I 
loss within Lgr5(+/-)PolγA(+/-) mice, and ~95% of crypts have Complex I loss within 
Lgr5(+/-)PolγA(-/-) mice. Figure 5-9D shows the frequency of crypts with Complex I and 
Complex IV loss grouped according to mouse genotype. For all mouse genotypes 
investigated, Complex I loss is significantly higher than Complex IV loss. It would appear, 
especially for Lgr5(+/-)PolγA(+/-) and Lgr5(+/-)PolγA(-/-) mice, that the frequency of crypts with 
Complex IV loss is approximately two-thirds that of crypts with Complex I loss. It can also 
be seen that the frequency of both crypts with Complex IV loss and crypts with Complex I 
loss for Lgr5(+/-)PolγA(-/-) mice totals >100%, indicating the presence of crypts with multiple 
respiratory complex loss within the colonic epithelium of Lgr5(+/-)PolγA(-/-) mice. 




Figure 5-9 Comparison of mitochondrial dysfunction within mouse colon 
Immunofluorescence for mitochondrial OXPHOS subunits NDUFB8 (Complex I) and 
MTCO1 (Complex IV) was performed on Lgr5(+/-)PolγA(+/+) (n=4), Lgr5(+/-)PolγA(+/-) 
(n=5) and Lgr5(+/-)PolγA(-/-) (n=4) mice according to the protocol in section 2.2.5. (A) 
Normal crypt comparison between Lgr5(+/-)PolγA(+/+), Lgr5(+/-)PolγA(+/-) and 
Lgr5(+/-)PolγA(-/-) mice (B) Complex IV comparison between Lgr5(+/-)PolγA(+/+), 
Lgr5(+/-)PolγA(+/-) and Lgr5(+/-)PolγA(-/-) mice (C) Complex I comparison between 
Lgr5(+/-)PolγA(+/+), Lgr5(+/-)PolγA(+/-) and Lgr5(+/-)PolγA(-/-) mice (D) Comparison of both 
Complex I and Complex IV between Lgr5(+/-)PolγA(+/+), Lgr5(+/-)PolγA(+/-) and 
Lgr5(+/-)PolγA(-/-) mice. 
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5.4.5 Multiple respiratory deficiency within mouse colon  
The mitochondrial OXPHOS status of all crypts was recorded and compared between each 
mouse and each genotype investigated. Figure 5-10 shows graphs of this data. Within the 
same data set, crypts were separated according to them being normal, Complex I deficient, 
Complex IV deficient, or both Complex I and Complex IV deficient. Figure 5-10A shows all 
crypt types for all Lgr5(+/-)PolγA(+/+) mice. The overwhelming majority of crypts from all 
mice were normal (99.5%). Where there was respiratory complex loss of expression, this was 
most often loss of Complex I (0.4%). Figure 5-10B shows all crypt types for all 
Lgr5(+/-)PolγA(+/-) mice. There was a variety of different types of crypts from all 5 
Lgr5(+/-)PolγA(+/-) mice investigated. The majority of crypts were normal within each mouse 
(50.1%). Complex I loss was significant (27.3%), followed by crypts with Complex IV loss 
(11.0%) to a lesser extent. There was also a fraction of crypts that had loss of both respiratory 
complexes (11.6%). Figure 5-10C shows all crypt types for all Lgr5(+/-)PolγA(-/-) mice. This 
time, the majority of crypts had loss of expression of both respiratory complexes (57.1%) 
followed by crypts with loss of Complex I expression only (38.8%). There were crypts that 
had Complex IV loss of expression (3.8%) and there were a few crypts that were completely 
normal for Complex I and Complex IV expression (0.5%). Therefore, if a crypt had loss of 
Complex IV, it was almost certain to have Complex I loss as well. However, if a crypt had 
Complex I loss, there was a higher chance that Complex IV expression remained intact. 
Figure 5-10D shows a comparison of three genotypes investigated. With decreasing 
mitochondrial polymerase proofreading ability, there is a decreasing shift in the fraction of 
normal crypts that are observed within mice aged between 11-12 months. It appears that the 
rate of Complex I loss takes place at an increased rate compared with Complex IV loss within 
colon epithelium. The higher the effective mutation rate, the less time required for the 
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5.5 DISCUSSION 
It is clear that there are differences between Lgr5(+/-)PolγA(+/+), Lgr5(+/-)PolγA(+/-)and 
Lgr5(+/-)PolγA(-/-) mice in terms of the frequency of respiratory chain complex loss within 
colonic epithelium. Due to the genotypes of the mice being investigated, this difference can 
be solely attributed to a decreasing proofreading ability of the mitochondrial polymerase γ, 
effectively increasing the constant rate of de novo point mutation acquisition during mtDNA 
replication (Figure 5-5). The frequency of crypts harbouring Complex I loss was significantly 
higher than those harbouring Complex IV loss (Figure 5-6, Figure 5-7 and Figure 5-8). This 
was true for all mice being investigated and not just a phenomenon attributed to the 
mitochondrial mutator mice. This indicates that the rate of Complex I loss is much faster than 
that of Complex IV loss within mouse colonic epithelium. This could be attributable to a 
variety of causes. Firstly, the mitochondrial genome encodes 7 subunits for Complex I 
compared to 3 subunits for Complex IV. The number of base pairs that contribute to the 7 
genes for Complex I equals 6349 with 19047 possible base substitutions. The number of base 
pairs that contribute to the 3 genes for Complex IV equals 3007 with 9021 possible base 
substitutions. The fact that twice as many base pairs contribute towards mitochondrial 
genome encoded genes for Complex I results in double the chance of Complex I genes 
acquiring a de novo mutation compared to Complex IV genes. Furthermore, the fact that four 
more mitochondrially encoded genes encode subunits that contribute to Complex I compared 
to Complex IV increases the chance of there being Complex I dysfunction as de novo 
mutations not only alter the function of the respiratory complex, they also hinder the 
assembly of the complex as well. Complex I is a highly complex and dynamic structure as 
shown from 3D electron microscopy from Y.lipolytica (Radermacher et al., 2006). ~38 
subunits have been described for human Complex I, 7 of which are encoded by the 
mitochondrial genome (Hirst et al., 2003). Complex I is made of 3 modules (N, Q and P), 
each performing a different role. NADH oxidation is conducted within the N module, 
(Walker, 1992) electron transfer and ubiquinone reduction is conducted within the Q module 
(Sazanov, 2007) and proton transfer across the membrane is conducted within module P, 
which relies on specific conformational change (Efremov et al., 2010; Baradaran et al., 
2013). The Q module consists of all the subunits encoded by the mitochondrial genome, 
therefore not only will those subunits be important for assembly of Complex I as a whole, 
lack of mtDNA encoded subunits will result in a reduced capacity to set up the proton 
gradient, impacting on the cells ability to synthesise ATP. 
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It is surprising that such a highly proliferative tissue such as the colon is able to tolerate such 
high levels of Complex I and Complex IV deficiency via NDUFB8 and MTCO1 loss of 
expression. This could be due to a variety of factors. For instance, a heteroplasmy threshold 
will exist for every pathogenic mutation present where wild type mtDNA molecules are able 
to compensate for mutated mtDNA molecules up to a point (Sciacco et al., 1994). There will 
also be a tissue specific threshold present whereby a certain level of OXPHOS deficiency can 
be tolerated before a biochemical phenotype is observed (Rossignol et al., 1999). Both these 
factors may explain why such high levels of respiratory deficiency can be tolerated within the 
mouse colon. 
Having more subunits encoded by the mitochondrial genome increases the chance of a de 
novo mutation disrupting the assembly of the Complex as a whole, resulting in Complex I 
loss. It is likely that the main contributory factor for the difference in rate of Complex I and 
IV loss is due to the number of genes and the individual gene sizes within the mitochondrial 
genome. De novo mutations within other regions of the mitochondrial genome, for instance 
tRNA and rRNA genes, will affect the translation of all mRNA gene products equally once a 
certain threshold for the fraction of mutated mtDNA has been reached within the cell. 
This study shows the presence of crypts with Complex I or Complex IV loss within mouse 
colonic epithelium. Both types of crypts would be classed as respiratory deficient, resulting in 
a reduced capacity for mitochondria to synthesise ATP for cellular energy. However, studies 
that assess whether a cell is respiratory deficient by just looking for Complex IV (COX 
activity) are more likely missing the cells true OXPHOS status due to Complex I loss being 
more likely. Therefore, it is important to test for the presence of multiple respiratory 
complexes in order to classify a cells true mitochondrial OXPHOS status. 
Within mitochondrial mutator mice, we see that there exists a significant fraction of crypts 
that harbour both Complex I and Complex IV loss. This observation has also been shown 
within ageing human colon (Greaves et al., 2010). Furthermore, some mitochondrial disease 
patients with only mitochondrial genome encoded Complex I gene mutations show multiple 
respiratory chain loss (Hinttala et al., 2006). This is reinforced in a recent mouse colon study 
showing that mutations in mitochondrial genome encoded Complex I genes can result in 
COX deficiency (Baines et al., 2014). It is thought that respiratory chain Complexes I, III and 
IV can exist as a supercomplex structure known as a ‘respirasome’ (Schagger and Pfeiffer, 
2000). As Complex I is thought to be an integral part of the respirasome structure (Moreno-
Chapter Five   Development and validation of mouse model 
166 
Lastres et al., 2012; Winge, 2012), with its assembly dependent on each contributing subunit 
(Acin-Perez et al., 2008), COX deficiency may result from an individual point mutation 
within a Complex I gene, hindering the assembly and function of the supercomplex structure, 
leading to a breakdown and loss of all respiratory complexes involved. Therefore, the fact 
that a crypt has Complex I loss may make it more likely for Complex IV to be lost as well 
with the supercomplex rationale, which may also increase the rate of Complex IV loss once 
Complex I has already been lost.  
5.6 CONCLUSION 
There are obvious differences between Lgr5(+/-)PolγA(+/+), Lgr5(+/-)PolγA(+/-)and 
Lgr5(+/-)PolγA(-/-) mice in terms of their phenotype and mitochondrial dysfunction within their 
colonic epithelium. The frequency of mitochondrial dysfunction within mitochondrial 
mutator mouse colons allows respiratory deficient crypts and the cells within these crypts to 
be investigated within the PolγA mice crossed with Lgr5 mice. C57Bl/6J mice would not 
cater for this due to the lack of crypts harbouring mitochondrial dysfunction There was a 
similar level of Complex IV deficiency via MTCO1 loss of expression within 12 month old 
Lgr5(+/-)PolgA(+/-) mouse colon (~20%) compared to COX deficiency within age human colon 
(~15%), indicating their potential use for making comparisons between mouse and human 
colonic epithelium. It is also important to assess multiple respiratory complex deficiency in 
order to understand a crypts true mitochondrial OXPHOS status due to crypts exhibiting 
deficiency within individual respiratory complexes. 
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Chapter 6 Cell cycle kinetics of cells with mitochondrial dysfunction 
within mouse colon 
6.1 INTRODUCTION 
6.1.1 Stem cell ageing 
The inability of adult stem cell populations to maintain the same level of function throughout 
life is largely responsible for age-related frailty and disease (Sharpless and DePinho, 2007). 
A decline in adult stem cell function results in ageing phenotypes such as hair loss, hair 
greying, decreased wound repair and substantial immune system deficiency (Sharpless and 
DePinho, 2007). As stem cells are long-lived within the majority of tissues due to their ability 
to self-renew, they are susceptible to age-related damage via chronological and replicative 
ageing (Liu and Rando, 2011). Molecular damage such as DNA mutagenesis is one form of 
age-related damage that accumulates within long-lived stem cell populations, with the rate of 
accumulation dependent on the rate of tissue regeneration. Therefore, rapidly replicating 
tissues, such as the gut, are subject to greater replicative ageing via DNA damage (Liu and 
Rando, 2011). The accumulation of age-related damage has been hypothesised to perturb 
normal stem cell homeostasis (Liu and Rando, 2011). This has been hypothesised to result in 
a reduction of stem cell numbers (Maslov et al., 2004), increased probability of tumour 
formation and cancer progression (Liu and Rando, 2011), and biased differentiation of stem 
cell progeny cells (Rossi et al., 2005). Understanding the impact age-related damage has on 
stem cells is of paramount importance so that we can develop novel treatments that maintain 
stem cell homeostasis for longer, thereby postponing age-related frailty and disease, and 
increasing quality of life in people of advanced age. 
6.1.2 Mitochondria and stem cell ageing 
6.1.2.1 Impact of mitochondrial dysfunction on stem cell ageing 
A variety of replicative tissues, derived from self-renewing stem cells, have been shown to 
accumulate mtDNA point mutations with age that result in focal respiratory chain deficiency 
(Taylor et al., 2003; McDonald et al., 2008; Fellous et al., 2009). As stem cells are the only 
cell types that persist within rapidly dividing tissues, somatic mtDNA mutations must be 
acquired and clonally expand within the stem cells (Kirkwood, 2008). As focal respiratory 
chain deficiency has been shown to increase exponentially with age within human colon 
(Taylor et al., 2003), mtDNA point mutations may have a contributory role in stem cell 
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ageing. As has been previously described, colon epithelium is an ideal tissue to study stem 
cell populations (section 4.1). One such functional study investigated the proliferative 
capacity of stem cell progeny cells within aged human colonic epithelium between normal 
and respiratory deficient crypts (Nooteboom et al., 2010). Even though the stem cells were 
not explicitly investigated within this study, stem cell progeny cells showed an ~20% 
reduction in the frequency of actively dividing cells between normal crypts and crypts with a 
cytochrome c oxidase subunit I (MTCO1) loss, which is indicative of Complex IV 
deficiency. Therefore, it would appear that the accumulation of mtDNA mutation within the 
stem cell pool of crypts is altering the proliferative capacity of the stem cell progeny cells. 
Though, further investigation is required in order to determine whether these effects translate 
as perturbed stem cell function as well. 
6.1.2.2 MtDNA mutations and colorectal cancer 
Colorectal cancer is one of the most common types of cancer in the western world, with age 
being the main risk factor associated with its incidence (Ferlay et al., 2010). The majority of 
cancer cells are associated with decreased OXPHOS with a corresponding increase in 
glycolysis, known as the Warburg effect (Warburg, 1956). Therefore, mitochondrial 
OXPHOS dysfunction has long been hypothesised to be a driving factor behind tumour 
formation and cancer progression. The role for mitochondrial dysfunction in cancer 
development is well supported by a variety of evidence. Firstly, mitochondria are heavily 
involved in apoptosis, a process cancer cells are able to escape (Cavalli and Liang, 1998). 
Furthermore, cancer cells often display focal respiratory chain deficiency (Carew and Huang, 
2002), altered mitochondrial membrane potential (Chen, 1988), and increased ROS 
generation and oxidative damage (Toyokuni et al., 1995). 
Many cancers have been shown to harbour mtDNA point mutations, for instance colorectal, 
gastric, liver, lung and breast malignancies (Ivanova et al., 1998; Jeronimo et al., 2001; 
Nomoto et al., 2002; Tan et al., 2002; Lee et al., 2005). Colorectal cancers have been shown 
to contain homoplasmic and heteroplasmic mtDNA point mutations in a variety of locations 
within the mitochondrial genome (Polyak et al., 1998; Coller et al., 2001; Lee et al., 2005; 
Lievre et al., 2005; Nishikawa et al., 2005; Sui et al., 2006). It has been suggested that 
mtDNA mutations selectively predispose cells to undergo carcinogenesis due to the changes 
in oxidative environment, ROS signalling and apoptosis (Park et al., 2009). With this, it has 
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been suggested that mtDNA point mutations could serve as a prognostic tool to determine the 
rate of colorectal cancer progression and patient survival (Lievre et al., 2005). 
However, the presence of mtDNA point mutations within cancer cells does not prove that 
they are the contributory factor to malignant transformation. However, it is plausible that the 
accumulation of mtDNA mutations within stem cells with age causes biochemical changes 
that makes them more susceptible to malignant transformation and early tumorigenesis (Liu 
and Rando, 2011). Understanding the functional effects of mtDNA point mutations on ageing 
stem cells needs to be resolved in order to understand normal tissue ageing and age-related 
diseases, such as cancer. 
6.1.3 Mouse models 
All cells within the colon epithelium are clonally derived from the stem cells located at the 
base of crypts. A mouse model known as Lgr5-EGFP-Ires-CreERT2 was engineered by 
Barker et al that enabled Lgr5+ stem cells to express high levels of EGFP, hence allowing 
their detection (Barker et al., 2007). A Cre-recombinase system was also incorporated, 
allowing Lgr5+ cell specific excision of any gene flanked by loxP sites upon tamoxifen 
induction. Lgr5+ stem cells have been shown to be the long-lived functional stem cells with 
the capacity of regenerating all the cells of the crypt throughout life (Barker et al., 2007). 
Single Lgr5+ stem cells from mouse small intestinal epithelium have been shown to build 
crypt villus organoids in culture (Sato et al., 2009), reinforcing the ability of these cells to 
regenerate entire crypts. Lgr5+ stem cell dynamics have also been intensely investigated 
within mouse colon in order to understand the stem cell niche succession phenomenon, 
providing insight into stem cell replacement under normal tissue homeostasis (Snippert et al., 
2010). They have also been shown to be the primary cells that drive tumour growth within 
APC knock-out mice, caused by constitutive Wnt-pathway activation (Barker et al., 2009). 
The evidence discussed suggests that cells with high levels of Lgr5 receptor expression are 
the true stem cells within intestinal and colonic epithelium and all studies investigating these 
stem cells should do so by identifying Lgr5 expression. 
As has been detailed in section 5.4.2, PolγA mitochondrial mutator mice have an increased 
rate of somatic mtDNA point mutation accumulation, resulting in an increased frequency of 
respiratory chain deficient cells with age. The crossing of mitochondrial mutator mice with 
Lgr5+ mice would allow the functional consequences of respiratory chain deficiency to be 
investigated within Lgr5+ stem cells within mouse colonic epithelium. 
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6.2 AIMS OF STUDY 
To determine whether mitochondrial OXPHOS dysfunction alters the cell cycle kinetics of 
stem cells and stem cell progeny within mouse colonic epithelium. In order for this question 
to be answered, a method of determining mitochondrial OXPHOS function was required in 
conjunction with a method of characterising cell cycle kinetics of each cell within individual 
crypts. As shown in chapter 5, a method of determining the presence of mitochondrial 
OXPHOS complexes was available. An in vivo technique known as double thymidine 
analogue labelling was adapted for use within mouse colon in order to characterise the cell 
cycle kinetics of Lgr5+ stem cells and stem cell progeny within mouse colon. Cell type and 
cell cycle kinetic markers included: 
1. Ki67 marker of cells proliferating at time of animals death 
2. CldU marker of cells divided within 1 week of animals death 
3. IdU marker of cells divided within ~15 hours of animals death 
4. EGFP marker of Lgr5+ stem cells 
Using an immunofluorescence technique to identify combinations of the markers specified, 
comparisons of the cell cycle kinetics of stem cells and stem cell progeny can be made 
between Lgr5(+/-)PolγA(+/+), Lgr5(+/-)PolγA(+/-) and Lgr5(+/-)PolγA(-/-) mice and also crypts with 
and without mitochondrial dysfunction. 
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6.3 METHODOLOGY 
6.3.1 Double thymidine analogue labelling 
Lgr5-EGFP-Ires-CreERT2 (Lgr5+) mice were bred with heterozygote mitochondrial mutator 
PolγA(+/-) mice within the comparative biology centre (Newcastle University) (section 
2.2.2.2). Lgr5(+/-)PolγA(+/+) (n=4), Lgr5(+/-)PolγA(+/-) (n=5) and Lgr5(+/-)PolγA(-/-) (n=4) were 
aged to 11-12 months and then underwent a thymidine analogue intra-peritoneal injection 
schedule in order to label dividing cells (section 2.2.3). Once complete, mice were killed and 
mouse colons were removed for tissue processing (section 2.2.4). 
6.3.2 Detection of mitochondrial dysfunction and cell cycle kinetic markers  
Immunofluorescence was carried out to determine the expression levels of cytochrome c 
oxidase subunit 1 (MTCO1) of Complex IV and the NDUFB8 subunit of Complex I within 
mouse colon (section 2.2.5). Immunofluorescence was also carried out to detect proliferating 
cells (Ki67), thymidine analogue markers (CldU and IdU) and stem cell marker (EGFP-
Lgr5). As all markers could not be applied to a single tissue section, to see all characteristics 
of individual crypts, serial sectioning was performed and matching crypts were located as 
described in Figure 6-1. Fluorescence microscopy and image analysis was carried out as 
previously described (section 2.2.7). 
 
Figure 6-1 Mitochondrial dysfunction and cell cycle kinetic labelling method 
Three mouse colon serial sections were cut using the microtome for the sections that 
would have primary antibody applied. Sections 1 and 3 underwent immunofluorescence 
for mitochondrial OXPHOS subunit expression. Section 2 underwent immunofluorescence 
for cell cycle kinetic and Lgr5 stem cell markers. 
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6.4 RESULTS 
6.4.1 Determining cell cycle kinetics within mouse colon 
Immunofluorescence and fluorescence microscopy were employed to detect the 
mitochondrial OXPHOS status and the cell cycle kinetics of individual crypts within mouse 
colon. As determined within chapter 5, it was important to include both Complex I (NDUFB8 
subunit) and Complex IV (MTCO1 subunit) expression markers to ascertain the cells true 
mitochondrial OXPHOS status. An EGFP marker was used to detect Lgr5+ stem cells, a 
Ki67 cell marker was used to detect cells that were actively proliferating, CldU and IdU were 
used to detect cells that had entered the S phase of the cell cycle within a specific time frame. 
CldU was injected twice daily for 3 days and once on the fourth day. Therefore, all the cells 
that underwent DNA synthesis whilst CldU was in the animal’s system would have 
incorporated the CldU thymidine analogue. IdU was injected once on the fourth day, only 
being present within the animal’s system for approximately 15 hours before its death. 
Therefore, all the cells that underwent DNA synthesis during this time would have 
incorporated the IdU thymidine analogue. This provides information about the total number 
of cells proliferating at the time of the animal’s death (Ki67), the total number of cells that 
have divided from the first CldU injection, the total number of cells that have divided from 
the first IdU injection, and the total number of cells that have re-entered the cell cycle in 
quick succession by detecting the cells that have incorporated both CldU and IdU. Figures 6-
2,3,4 depict typical fluorescence images obtained from Lgr5(+/-)PolγA(+/+) (Figure 6-2), 
Lgr5(+/-)PolγA(+/-) (Figure 6-3) and Lgr5(+/-)PolγA(-/-) (Figure 6-4) mouse colon for both 
mitochondrial OXPHOS status and cell cycle kinetics. As can be seen, three serial sections 
were cut, with the first and third identifying the mitochondrial OXPHOS status of a particular 
crypt, and the sandwiched section identifying the cell cycle kinetics of that same crypt. This 
was to make sure that the mitochondrial OXPHOS status was the same from one section to 
the next. If that was the case, this would imply that section two had the same mitochondrial 
OXPHOS status. If this was not the case, those crypts were discarded. This was only the case 
for a small minority of crypts observed.  
Only those crypts that contained EGFP+ cells were of interest as this was the means of 
detecting Lgr5+ cells. Figure 6-2 is from Lgr5(+/-)PolγA(+/+) mouse colon and shows two 
crypts with EGFP+ cells. Both of these crypts have normal expression levels of NDUFB8 
(Complex I) and MTCO1 (Complex IV). Figure 6-3 is from Lgr5(+/-)PolgA(+/-) mouse colon 
Chapter Six   Cell cycle kinetics within mouse colon 
174 
and shows one crypt with EGFP+ cells. This crypt is normal for NDUFB8 (Complex I) and 
MTCO1 (Complex IV). However, the crypt to the right which is EGFP- has NDUFB8 
(Complex I) loss of expression. Figure 6-4 is from Lgr5(+/-)PolgA(-/-) mouse colon and shows 
one crypt with EGFP+ cells. This crypt is normal for MTCO1 (Complex IV) but has 
NDUFB8 (Complex I) loss of expression. The crypt to the farthest right is EGFP- and has 
both NDUFB8 (Complex I) and MTCO1 (Complex IV) loss of expression. 
The majority of crypts identified from Lgr5(+/-)PolγA(+/+) mice were normal for mitochondrial 
OXPHOS subunit expression. There was a mosaic pattern of mitochondrial OXPHOS subunit 
expression for Lgr5(+/-)PolgA(+/-) mice. The majority of crypts identified from Lgr5(+/-)PolgA(-
/-) had some form of mitochondrial OXPHOS subunit loss of expression. This is the same as 
was seen in chapter 5. As crypts were identified based on having EGFP+ cells, the 
mitochondrial OXPHOS status of the crypt was not explicitly selected at the time of image 
capture. The fractions of EGFP+ stem cells and crypts with their associated mitochondrial 
OXPHOS status are exemplified in Figure 6-5 and have been tabulated within Table 6.1. This 
affected how many crypts and Lgr5+ stem cells were included in the analysis when 
segregating crypts based on mitochondrial OXPHOS status group. 
  






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 6-5 Mitochondrial OXPHOS status sampling fractions 
Only EGFP+ crypts were chosen for fluorescence imaging in order to assess the cell cycle 
kinetics of Lgr5+ stem cells. This meant the mitochondrial OXPHOS status was not 
identified explicitly at the time of image capture. (A) Represents the fraction of crypts that 
were normal, or had CIV loss only, CI loss only, or CI and CIV loss from 
Lgr5(+/-)PolγA(+/+) mice (n=267), Lgr5(+/-)PolγA(+/-) mice (n=324) and Lgr5(+/-)PolγA(-/-) 
mice (n=137). (B) Represents the fractions of Lgr5+ stem cells that were normal, or had 
CIV loss only, CI loss only, or CI and CIV loss from Lgr5(+/-)PolγA(+/+) mice (n=1355), 
Lgr5(+/-)PolγA(+/-) mice (n=1618) and Lgr5(+/-)PolγA(-/-) mice (n=757). 
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6.4.2 Number of cells within crypts  
The number of cells observed within longitudinal cross sections of crypts was quantified. The 
data was segregated based on mitochondrial OXPHOS status and mouse genotype. This is 
shown within Figure 6-6. It can be seen that for Lgr5(+/-)PolγA(+/+) (wild type) mice there is 
not a statistically significant difference between the number of cells that contribute to these 
crypts, with on average ~48 cells observed within each longitudinal crypt (Figure 6-6A). The 
same is true for Lgr5(+/-)PolγA(+/-) mice which have on average ~47 cells contributing towards 
each longitudinal crypt (Figure 6-6B). However, Lgr5(+/-)PolγA(-/-) mice have substantially 
larger crypts, with on average ~63 cells contributing towards each longitudinal crypt, with no 
statistically significant difference between each mouse (Figure 6-6C).  
  





Figure 6-6 Number of cells in crypts 
The number of cells within normal and respiratory deficient crypts was quantified. This 
was carried out on all crypts from Lgr5(+/-)PolγA(+/+)(n=4), Lgr5(+/-)PolγA(+/-)(n=5) and 
Lgr5(+/-)PolγA(-/-)(n=4) mouse colon that contained EGFP positive cells (i.e. Lgr5+ stem 
cells). (A) Number of cells within crypts, segregated for each Lgr5(+/-)PolγA(+/+) mouse. 
There was not a statistically significant difference between groups as determined by one-
way ANOVA (F(3,269) = 2.586, p = 0.054) (B) Number of cells within crypts, segregated 
for each Lgr5(+/-)PolγA(+/-) mouse. There was not a statistically significant difference 
between groups as determined by one-way ANOVA (F(4,323) = 1.759, p = 0.137) (C) 
Number of cells within crypts, segregated for each Lgr5(+/-)PolγA(-/-) mouse. There was not 
a statistically significant difference between groups as determined by one-way ANOVA 
(F(3,136) = 0.661, p = 0.578) (D) Number of cells within crypts, segregated for each 
mouse genotype and for mitochondrial OXPHOS status of those crypts. There was a 
statistically significant difference between groups as determined by one-way ANOVA 
(F(3,728) = 58.65, p < 0.0001). A Dunnett’s multiple comparison post-hoc test was 
conducted to determine which groups were significantly different compared to the wild 
type normal group. Only the PolγA(-/-)deficient group showed a significant increase (15.83 
± 3.19, p < 0.001). 
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6.4.3 Frequency of proliferating cells within mouse colon 
Proliferating cells were detected using an antibody against the Ki67 protein. Ki67 is highly 
expressed within a cell’s nucleus at all cell cycle stages, excluding G0 (quiescence phase). 
This allows the proliferating cell frequency to be quantified within individual crypts. As 
EGFP+ cells defined Lgr5+ stem cells, those that contained EGFP were deemed stem cells 
and those that did not were deemed stem cell progeny. The fraction of proliferating stem cells 
and stem cell progeny were compared between Lgr5(+/-)PolγA(+/+), Lgr5(+/-)PolγA(+/-) and 
Lgr5(+/-)PolγA(-/-) mice. There was not a statistically significant difference in the means 
between mouse groups for both stem cells (Figure 6-7A) and stem cell progeny cells (Figure 
6-7B) as determined by one-way ANOVA. The mean percentage of proliferating stem cells 
was ~95% and the mean percentage of proliferating stem cell progeny cells was ~75% for all 
mouse groups. The fraction of proliferating stem cells and stem cell progeny cells was next 
compared between normal and respiratory deficient crypts. There was not a statistically 
significant difference in the means between normal and respiratory deficient crypts for both 
stem cells (Figure 6-7C) and stem cell progeny cells (Figure 6-7D) as determined by an 
unpaired t-test. This indicates that respiratory deficiency does not have an effect on the 
proliferative activity (i.e. the number of actively dividing cells) of stem cells and stem cell 
progeny cells within mouse colon. 
  




Figure 6-7 Ki67 proliferating cell marker 
The frequency of actively proliferating cells at the time of the animal’s death was 
quantified via the detection of Ki67. This was carried out on all crypts from 
Lgr5(+/-)PolγA(+/+)(n=4), Lgr5(+/-)PolγA(+/-)(n=5) and Lgr5(+/-)PolγA(-/-)(n=4) mouse colon 
that contained EGFP positive cells (i.e Lgr5+ stem cells). (A) Percentage of Lgr5+ stem 
cells that are actively proliferating, segregated for mouse genotype. There was not a 
statistically significant difference between groups as determined by one-way ANOVA 
(F(2,10) = 0.796, p = 0.48) (B) Percentage of stem cell progeny cells that are actively 
proliferating, segregated for mouse genotype. There was not a statistically significant 
difference between groups as determined by one-way ANOVA (F(2,10) = 1.699, p = 
0.23) (C) Percentage of Lgr5+ stem cells that are actively proliferating, segregated based 
on their mitochondrial OXPHOS status. There was not a statistically significant difference 
in the mean percentages for normal (M=93.8, SD=6.71) and respiratory deficient 
(M=94.3, SD=9.84) crypts as determined by an unpaired t-test; t(16) = 0.14, p = 0.89. (D) 
Percentage of stem cell progeny cells that are actively proliferating, segregated based on 
their mitochondrial OXPHOS status. There was not a statistically significant difference in 
the mean percentages for normal (M=73.2, SD=10.01) and respiratory deficient (M=74.8, 
SD=11.54) crypts as determined by an unpaired t-test; t(16) = 0.31, p = 0.76. 
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6.4.4 Frequency of cells that incorporated a thymidine analogue 
Cells that had undergone DNA synthesis as part of their transition through the cell cycle 
whilst the thymidine analogues CldU and IdU were present within the animal’s system would 
have incorporated them into their newly synthesised DNA. As antibodies are available that 
can specifically bind to one or the other thymidine analogue, the frequency of cells that have 
traversed the cell cycle could be quantified. The fraction of cells that incorporated either 
thymidine analogue was quantified (Figure 6-8). The fraction of stem cells and stem cell 
progeny that had incorporated either of the two thymidine analogues were compared between 
Lgr5(+/-)PolγA(+/+)(n=4), Lgr5(+/-)PolγA(+/-)(n=5) and Lgr5(+/-)PolγA(-/-)(n=4) mice (Figure 6-
8A/B). There was no statistically significant difference in the means between mouse groups 
for stem cells as determined by one-way ANOVA (F(2,10) = 0.936, p = 0.42) (Figure 6-8A). 
The mean percentage of stem cells that had incorporated a thymidine analogue was 87%. 
However, there was a statistically significant difference in the means between mouse groups 
for stem cell progeny as determined by one-way ANOVA (F(2,10) = 8.614, p = 0.007) 
(Figure 6-8B). A Dunnet’s multiple comparison test was conducted which showed that there 
was a statistically significant increase in stem cell progeny cells incorporating either 
thymidine analogue between Lgr5(+/-)PolγA(+/+) (73.5%) and Lgr5(+/-)PolγA(-/-)mice (84%) of 
~10% of total cells (10.5 ± 2.54%, p = 0.004). 
The fraction of stem cells and stem cell progeny incorporating a thymidine analogue was next 
compared between normal and respiratory deficient crypts. There was a statistically 
significant increase in the means between normal (85%) and respiratory deficient stem cells 
(90%) incorporating a thymidine analogue as determined by an unpaired t-test (t(16) = 3.528, 
p = 0.003) (Figure 6-8C). There was also a statistically significant increase in the means 
between normal (76%) and respiratory deficient stem cell progeny cells (82%) incorporating 
a thymidine analogue as determined by an unpaired t-test (t(16) = 3.957, p = 0.0013) (Figure 
6-8D). 
These results indicate that respiratory deficiency is having a small but significant effect on 
the rate of thymidine analogue incorporation over a prolonged period of time. This was true 
when crypts were grouped according to mouse genotype and also their mitochondrial 
OXPHOS status. 
  




Figure 6-8 Thymidine analogue cell division marker 
The frequency of cells that have incorporated a thymidine analogue upon DNA replication 
before the animal’s death was quantified via detection of CldU and IdU. This was carried 
out on all crypts from Lgr5(+/-)PolγA(+/+)(n=4), Lgr5(+/-)PolγA(+/-)(n=5) and Lgr5(+/-)PolγA(-
/-)(n=4) mouse colon that contained EGFP positive cells (i.e Lgr5+ stem cells). (A) 
Percentage of Lgr5+ stem cells that have incorporated a thymidine analogue, segregated 
for mouse genotype. There was not a statistically significant difference between groups as 
determined by one-way ANOVA (F(2,10) = 0.936, p = 0.42). (B) Percentage of stem cell 
progeny cells that have incorporated a thymidine analogue, segregated for mouse 
genotype. There was a statistically significant difference between groups as determined by 
one-way ANOVA (F(2,10) = 8.614, p = 0.007). A Dunnet multiple comparison post-hoc 
test was conducted to determine which groups were significantly different compared to the 
Lgr5(+/-)PolγA(+/+) mouse group. Only Lgr5(+/-)PolγA(-/-) mice showed a significant increase 
(10.5 ± 2.54%, p = 0.004). (C) Percentage of Lgr5+ stem cells that have incorporated a 
thymidine analogue, segregated based on their mitochondrial OXPHOS status. There was 
a statistically significant difference in the mean percentages for normal (M=84.8, 
SD=2.66) and respiratory deficient (M=89.5, SD=2.73) crypts as determined by an 
unpaired t-test; t(16) = 3.528, p = 0.003. (D) Percentage of stem cell progeny cells that 
have incorporated a thymidine analogue, segregated based on their mitochondrial 
OXPHOS status. There was a statistically significant difference in the mean percentages 
for normal (M=75.6, SD=3.97) and respiratory deficient (M=82.1, SD=2.64) crypts as 
determined by an unpaired t-test; t(16) = 3.957, p = 0.0013. 
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6.4.5 Frequency of newly divided cells 
Cells that had undergone DNA synthesis as part of their transition through the cell cycle 
whilst the thymidine analogue IdU was present ~15 hours before the animal’s death would 
have incorporated it into their newly synthesised DNA. The fraction of cells that had 
incorporated the IdU thymidine analogue was quantified (Figure 6-9). The fraction of stem 
cells and stem cell progeny that had incorporated the IdU thymidine analogue was compared 
between Lgr5(+/-)PolγA(+/+)(n=4), Lgr5(+/-)PolγA(+/-)(n=5) and Lgr5(+/-)PolγA(-/-)(n=4) mice 
(Figure 6-9A/B). There was not a statistically significant difference in the means between 
mouse groups for stem cells as determined by one-way ANOVA (F(2,10) = 3.896, p = 
0.056) (Figure 6-9A). The mean percentage of stem cells that had incorporated the IdU 
thymidine analogue was 35%. However, there was a statistically significant difference in the 
means between mouse groups for stem cell progeny as determined by one-way ANOVA 
(F(2,10) = 6.403, p = 0.016) (Figure 6-9B). A Dunnet’s multiple comparison test was 
conducted which showed that there was a statistically significant increase in stem cell 
progeny cells incorporating the IdU thymidine analogue between Lgr5(+/-)PolγA(+/+) (15%) 
and Lgr5(+/-)PolγA(-/-) mice (23%) of ~9% of total cells (8.79 ± 2.62%, p = 0.013). 
The fraction of stem cells and stem cell progeny incorporating the IdU thymidine analogue 
was next compared between normal and respiratory deficient crypts. There was a statistically 
significant increase in the means between normal (26%) and respiratory deficient stem cells 
(34%) incorporating the IdU thymidine analogue as determined by an unpaired (t(16) = 
2.323, p = 0.035) (Figure 6-9C). There was also a statistically significant increase in the 
means between normal (15%) and respiratory deficient stem cell progeny cells (20%) 
incorporating the IdU thymidine analogue as determined by an unpaired t-test (t(16) = 2.323, 
p = 0.016) (Figure 6-9D). 
These results indicate that respiratory deficiency is having a small but significant effect on 
the rate of thymidine analogue incorporation over a short ~15 hour time frame. This was true 
when crypts were grouped according to mouse genotype and also their mitochondrial 
OXPHOS status. 
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Figure 6-9 Cells undergoing division within ~15 hours of animals death 
The frequency of cells that have incorporated a thymidine analogue upon DNA replicatio n 
~15 hours before the animal’s death was quantified via IdU detection. This was carried out 
on all crypts from Lgr5(+/-)PolγA(+/+)(n=4), Lgr5(+/-)PolγA(+/-)(n=5) and Lgr5(+/-)PolγA(-
/-)(n=4) mouse colon that contained EGFP positive cells (i.e Lgr5+ stem cells). (A) 
Percentage of Lgr5+ stem cells that have incorporated IdU, segregated for mouse 
genotype. There was not a statistically significant difference between groups as 
determined by one-way ANOVA (F(2,10) = 3.896, p = 0.056). (B) Percentage of stem 
cell progeny cells that have incorporated IdU, segregated for mouse genotype. There was a 
statistically significant difference between groups as determined by one-way ANOVA 
(F(2,10) = 6.403, p = 0.016). A Dunnetts multiple comparison post-hoc test was 
conducted to determine which groups were significantly different compared to the 
Lgr5(+/-)PolγA(+/+) mouse group. Only Lgr5(+/-)PolγA(-/-) mice showed a significant increase 
(8.79 ± 2.62%, p = 0.013). (C) Percentage of Lgr5+ stem cells that have incorporated IdU, 
segregated based on their mitochondrial OXPHOS status. There was a statistically 
significant difference in the mean percentages for normal (M=25.7, SD=6.43) and 
respiratory deficient (M=34.0, SD=8.28) crypts as determined by an unpaired t-test; t(16) 
= 2.323, p = 0.0346. (D) Percentage of stem cell progeny cells that have incorporated IdU, 
segregated based on their mitochondrial OXPHOS status. There was a statistically 
significant difference in the mean percentages for normal (M=14.7, SD=2.64) and 
respiratory deficient (M=19.9, SD=5.12) crypts as determined by an unpaired t-test; t(16) 
= 2.323, p = 0.016. 
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6.4.6 Frequency of cells re-entering the cell cycle 
Cells that had undergone DNA synthesis whilst the thymidine analogue CldU was present 
within the animal’s system, and subsequently whilst the thymidine analogue IdU was present 
within the animal’s system would have incorporated both thymidine analogues into their 
newly synthesised DNA. This provides a measure of the cell cycle re-entry rate. The fraction 
of cells that had incorporated both CldU and IdU thymidine analogues was quantified (Figure 
6-10). The fraction of stem cells and stem cell progeny that had incorporated both thymidine 
analogues were compared between Lgr5(+/-)PolγA(+/+)(n=4), Lgr5(+/-)PolγA(+/-)(n=5) and 
Lgr5(+/-)PolγA(-/-)(n=4) mice (Figure 6-10A/B). There was a statistically significant difference 
in the means between mouse groups for stem cells as determined by one-way ANOVA 
(F(2,10) = 6.593, p = 0.0149) (Figure 6-10A). A Dunnet’s multiple comparison test was 
conducted which showed that there was a statistically significant increase in stem cells 
incorporating both thymidine analogues between Lgr5(+/-)PolγA(+/+) (22%) and 
Lgr5(+/-)PolγA(-/-) mice (32%) of ~10% of total cells (10.00 ± 3.42%, p = 0.027). There was 
also a statistically significant difference in the means between mouse groups for stem cell 
progeny cells as determined by one-way ANOVA (F(2,10) = 10.12, p = 0.0040) (Figure 6-
10B). A Dunnet’s multiple comparison test was conducted which showed that there was a 
statistically significant increase in stem cell progeny cells incorporating both thymidine 
analogues between Lgr5(+/-)PolγA(+/+) (10%) and Lgr5(+/-)PolγA(-/-) mice (18%) of ~8% of total 
cells (8.25 ± 1.97%, p = 0.003). 
The fraction of stem cells and stem cell progeny incorporating both thymidine analogues was 
next compared between normal and respiratory deficient crypts. There was a statistically 
significant increase in the means between normal (19%) and respiratory deficient stem cells 
(27%) incorporating both thymidine analogues as determined by an unpaired t-test (t(16) = 
2.474, p = 0.0250) (Figure 6-10C). There was also a statistically significant increase in the 
means between normal (10%) and respiratory deficient stem cell progeny cells (14%) 
incorporating both thymidine analogues as determined by an unpaired t-test (t(16) = 2.622, p 
= 0.019) (Figure 6-10D). 
These results indicate that respiratory deficiency is having a small but significant effect on 
the rate of cell cycle re-entry. This was true when crypts were grouped according to mouse 
genotype and also their mitochondrial OXPHOS status. 
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Figure 6-10 Cell cycle re-entry before animals death  
The frequency of cells that have incorporated both thymidine analogues upon DNA 
replication before the animal’s death was quantified via CldU and IdU colocalisation. This 
was carried out on all crypts from Lgr5(+/-)PolγA(+/+)(n=4), Lgr5(+/-)PolγA(+/-)(n=5) and 
Lgr5(+/-)PolγA(-/-)(n=4) mouse colon that contained EGFP positive cells (i.e Lgr5+ stem 
cells). (A) Percentage of Lgr5+ stem cells that have incorporated both thymidine 
analogues, segregated for mouse genotype. There was a statistically significant difference 
between groups as determined by one-way ANOVA (F(2,10) = 6.593, p = 0.0149). A 
Dunnetts multiple comparison post-hoc test was conducted to determine which groups 
were significantly different compared to the Lgr5(+/-)PolγA(+/+) mouse group. Only 
Lgr5(+/-)PolγA(-/-) mice showed a significant increase (10.00 ± 3.42%, p = 0.027). (B) 
Percentage of stem cell progeny cells that have incorporated both thymidine analogues, 
segregated for mouse genotype. There was a statistically significant difference between 
groups as determined by one-way ANOVA (F(2,10) = 10.12, p = 0.0040). A Dunnetts 
multiple comparison post-hoc test was conducted to determine which groups were 
significantly different compared to the Lgr5(+/-)PolγA(+/+) mouse group. Only 
Lgr5(+/-)PolγA(-/-) mice showed a significant increase (8.25 ± 1.97%, p = 0.003). (C) 
Percentage of Lgr5+ stem cells that have incorporated both thymidine analogues, 
segregated based on their mitochondrial OXPHOS status. There was a statistically 
significant difference in the mean percentages for normal (M=19.1, SD=5.26) and 
respiratory deficient (M=26.9, SD=7.83) crypts as determined by an unpaired t-test; t(16) 
= 2.474, p = 0.0250. (D) Percentage of stem cell progeny cells that have incorporated both 
thymidine analogues, segregated based on their mitochondrial OXPHOS status. There was 
a statistically significant difference in the mean percentages for normal (M=9.7, SD=2.35) 
and respiratory deficient (M=14.1, SD=4.51) crypts as determined by an unpaired t-test; 
t(16) = 2.622, p = 0.019. 
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6.4.7 Frequency of cells re-entering the cell cycle within PolγA heterozygote mice 
Lgr5(+/-)PolγA(+/-) mice have a mosaic pattern of mitochondrial OXPHOS deficiency within 
their colonic epithelium. Therefore, normal and respiratory deficient crypts could be 
quantified within the same mouse genotype.  
The fraction of stem cells and stem cell progeny cells incorporating both thymidine analogues 
was compared between normal and respiratory deficient crypts within Lgr5(+/-)PolγA(+/-) mice 
(Figure 6-11). There was not a statistically significant difference in the means between 
normal (17%) and respiratory deficient stem cells (23%) incorporating both thymidine 
analogues as determined by an unpaired t-test (t(8) = 1.309, p = 0.23) (Figure 6-11A). 
However, there was a statistically significant mean increase between normal and respiratory 
deficient stem cells of the same subject of ~6% as determined by a paired t-test (t(4) = 3.00, p 
= 0.040). (Figure 6-11B) 
There was not a statistically significant difference in the means between normal (10%) and 
respiratory deficient stem cell progeny cells (11%) incorporating both thymidine analogues as 
determined by an unpaired t-test (t(8) = 0.948, p = 0.37) (Figure 6-11C). Furthermore, there 
was not a statistically significant means difference between normal and respiratory deficient 
stem cell progeny cells of the same subject as determined by a paired t-test (t(4) = 1.159, p = 
0.311) (Figure 6-11D). 
These results indicate that within the Lgr5(+/-)PolγA(+/-) mouse, respiratory deficiency is only 
having a small but significant effect on the rate of cell cycle re-entry for the stem cells and 
not the stem cell progeny. 
  




Figure 6-11 Cell cycle re-entry within PolγA(+/-) crypts 
The frequency of cells that have incorporated both thymidine analogues upon DNA 
replication before the animal’s death was quantified via CldU and IdU colocalisation. The 
difference in frequency was investigated between normal and respiratory deficient crypts 
within Lgr5(+/-)PolγA(+/-) mouse colon that contained EGFP positive cells (i.e. Lgr5+ stem 
cells). (A) Percentage of Lgr5+ stem cells that have incorporated both thymidine 
analogues, segregated based on their mitochondrial OXPHOS status. There was not a 
statistically significant difference in the mean percentages for normal (M= 17.0, SD= 
6.52) and respiratory deficient (M=23.0, SD= 7.91) crypts as determined by an unpaired t-
test; t(8) = 1.309, p = 0.23. (B) Percentage of Lgr5+ stem cells that have incorporated both 
thymidine analogues, segregated based on their mitochondrial OXPHOS status. There was 
a statistically significant increase in the mean percentage between normal and respiratory 
deficient crypts for the same subjects (M=6.00, SD= 4.47) as determined by a paired t-test; 
t(4) = 3.00, p = 0.040. (C) Percentage of stem cell progeny cells that have incorporated 
both thymidine analogues, segregated based on their mitochondrial OXPHOS status. 
There was not a statistically significant difference in the mean percentages for normal (M= 
9.80, SD= 2.86) and respiratory deficient (M=11.2, SD= 1.64) crypts as determined by an 
unpaired t-test; t(8) = 0.948, p = 0.37. (D) Percentage of Lgr5+ stem cells that have 
incorporated both thymidine analogues, segregated based on their mitochondrial OXPHOS 
status. There was not a statistically significant difference in the mean percentage between 
normal and respiratory deficient crypts for the same subjects as determined by a paired t-
test; t(4) = 1.159, p = 0.311. 
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6.4.8 Cell cycle kinetics by individual complex deficiency 
As individual and multiple complex deficiency was observed and quantified within the data 
set, the effect of mitochondrial OXPHOS deficiency type on the cell cycle kinetics of stem 
cell and stem cell progeny cells was assessed (Figure 6-12). The effect of mitochondrial 
OXPHOS deficiency type was ascertained for the fraction of stem cells (Figure 6-12A) and 
stem cell progeny cells (Figure 6-12B) that are actively dividing. There was not a statistically 
significant difference in the means between OXPHOS expression groups for stem cells as 
determined by one-way ANOVA (F(3,28) = 0.465, p = 0.709) (Figure 6-12A). There was 
also not a statistically significant difference in the means between OXPHOS expression 
groups for stem cell progeny cells as determined by one-way ANOVA (F(3,28) = 0.282, p = 
0.838) (Figure 6-12B).  
Next, the effect of mitochondrial OXPHOS deficiency type was ascertained for the fraction 
of stem cells (Figure 6-12C) and stem cell progeny cells (Figure 6-12D) that had incorporated 
a thymidine analogue over a prolonged period of time. There was not a statistically 
significant difference in the means between OXPHOS expression groups for stem cells as 
determined by one-way ANOVA (F(3,28) = 0.465, p = 0.709) (Figure 6-12C). However, 
there was a statistically significant difference in the means between OXPHOS expression 
groups for stem cell progeny cells as determined by one-way ANOVA (F(3,28) = 7.573, p = 
0.001) (Figure 6-12D). A Dunnet’s multiple comparison test was conducted which showed 
that there was a statistically significant increase in the fraction of stem cell progeny cells 
incorporating a thymidine analogue between normal crypts (75.6%) and crypts with 
NDUFB8 (Complex I) loss (82.6%) (7.07 ± 1.73%, p = 0.001) and also between normal 
crypts (75.6%) and crypts with both NDUFB8 (Complex I) and MTCO1 (Complex I) loss 
(81.0%) (5.94 ± 1.73%, p = 0.006).  
Next, the effect of mitochondrial OXPHOS deficiency type was ascertained for the fraction 
of stem cells (Figure 6-12E) and stem cell progeny cells (Figure 6-12F) that had incorporated 
the IdU thymidine analogue over a short ~15 hour time frame. There was not a statistically 
significant difference in the means between OXPHOS expression groups for stem cells as 
determined by one-way ANOVA (F(3,28) = 0.974, p = 0.419) (Figure 6-12E). However, 
there was a statistically significant difference in the means between OXPHOS expression 
groups for stem cell progeny cells as determined by one-way ANOVA (F(3,28) = 4.70, p = 
0.009) (Figure 6-12F). A Dunnet’s multiple comparison test was conducted which showed 
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that there was a statistically significant increase in the fraction of stem cell progeny cells 
incorporating the IdU thymidine analogue between normal crypts (14.7%) and crypts with 
NDUFB8 (Complex I) loss (20.4%) (5.72 ± 2.02%, p = 0.024) and also between normal 
crypts (14.7%) and crypts with both NDUFB8 (Complex I) and MTCO1 (Complex I) loss 
(20.9%) (6.19 ± 2.02%, p = 0.014). 
Finally, the effect of mitochondrial OXPHOS deficiency type was ascertained for the fraction 
of stem cells (Figure 6-12G) and stem cell progeny cells (Figure 6-12H) that had incorporated 
both IdU and CldU thymidine analogues. There was a statistically significant difference in 
the means between OXPHOS expression groups for stem cells as determined by one-way 
ANOVA (F(3,28) = 5.025, p = 0.008) (Figure 6-12G). A Dunnet’s multiple comparison test 
was conducted which showed that there was a statistically significant increase in the fraction 
of stem cells incorporating both thymidine analogues between normal crypts (19.1%) and 
crypts with NDUFB8 (Complex I) loss (29.3%) (10.17 ± 3.66%, p = 0.029) and also between 
normal crypts (19.1%) and crypts with both NDUFB8 (Complex I) and MTCO1 (Complex I) 
loss (31.8%) (12.72 ± 3.82%, p = 0.008). There was also a statistically significant difference 
in the means between OXPHOS expression groups for stem cell progeny cells as determined 
by one-way ANOVA (F(3,28) = 4.800, p = 0.009) (Figure 6-12H). A Dunnet’s multiple 
comparison test was conducted which showed that there was a statistically significant 
increase in the fraction of stem cell progeny cells incorporating both thymidine analogues 
between normal crypts (9.25%) and crypts with NDUFB8 (Complex I) loss (14.0%) (5.13 ± 
1.79%, p = 0.022) and also between normal crypts (9.25%) and crypts with both NDUFB8 
(Complex I) and MTCO1 (Complex I) loss (14.9%) (5.63 ± 1.79%, p = 0.012). 
These results indicate that respiratory deficient stem cells and stem cell progeny that 
incorporate an element of NDUFB8 (Complex I) loss have an increased cell cycle 
progression and re-entry rate. 
  




Figure 6-12 Cell cycle kinetics and multiple complex deficiency 
The frequency of cells that are proliferative and have incorporated thymidine analogues 
upon DNA replication before the animal’s death were quantified via Ki67, CldU and IdU 
detection. This was carried out on all crypts from Lgr5(+/-)PolγA(+/+), Lgr5(+/-)PolγA(+/-) and 
Lgr5(+/-)PolγA(-/-) mouse colon that contained EGFP positive cells (i.e Lgr5+ stem cells). 
(A) Percentage of Lgr5+ stem cells that are actively proliferating, segregated based on 
their mitochondrial OXPHOS status. There was not a statistically significant difference 
between groups as determined by one-way ANOVA (F(3,28) = 0.465, p = 0.709). (B) 
Percentage of stem cell progeny cells that are actively proliferating, segregated based on 
their mitochondrial OXPHOS status. There was not a statistically significant difference 
between groups as determined by one-way ANOVA (F(3,28) = 0.282, p = 0.838). (C) 
Percentage of Lgr5+ stem cells that have incorporated a thymidine analogue, segregated 
based on their mitochondrial OXPHOS status. There was not a statistically significant 
difference between groups as determined by one-way ANOVA (F(3,28) = 0.717, p = 
0.550). (D) Percentage of stem cell progeny cells that have incorporated a thymidine 
analogue, segregated based on their mitochondrial OXPHOS status. There was a 
statistically significant difference between groups as determined by one-way ANOVA 
(F(3,28) = 7.573, p = 0.001). A Dunnetts multiple comparison post-hoc test was 
conducted to determine which groups were significantly different compared to the normal 
group. Both the CI loss (7.07 ± 1.73%, p = 0.001) and the CI and CIV loss (5.94 ± 1.73%, 
p = 0.006) groups showed a significant increase. (E) Percentage of Lgr5+ stem cells that 
have incorporated IdU, segregated based on their mitochondrial OXPHOS status. There 
was not a statistically significant difference between groups as determined by one-way 
ANOVA (F(3,28) = 0.974, p = 0.419). (F) Percentage of stem cell progeny cells that have 
incorporated IdU, segregated based on their mitochondrial OXPHOS status. There was a 
statistically significant difference between groups as determined by one-way ANOVA 
(F(3,28) = 4.70, p = 0.009). A Dunnetts multiple comparison post-hoc test was conducted 
to determine which groups were significantly different compared to the normal group. 
Both the CI loss (5.72 ± 2.02%, p = 0.024) and the CI and CIV loss (6.19 ± 2.02%, p = 
0.014) groups showed a significant increase. (G) Percentage of Lgr5+ stem cells that have 
incorporated both thymidine analogues, segregated based on their mitochondrial 
OXPHOS status. There was a statistically significant difference between groups as 
determined by one-way ANOVA (F(3,28) = 5.025, p = 0.008). A Dunnetts multiple 
comparison post-hoc test was conducted to determine which groups were significantly 
different compared to the normal group. Both the CI loss (10.17 ± 3.66%, p = 0.029) and 
the CI and CIV loss (12.72 ± 3.82%, p = 0.008) groups showed a significant increase. (H) 
Percentage of stem cell progeny cells that have incorporated both thymidine analogues, 
segregated based on their mitochondrial OXPHOS status. There was a statistically 
significant difference between groups as determined by one-way ANOVA (F(3,28) = 
4.800, p = 0.009). A Dunnetts multiple comparison post-hoc test was conducted to 
determine which groups were significantly different compared to the normal group. Both 
the CI loss (5.13 ± 1.79%, p = 0.022) and the CI and CIV loss (5.63 ± 1.79%, p = 0.012) 
groups showed a significant increase.  
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6.5 DISCUSSION 
Cell cycle kinetic parameters were quantified within Lgr5(+/-)PolγA(+/+), Lgr5(+/-)PolγA(+/-) and 
Lgr5(+/-)PolγA(-/-) mouse colon, segregated into stem cell and stem cell progeny cell groups, 
and were further segregated according to the mitochondrial OXPHOS status. The 
mitochondrial OXPHOS status of stem cell and stem cell progeny cells was assumed by the 
status of the crypt as a whole. Lgr5+ stem cells have been shown to be the long-lived 
functional stem cells within mouse small intestinal and colon epithelium, having the ability to 
generate every cell type within crypts (Barker et al., 2007; Sato et al., 2009). Therefore, if the 
crypt as a whole had a mitochondrial OXPHOS deficiency, this would be derived solely from 
the Lgr5+ stem cells. 
The number of cells contained within each longitudinal crypt from each mouse genotype was 
quantified (Figure 6-6). For each mouse within their own genotype group there was no 
statistically significant difference for the average number of cells observed within 
longitudinal crypts. The average for Lgr5(+/-)PolγA(+/+) mouse crypts was 48 cells, the average 
for Lgr5(+/-)PolγA(+/-) mouse crypts was 47 cells, however the average for Lgr5(+/-)PolγA(-/-) 
mouse crypts was 63 cells. As all mouse crypts within this group averaged the same number 
of cells, this suggests that it is a true observation and not just variation caused by the way in 
which the colon tissue block was cut on the microtome. It is curious that respiratory deficient 
crypts from Lgr5(+/-)PolγA(+/-) mice do not show a difference compared to wild type normal 
crypts whereas respiratory deficient crypts from Lgr5(+/-)PolγA(-/-) mice do show a substantial 
difference. As was shown in section 5.4.2, respiratory deficiency is acquired much earlier 
within Lgr5(+/-)PolγA(-/-) mouse crypts compared to those from Lgr5(+/-)PolγA(+/-) mice. The 
fact that there is an observable phenotype within Lgr5(+/-)PolγA(-/-) respiratory deficient crypts 
compared to Lgr5(+/-)PolγA(+/-) respiratory deficient crypts may suggest that respiratory 
deficiency can be tolerated for a certain amount of time before a disruption to normal crypt 
morphology is acquired. The effect of respiratory deficiency on crypt size within human 
colon has previously been investigated (Nooteboom et al., 2010). This study showed that 
respiratory deficient crypts had a decreased crypt size compared to normal crypts 
(Nooteboom et al., 2010). The effect of respiratory deficiency seems to have contrasting 
effects on human and mouse crypts and may reflect species differences.  
Ki67 is a protein that is present within all stages of the cell cycle, excluding the G0 
quiescence phase. Therefore, the frequency of actively dividing cells was quantified via Ki67 
Chapter Six  Cell cycle kinetics within mouse colon  
197 
labelling. It has previously been shown that there is an approximate 20% reduction in the 
frequency of Ki67+ stem cell progeny cells between normal and respiratory chain deficient 
crypts from aged human colon (Nooteboom et al., 2010). The same observation was not 
observed within mouse colon, with no statistically significant difference between mouse 
groups and mitochondrial OXPHOS status for stem cell progeny cells and also the stem cells 
themselves (Figure 6-7 and Figure 6-12A/B). In this study, we see a greater fraction of Ki67+ 
stem cell progeny cells in mouse crypts (70%) compared to within the study by Nooteboom 
et al which saw a Ki67+ fraction of stem cell progeny of approximately 25%. This may be 
explained by the differences that exist between mouse and human colonic epithelium. Firstly, 
mouse crypts contain ~250 cells (Kellett et al., 1992), whereas human crypts contain ~2000 
cells (Yatabe et al., 2001; Nicolas et al., 2007; Nooteboom et al., 2010). Furthermore, cell 
cycle time differences exist between human and mouse stem cells and stem cell progeny 
cells. Crypt stem cells divide approximately once per week within humans (Potten and 
Loeffler, 1990; Potten et al., 1992; Kim and Shibata, 2002), whereas mouse stem cells divide 
once per day (Kellett et al., 1992; Potten et al., 1992). Therefore, mouse crypts regenerate 5 
times faster than human crypts. However, as the average lifespan for humans is 80 years and 
3 years for the average laboratory mouse, stem cells are expected to divide 5 times as much at 
the end of a human’s lifespan as opposed to the end of a mouse’s. These differences, along 
with the fact that only 11-12 month old mice were used within this study, may account for the 
difference we see between mouse and humans. As no difference was seen in the frequency of 
Ki67+ stem cell progeny cells between normal and respiratory deficient crypts in mouse, this 
indicates that the observed difference between normal and respiratory deficient crypts within 
humans may be compounded by the replicative and chronological age of the stem cells. 
The in vivo technique of thymidine analogue labelling was used to assess the rate at which 
stem cells and stem cell progeny cells within mouse colon were dividing. All cells dividing 
and transiting through the S-phase (DNA synthesis) of the cell cycle would incorporate the 
thymidine analogue into the newly replicated DNA. A double thymidine analogue method of 
labelling dividing cells using IdU and CldU was adopted with the help of Dr Elizabeth Stoll 
(Newcastle University) where it had already been used to assess neurogenic decline within 
mouse brain subventricular zone (Stoll et al., 2011). Antibodies were commercially available 
that could bind specifically to each thymidine analogue. This allowed cell cycle kinetic 
parameters to be compared between Lgr5(+/-)PolγA(+/+), Lgr5(+/-)PolγA(+/-)and Lgr5(+/-)PolγA(-
/-) mouse colon and also between normal and respiratory deficient crypts. The cell cycle 
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kinetics parameters to be compared included; number of cells that had undergone division 
over a 4 day time period, over a ~15 hour time period, and also those cells that had re-entered 
the cell cycle in quick succession.  
Firstly, the frequency of stem cell and stem cell progeny cells that had undergone division 
over 4 days prior to the animal’s death was assessed (Figure 6-8). There was an ~10% 
increase in the frequency of cells incorporating a thymidine analogue within stem cell 
progeny cells within Lgr5(+/-)PolγA(-/-) mouse colon compared to Lgr5(+/-)PolγA(+/+)  mouse 
colon (Figure 6-8B). As Lgr5(+/-)PolγA(+/+)  mouse colon purely sampled normal crypts and 
Lgr5(+/-)PolγA(-/-) mouse colon contained mostly respiratory deficient crypts, this can be 
thought of as a direct comparison between normal and respiratory deficient crypts. It has 
previously been shown that the number of cells actively dividing within mouse colon is the 
same between different mouse groups (Figure 6-7), the fact that there is a greater thymidine 
analogue incorporation within respiratory deficient crypts indicates that these crypts are 
regenerating at a faster rate. This result is replicated by the frequency of stem cell progeny 
cells that have incorporated only the IdU thymidine analogue (Figure 6-9). There was no 
statistically significant difference for Lgr5+ stem cells between mouse groups (Figure 6-8 
and Figure 6-9). As the effects of respiratory deficiency on cell cycle kinetics may be small, 
wider variation in the data sets may make it difficult to resolve those differences via 
statistical significance testing. 
As the data within this study shows that there was increased cell division for respiratory 
deficient crypts compared with normal crypts, the frequency of stem cells and stem cell 
progeny that incorporated both CldU and IdU thymidine analogues, hence cell cycle re-entry, 
was quantified (Figure 6-10). This would determine whether the increased cell division 
observed could be explained by a more rapid progression through the cell cycle. This time 
there were observable differences for stem cells and stem cell progeny cells between mouse 
groups (Figure 6-10A/B) and between normal and respiratory deficient crypts (Figure 6-
10C/D). This was also done within the PolγA(+/-) mouse group that contained both normal and 
respiratory deficient crypts (Figure 6-11). There was a small 6% increase in the frequency of 
cell cycle re-entry for respiratory deficient stem cells, but not stem cell progeny cells. Again, 
reducing the number of cells and crypts analysed, which looking at one mouse group will do, 
adds to the variability in the data set, suggesting a possible reason why a difference could not 
be seen for stem cell progeny cells within the PolγA(+/-) mouse group. These data provide 
evidence that there is increased cell division for respiratory deficient crypts and that this is 
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due to an increased rate of cell cycle progression for respiratory deficient cells. Furthermore, 
when the cell cycle kinetics data was segregated based on each mitochondrial OXPHOS 
deficiency type (Figure 6-12), Complex I deficient crypts showed a more substantial increase 
in cell division rate and cell cycle re-entry. This suggests that Complex I loss triggers more 
pronounced cell cycle kinetic perturbations. 
Perturbations to cell cycle kinetics within stem cells and stem cell progeny cells were more 
apparent within Lgr5(+/-)PolγA(-/-)  mouse crypts. As has been stated previously, respiratory 
deficiency is acquired much earlier within Lgr5(+/-)PolγA(-/-) mouse crypts, suggesting that 
perturbations to cell cycle kinetics and crypt morphology occur long after the acquisition of 
respiratory deficiency, meaning that the stem cells are able to tolerate the respiratory 
deficiency for a certain amount of time before it starts to perturb the stem cells cellular 
function. 
6.6 CONCLUSION 
Even though mouse and human crypts have similar structural architecture and provide the 
same function, they are still unique, adding to the complexity for comparing mouse crypts to 
human crypts. This can be emphasised within this study when proliferation and cell cycle 
progression are so different between the two species, but plays an integral part within this 
study. As the frequency of actively dividing cells remains constant between normal and 
respiratory deficient crypts within mouse colon, the fact that we see increased cell division 
and cell cycle re-entry within respiratory deficient crypts provides evidence that respiratory 
deficient cells progress through the cell cycle at a much faster rate. This is true for both stem 
cells and stem cell progeny. This is the first study that has shown respiratory deficiency does 
alter the cell cycle kinetics of stem cells of the colon.  
Future work includes investigating what the mechanism is behind respiratory deficiency 
altering cell cycle kinetics within colonic epithelium, and also discovering how stem cells are 
able to tolerate respiratory deficiency before alterations to cellular function arise.
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Chapter 7 Final discussion and future work 
The accumulation of mitochondrial dysfunction within colonic epithelium and its impact on 
the stem cells and stem cell progeny have been investigated in depth within this thesis using 
both experimental and computational methodologies. Understanding the accumulation of 
mitochondrial dysfunction and its impact on ageing tissues is extremely important as it has 
the ability to compromise a tissues function, leading to tissue failure (Taylor and Turnbull, 
2005). Mitochondrial dysfunction has been linked to a variety of age-related diseases such as 
macular degeneration (Blasiak et al., 2013), diabetes mellitus (Sivitz and Yorek, 2010) and 
certain neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease (Reeve et 
al., 2008). Mitochondrial dysfunction has also been linked to cancer development within 
ageing tissues due to favourable metabolic perturbations that exist within those cells with 
mitochondrial dysfunction (Warburg, 1956; Toyokuni et al., 1995; Carew and Huang, 2002; 
Park et al., 2009). Colorectal cancer is the third most commonly diagnosed cancer 
worldwide, and the fourth most common cause of death from cancer (Ferlay et al., 2010), 
with age being the biggest risk factor (CDC, 2015). Therefore, understanding the functional 
consequences of mitochondrial dysfunction within the colon is of high importance. 
7.1 ACCUMULATION OF MITOCHONDRIAL DYSFUNCTION 
Investigating the accumulation of mitochondrial dysfunction within human colonic 
epithelium has revealed important characteristics about the biology of the colon as a whole. 
The biological data, as well as model optimisations, were able to determine that there are an 
average of 5 stem cells contained within human colonic crypts. This is similar to previously 
published numbers of stem cells within mouse (7 stem cells) and human (4-6 stem cells) 
colonic crypts (Kozar et al., 2013; Baker et al., 2014). The number of functional stem cells 
that are contained at the base of crypts is an important factor as this will influence the rate at 
which niche succession occurs, hence the rate at which mitochondrial dysfunction, or 
mutations to the nuclear DNA, are able to accumulate. Furthermore, the ratio between 
partially and fully COX deficient crypts meant that simulations could only be matched when 
the majority of stem cell divisions were asymmetric. This was true for all numbers of stem 
cells simulated, with a model of 5 stem cells requiring asymmetric stem cell divisions to 
occur 99% of the time. This is in contrast to reports that suggest symmetric division occurs 
all the time (Snippert et al., 2010; Baker et al., 2014). This discrepancy may be due to the 
explicit way in which the stem cell dynamics are simulated within the model presented, 
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resulting in a more biologically accurate model. The Cairns Hypothesis postulates that upon 
stem cell division, newly replicated DNA is segregated out of the stem cell pool and passed 
onto the non-stem cell daughter cells, minimising the number of mutations that accumulate 
within the stem cells (Cairns, 1975). This would mean stem cells are in fact dividing 
asymmetrically at the point of division. This is in agreement with findings from this study. As 
colonic stem cells have a high turnover rate in order to regenerate the crypt on weekly basis 
(Potten and Loeffler, 1990), it makes sense that asymmetric division occurs the majority of 
the time as a measure of minimising nuclear mutations over the human lifespan. 
It was soon realised that a model of neutral drift stem cell dynamics was unable to the match 
the biological data, due to the increase in partially COX deficient crypts with age. This meant 
that the rate at which COX deficient stem cells were being generated and were accumulating 
within the colon was increasing over time. An increasing mtDNA mutation rate has the 
potential to increase the rate at which COX deficient stem cells are acquired. However, a 
previous study looking at mtDNA mutation rate within ageing human colon has shown that 
there is no statistically significant increase in mtDNA mutation rate with age (Greaves et al., 
2014). On the other hand, as it has previously been discussed (section 4.5), the RMC assay 
used to infer mtDNA mutation rate includes high intrinsic variability; therefore a subtle 
increase in mutation rate cannot be completely ruled out and should be incorporated into the 
model (Greaves et al., 2014).  
The ability of COX deficient stem cells to expand was assessed. This was done by increasing 
the probability of symmetric stem cell division (2 stem cells) for COX deficient stem cells. 
This resulted in an increasing frequency of partially COX deficient crypts with age, 
reminiscent of what was observed within the biological data, suggesting that mitochondrial 
dysfunction is having an advantageous impact on a COX deficient stem cells ability to 
expand. 
Using two sets of biological data, it was shown that mutated mtDNA clonal expansion within 
the colon was unlikely to occur via relaxed replication and random segregation. It has 
previously been shown that mammary epithelial cells segregate their young and old 
mitochondria asymmetrically upon division (Katajisto et al., 2015). Therefore, it was 
rationalised that newly replicated mtDNA (mtDNA acquiring mutation) may be segregated 
out of the stem cell pool upon asymmetric stem cell division. This hypothesis allowed the 
model to match both COX deficiency frequency and the number of mutations within 
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individual cells with an extremely marginal segregation bias being set. This suggests that 
stem cells may have a mechanism for the prevention of mutated mtDNA accumulation, via 
biasing the segregation of newly replicated mtDNA out of the stem cell pool. 
7.2 IMPACT OF MITOCHONDRIAL DYSFUNCTION  
In order to investigate the impact of mitochondrial dysfunction within colonic stem cells, 
mouse models were employed. Lgr5 is a well-accepted stem cell marker within mouse colon, 
with Lgr5-EGFP-Ires-CreERT2 (Lgr5(+/-)) mice expressing a detectable EGFP molecule 
within Lgr5+ stem cells (Barker et al., 2007). Wild type C57Bl/6J mice do not accumulate 
significant levels of mitochondrial dysfunction within their colons (Greaves et al., 2011). 
However, mitochondrial mutator (PolγA(+/-) and PolγA(-/-)) mice do accumulate substantial 
mitochondrial dysfunction within their colons (Baines et al., 2014). Therefore, in order to 
visualise a substantial number of stem cells and stem cell progeny cells harbouring 
mitochondrial dysfunction within mouse colon, Lgr5(+/-) mice were crossed with PolγA(+/-) 
mice. The use of the Lgr5(+/-)PolγA(+/-) and Lgr5(+/-)PolγA(-/-)  was validated due to their 
accumulation of substantial levels of mitochondrial dysfunction at 11-12 months. 
Mitochondrial dysfunction was assessed via OXPHOS subunit expression levels for 
NDUFB8 (Complex I) and MTCO1 (Complex IV). It was observed that NDUFB8 expression 
was more likely to be lost than MTCO1, indicating its greater susceptibility to random 
mtDNA mutations overtime. Furthermore, it shows that a mosaic pattern of respiratory 
deficiency can result due to mtDNA mutations within ageing tissues. This has also been 
shown within human aged colonic epithelium (Greaves et al., 2010). Therefore, it is 
important to recognise all respiratory complexes when assessing the mitochondrial OXPHOS 
status of individual cells and crypts. 
The double thymidine analogue labelling methodology was able to compare the stem cell and 
stem cell progeny cell turnover times between mouse genotypes and between normal and 
respiratory deficient crypts. The fraction of proliferative cells stayed the same between all 
mouse genotypes and the same is true between normal and respiratory deficient crypts. 
However, there was on average an increased stem cell and stem cell progeny cell turnover 
rate between normal and respiratory deficient crypts due to the increased fraction of 
respiratory deficient stem cells and stem cell progeny incorporating a thymidine analogue 
within a defined time frame. This suggests that mitochondrial dysfunction is increasing the 
rate at which cells are transitioning through the cell cycle. This was more apparent within the 
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Lgr5(+/-)PolγA(-/-) mouse, indicating that stem cells that have endured respiratory deficiency 
for longer are more likely to develop perturbed stem cell dynamics and cell cycle kinetics 
over time. This may mean that respiratory deficient stem cells not only have an advantage to 
expand within the colon, but they may also have an increased rate of cell cycle progression. 
With this, stem cells with mitochondrial dysfunction are more likely to out-compete normal 
stem cells over time. This has implications for cancer development as well. For instance, 
stem cells with mitochondrial dysfunction may have fewer cellular barriers to overcome 
before malignant transformation results, making malignant transformation more likely. 
Furthermore, if malignant transformation does occur within stem cells with mitochondrial 
dysfunction, tumour growth is faster.  
7.3 MODELLING COMBINED EFFECTS 
Results from chapter 6 show that there is a 6-12% increase in the frequency of OXPHOS 
deficient stem cells re-entering the cell cycle compared to OXPHOS normal cells. Within the 
model, this would equate to 5 COX deficient stem cell divisions for every 4 normal stem 
divisions. Model code was developed that allowed this parameter to be entered into the 
model. Results for this are shown in Figure 7-1. 
A combination of small changes in parameter values were simulated within the model. Small 
changes in parameter values included: 2-fold mutation rate increase from 0-80 years, a 3-fold 
COX deficient stem cell division advantage, and a 1.25-fold cell cycle rate increase for COX 
deficient stem cells. The best fit to the biological data was achieved when all three 
perturbations were incorporated into the simulation (Figure 7-1D). 
A better fit to the biological data via this method suggests that ageing is a multi- factorial 
process that cannot be described by one parameter, indicating that a combination of small 
perturbations in cellular homeostasis may be enough to drive the accumulation of 
mitochondrial dysfunction within tissues, contributing to the ageing process.  
  





Figure 7-1 Modelling combined effects within niche succession model 
A parameter scan was conducted with small alterations to the COX deficient stem cell advantages 
and mutation rate increase to simulate the effects of small perturbations to COX deficient stem 
cells. 5000 crypts were simulated, 75% mutated mtDNA conferred COX deficiency to a stem cell. 
5 stem cells were simulated, each with 100 mtDNA molecules present. Asymmetric division 
probability was set to 0.99. A constant de novo mutation rate was set at 2 x 10-4 mutated 
mtDNA/mtDNA replication unless otherwise stated. A division segregation factor was set at 1.03. 
(A) No advantage to COX deficient stem cells. (B) 1.25x increase in COX deficient stem cell 
divisions compared to normal. (C) 1.25x increase in COX deficient stem cell divisions compared 
to normal, plus a 3x increase in COX deficient stem cell divisions occurring symmetrically (2 stem 
cells). (D) The best fit simulation is acquired with a 1.25x increase in COX deficient stem cell 
divisions compared to normal, plus a 3x increase in COX deficient stem cell divisions occurring 
symmetrically (2 stem cells), plus a 2x increase in mutation rate from 0 to 80 years of age. 
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7.4 FUTURE WORK 
As the model of human COX deficiency accumulation suggests there is an advantage for 
stem cells to divide symmetrically (2 stem cells) more often, this should be verified within an 
in vivo animal model. One method of determining division type involves visualising the 
orientation of the mitotic spindle within the stem cell compartment (Quyn et al., 2010). 
Asymmetrically dividing stem cells orient their mitotic spindle perpendicular to the apical 
surface, whilst symmetrically dividing stem cells orient their mitotic spindle parallel to the 
apical surface (Quyn et al., 2010). High resolution multiphoton microscopy was required to 
determine the orientation of the mitotic spindle within dividing colonic stem cells (Quyn et 
al., 2010). Quyn et al showed that precancerous and cancerous tissue from APCMin/- mice lost 
their perpendicular alignment of the mitotic spindle, indicating that symmetric divisions were 
more prevalent (Quyn et al., 2010). Determining whether this is true for colonic stem cells 
with mitochondrial dysfunction would strengthen the link between mitochondrial dysfunction 
and increased probability of malignant transformation, whilst also validating model findings.  
As the work presented as part of this thesis suggests there is an advantage for stem cells with 
mitochondrial dysfunction to out-compete normal stem cells via a cell expansion advantage 
and a reduced cell cycle time, the mechanism by which this is brought about requires further 
investigation. One potential method of identifying this mechanism is by conducting RNA 
sequencing (RNA-seq) on normal and respiratory deficient stem cells (Tang et al., 2009; 
Islam et al., 2011; Hashimshony et al., 2012). RNA-seq uses next generation sequencing 
technology to identify gene expression changes between two samples. In order to do this, 
single Lgr5+ stem cells from Lgr5(+/-) mouse colons would need to be sorted via their innate 
fluorescence using a fluorescently activated cell sorting (FACS) method (Munoz et al., 
2012). Currently, it is not possible to determine the mitochondrial OXPHOS status of a cell 
before it has been FACS sorted, which would have to be done if one wants to compare 
normal versus respiratory deficient stem cells. However, as the majority of colonic stem cells 
from Lgr5(+/-)PolγA(-/-) mice are respiratory deficient (i.e. at least Complex I deficient) (section 
5.4.4) stem cells sorted from Lgr5(+/-)PolγA(-/-) mouse colons can be classed as respiratory 
deficient and stem cells sorted from Lgr5(+/-)PolγA(+/+) mouse colons can be classed as 
normal. Therefore, the differentially expressed genes between normal and respiratory 
deficient cells can be investigated to determine candidate genes that influence cell cycle and 
division characteristics. If mitochondrial dysfunction is conveying an advantage to colonic 
stem cells, understanding the mechanism driving this is extremely important in order to target 
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the cellular pathways responsible. Slowing down the accumulation of mitochondrial 
dysfunction with age could slow down the rate at which tissues acquire dysfunction, which 
may be a key factor for allowing people to live healthier for longer.  
Furthermore, as a dynamic relationship exists between the stem cell niches external 
environment and the stem cells themselves (section 1.8.3), it would also be advantageous to 
determine how ageing and mitochondrial dysfunction within the niche perturbs the actual 
function of normal stem cells, as this may be a contributory factor for cancer initiation and 
disease progression before an observable stem cell phenotype can be observed. 
7.5 FINAL CONCLUSION 
This thesis has provided evidence for mitochondrial dysfunction influencing the stem cell 
dynamics and cell cycle kinetics of mouse and human colonic stem cells. It has also provided 
evidence that there are 5 stem cells within normal human colonic crypts which divide 
asymmetrically the majority of the time under tissue homeostasis. 
Due to the advantage stem cells with mitochondrial dysfunction possess, this significantly 
impacts on the rate at which mitochondrial dysfunction is accumulated within the colonic 
epithelium as a whole. Furthermore, due to this advantage, this may make it more likely for 
malignant transformation to take hold, and allow those stem cells to form tumours at a faster 
rate. This could be via ROS causing nuclear DNA damage, or increased number of cell 
divisions increasing the chance of nuclear DNA mutations. It has previously been suggested 
that tissues with higher number of cell divisions were more likely to develop cancer due to 
increased incorporation of DNA errors (Tomasetti and Vogelstein, 2015). 
Understanding the mechanism by which this advantage acts is of great importance for it to be 
possible to target those cellular pathways responsible. 
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